Passing authentication token to authorize access to rest calls via web sockets

Description

TECHNICAL FIELD

This disclosure relates to the field of clinical messaging, and particularly to techniques for facilitating clinical messaging within and across various network environments.

BACKGROUND

Modern medical care often involves the use of medical infusion pumps to deliver fluids and/or fluid medicine to patients. Infusion pumps permit the controlled delivery of fluids to a patient and provide flexible yet controlled delivery schedules. Infusion pumps can communicate with a server configured to manage the infusion statuses of the individual infusion pumps.

SUMMARY

Various techniques for facilitating communication with and across a clinical environment and a cloud environment are described herein. These techniques may include converting pump messages into standardized dataset messages (also referred to herein simply as “messages”), merging the messages into a cache, transmitting the messages to a cloud server, detecting network outages, clearing an outbound queue, detecting missing messages, authenticating a connectivity adapter for cloud access, providing a segmented data structure, among others. These and other embodiments are described in greater detail below with reference to FIGS. 1-13. Although many of the examples are described in the context of a hospital environment including infusion pumps, the techniques described herein can be applied to any network environment including other medical devices (e.g., patient care monitors configured to display blood pressure, heart rate, blood oxygenation, and the like), or non-medical devices, or any combination thereof.

BRIEF DESCRIPTION OF THE DRAWINGS

The embodiments described herein are illustrated by way of example, and not by way of limitation, in the figures of the accompanying drawings in which like references indicate similar elements.

FIG. 1 is a block diagram of an example clinical environment and an example cloud environment in accordance with aspects of the present disclosure.

FIG. 2 is a block diagram illustrating components of a clinical environment in accordance with aspects of the present disclosure.

FIG. 3 is a schematic diagram illustrating components of an infusion pump and a connectivity adapter of a clinical environment in accordance with aspects of the present disclosure.

FIG. 4 is a block diagram illustrating components of a cloud environment in accordance with aspects of the present disclosure.

FIG. 5 is a schematic diagram illustrating components of a data flow manager of a cloud environment in accordance with aspects of the present disclosure.

FIG. 6 is a flow diagram illustrating an example method for clearing an outbound queue in accordance with aspects of the present disclosure.

FIG. 7 is a flow diagram illustrating an example method for detecting missing messages in accordance with aspects of the present disclosure.

FIG. 8 is a flow diagram illustrating an example method for merging messages into a cache in accordance with aspects of the present disclosure.

FIG. 9 is a flow diagram illustrating an example method for converting a pump message to a standardized dataset message in accordance with aspects of the present disclosure.

FIG. 10 is a schematic diagram illustrating an example method for authenticating a connectivity adapter using an authentication proxy in accordance with aspects of this disclosure.

FIG. 11 is a flow diagram illustrating an example method for authenticating a connectivity adapter using an authentication proxy in accordance with aspects of this disclosure.

FIG. 12 is a block diagram illustrating a segmented data structure in accordance with aspects of the present disclosure.

FIG. 13 is a flow diagram illustrating an example method for moving data nodes in a segmented data structure in accordance with aspects of this disclosure.

DETAILED DESCRIPTION

Overview of Example Network Environment

FIG. 1 illustrates network environment 100 in which clinical environment 102 communicates with cloud environment 106 via network 104. The clinical environment 102 may include one or more healthcare facilities (e.g., hospitals). The components of the clinical environment 102 are described in greater detail below with reference to FIG. 2. The network 104 may be any wired network, wireless network, or combination thereof. In addition, the network 104 may be a personal area network, local area network, wide area network, over-the-air broadcast network (e.g., for radio or television), cable network, satellite network, cellular telephone network, or combination thereof. For example, the network 104 may be a publicly accessible network of linked networks such as the Internet. For example, the clinical environment 102 and the cloud environment 106 may each be implemented on one or more wired and/or wireless private networks, and the network 104 may be a public network (e.g., the Internet) via which the clinical environment 102 and the cloud environment 106 communicate with each other. The cloud environment 106 may be a cloud-based platform configured to communicate with multiple clinical environments. The cloud environment 106 may include a collection of services, which are delivered via the network 104 as web services. The components of the cloud environment 106 are described in greater detail below with reference to FIG. 4.

Components of Clinical Environment

FIG. 2 illustrates the clinical environment 102, which includes one or more clinical IT systems 202, one or more infusion pumps 204, and one or more connectivity adapters 206. Further, the clinical environment 102 may be configured to provide cloud user interfaces 208 (e.g., generated and provided by the cloud environment 106). The clinical IT system 202 may include a hospital infusion system (HIS) designed to manage the facilities' operation, such as medical, administrative, financial, and legal issues and the corresponding processing of services. The HIS can include one or more electronic medical record (EMR) or electronic health record (EHR) systems, as well. The infusion pump 204 is a medical device configured to deliver medication to a patient. The connectivity adapter 206 is a network component configured to communicate with other components of the clinical environment 102 and also communicate with the cloud environment 106 on behalf of the other components of the clinical environment 102. In one embodiment, all messages communicated between the clinical environment 102 and the cloud environment 106 pass through the connectivity adapter 206. In some cases, the connectivity adapter 206 is a network appliance with limited storage space (e.g., memory and/or persistent storage). The cloud user interfaces 208 may be provided to a user in the clinical environment 102 via a browser application, desktop application, mobile application, and the like. The user may access status reports and other data stored in the cloud environment 106 via the cloud user interfaces 208.

The components 202-208 illustrated in FIG. 2 may communicate with one or more of the other components in the clinical environment 102. For example, each of the clinical IT system 202 and the infusion pump 204 may communicate with the connectivity adapter 206 via physical local area network (LAN) and/or virtual LAN (VLAN). Although not shown in FIG. 2, the clinical environment 102 may include other medical devices and non-medical devices that facilitate the operation of the clinical environment 102.

Overview of Messaging in the Clinical Environment

FIG. 3 illustrates the messages received, stored, and transmitted by the connectivity adapter 206 in the clinical environment 102. As shown in FIG. 3, the infusion pump 204 may include motor controller unit (MCU) 204A and communications engine (CE) 204B. Although not shown in FIG. 3, the infusion pump 204 may include one or more memories and storage media configured to store various instructions, parameters, and/or messages. The connectivity adapter 206 may include transformation worker 206A, device status manager 206B, cache 206C, and outbound queue 206D. The MCU 204A may generate and send messages to the CE 204B for storage and transmission to the connectivity adapter 206. In some cases, the messages are each associated with a message identifier (ID). In some embodiments, the MCU 204A is a very small processor (e.g., 12 Mhz) and the CE 204B is a more powerful processor (e.g., 400 Mhz). Pump messages sent to the connectivity adapter 206 generated by the MCU 204A may be transformed into a standardized dataset message (e.g., message format used by the connectivity adapter 206 to communicate with the cloud environment 106, also referred to herein simply as “messages”). In some embodiments, the standardized dataset format may allow multiple messages to be merged into a single standard dataset message that includes all the information included in the multiple messages. For example, a pump message that indicates the start of an infusion and another pump message that indicates the presence of an air-in-line alarm may occupy different locations within the standardized dataset message. Even though the start-of-infusion message was generated long before the air-in-line-alert message, they may be transmitted together packaged in the standardized dataset message without having to worry about having incomplete information about the infusion pump 204 at any given moment or having to request older messages that have been lost or become unavailable. The device status manager 206B processes the transformed messages provided by the transformation worker 206A and merges the data included in the transformed messages into the cache 206C, which represents the current state of the infusion pump 204. For example, the cache 206C may include all of the current parameter values (or to the extent available to the connectivity adapter 206) at the infusion pumps connected to the connectivity adapter 206 (e.g., power status, infusion status, battery status, network status, infusion start time, volume to be infused, volume infused, dose, and the like). Although not shown in FIG. 3, the clinical IT system 202 may maintain the identities of the patients assigned to the individual infusion pumps 204 and other data that the connectivity adapter 206 may utilize in order to merge the messages from the pump into the cache 206C. For example, the client IT system 202 may send instructions for programming the infusion pump 204 for initiating an infusion on a patient, and the instructions may include identifiers such as an infusion ID and a patient ID. Upon receiving a pump message containing the infusion ID, the connectivity adapter 206 can use the infusion ID to determine that the pump message relates to the patient having the patient ID (even when the pump message does not include the patient ID) based on the prior instructions received from the client IT system 202. The connectivity adapter 206 can then add the information included in the pump message to the cache 206C along with the patient ID.

The device status manager 206B also sends the transformed messages to the outbound queue 206D for transmission to the cloud environment 106. The messages stored in the outbound queue 206D may be associated with one or more message IDs. For example, a message can be associated with a single message ID corresponding to the original pump message. In another example, a message can include data from multiple pump messages and therefore include multiple message IDs. The messages transmitted from the outbound queue 206D to the cloud environment 106 may be stored in the cloud environment 106 for providing reports and other data to a client (e.g., via the cloud user interfaces 208) and/or for compliance purposes. Additional details regarding the messaging in the clinical environment 102 are provided below.

Components of Cloud Environment

FIG. 4 illustrates the cloud environment 106, which includes drug library manager (DLM) 402, report manager 404, device manager 406, data flow manager (DFM) 408, cloud manager (CM) 410, data analyzer (DA) 412, and database 414.

The DLM 402 may provide a set of features and functions involved in the creation and management of drug libraries for use with infusion pumps. These drug libraries may provide user-defined settings for pump configuration and drug infusion error reduction.

The report manager 404 may provide various reporting capabilities for clinically relevant infusion data which users can choose to use for further analysis, such as tracking and trending of clinical practices.

The device manager 406 may oversee and manage the maintenance of infusion pumps, providing users the capability to view and manage asset and operational data. For example, the device manager 406 may schedule drug library and software updates for infusion pumps.

The DFM 408 may facilitate storing, caching, and routing of data between compatible infusion pumps 204, connectivity adapters 206, cloud services (e.g., infusion pump management software including modules 402-414 of FIG. 4), and external systems. For example, the DFM may store infusion and operational data received from infusion pumps, store and cache infusion pump drug libraries and software images, convert and route network messaging between the cloud environment 106 and the clinical environment 102, convert and route medication order information from a hospital information system to an infusion pump (e.g., auto-programming or smart-pump programming), and/or convert and route alert information and infusion events from infusion pumps to hospital information systems (e.g., alarm/alert forwarding, and auto-documentation, or infusion documentation).

The CM 410 may serve as a general-purpose computing platform for the other modules illustrated in FIG. 4. Functionally, the CM 410 may be similar to Microsoft Windows® or Linux® operating systems as it provides the following services: networking, computation, user administration and security, storage, and monitoring.

The DA 412 may provide data analytics tools for generating user interfaces and reports based on the data generated and/or received by the other modules illustrated in FIG. 4.

The database 414 may store data generated and/or received by the modules 402-412 of the cloud environment 106. Although not illustrated in FIG. 4, the cloud environment may provide other resources such as processors, memory, disk space, network, etc. The modules 402-412 may be hardware components configured to perform one or more of the techniques described herein. Alternatively, the modules 402-412 may be implemented using software instructions stored in physical storage and executed by one or more processors. Although illustrated as separate components, the modules 402-412 may be implemented as one or more hardware components (e.g., a single component, individual components, or any number of components), one or more software components (e.g., a single component, individual components, or any number of components), or any combination thereof.

In some embodiments, the cloud environment 106 can be implemented using a commercial cloud services provider (e.g., Amazon Web Services®, Microsoft Azure®, Google Cloud®, and the like). In other embodiments, the cloud environment can be implemented using network infrastructure managed by the provider and/or developer of the modules 402-412 shown in FIG. 4. In some embodiments, the features and services provided by one or more of the modules 402-412 may be implemented on one or more hardware computing devices as web services consumable via one or more communication networks. In further embodiments, one or more of the modules 402-412 are provided by one or more virtual machines implemented in a hosted computing environment. The hosted computing environment may include one or more rapidly provisioned and released computing resources, such as computing devices, networking devices, and/or storage devices.

Overview of Messaging in the Cloud Environment

FIG. 5 illustrates the messages received, stored, and transmitted by the cloud environment 106. As shown in FIG. 5, the DFM 408 may include cache 408A and outbound queue 408B. The cache 408A may store the current state of the infusion pump 204. For example, the cache 408A may include all of the current parameter values (or to the extent available to the DFM 408) at the infusion pump 204 (e.g., power status, infusion status, battery status, network status, infusion start time, volume to be infused, volume infused, dose, and the like). In some cases, the current state stored in the cache 408A is identical to the current state stored in the cache 206C. In other cases, the current state stored in the cache 408A includes additional information not stored in the cache 206C, or vice versa. For example, the DFM 408 may have access to data sources not accessible (or readily accessible) by the connectivity adapter 206, and the DFM 408 may have obtained additional data prior to merging the message and the additional data into the cache 408A. In another example, due to a network outage, the connectivity adapter 206 may have been able to update its own cache 206C but unable to transmit the relevant messages to the DFM 408. In such a case, the cloud cache 408A may include less information than the connectivity adapter cache 206C. The outbound queue 408B may include messages to be transmitted to the clinical environment 102. For example, the outbound queue 408B can include command messages (e.g., instructions to update the security settings on the connectivity adapter 206), request messages (e.g., requests for missing messages for logging purposes), etc. In other examples, the outbound queue 408B may include log requests, drug library updates, software updates, security updates, and the like. In some embodiments, the items in the outbound queue 408B are less time-sensitive than the items in the outbound queue 206D. The process of detecting and requesting missing messages from the clinical environment 102 is described in greater detail below with reference to FIG. 7. In some cases, the data stored in the cache 408A may be copied or moved to the database 414.

Generation and Transmission of Pump Messages

Referring back to FIG. 3, when there is an event at the infusion pump 204 (e.g., the device has been powered on, infusion has been started or finished, an alarm condition has been satisfied, etc.), the MCU 204A generates a message indicative of such an event and transmits the message to the CE 204B. Upon receiving one or more messages from the MCU 204A, the CE 204B packages the messages received so far into a pump message (e.g., according to a protocol specific to the infusion pump 204) and transmits the pump message to the connectivity adapter 206. For example, if multiple messages have been received from the MCU 204A since the most recent pump message transmitted to the connectivity adapter 206, the CE 204B may merge the information included in the multiple messages into a single pump message in accordance with the pump protocol. The pump message transmitted to the connectivity adapter 206 may be reflective of the current state of the infusion pump 204 at the time the pump message is transmitted to the connectivity adapter 206. In some embodiments, the infusion pumps 204 do not have Internet access and communicate only with the connectivity adapter 206 (e.g., to ensure that Internet connection is not needed for any clinical operations). In other embodiments, the infusion pumps 204 may communicate with network entities other than the connectivity adapter 206 (e.g., the cloud environment 106 via the Internet).

The infusion pump 204 may store its current and prior states (e.g., days, months, or years of messages received from the MCU 204A or transmitted by the CE 204B) in data store (not shown) located within the infusion pump 204. As discussed further below, the connectivity adapter 206 may process requests from the DFM 408 for pump messages. For example, the DFM 408 may request messages from the infusion pump 204 when the DFM 408 realizes that it is missing one or more pump message. Pump messages can be missed by the DFM 408 during network outages, or other disruptions to network traffic. In such situations, as will be discussed in greater detail below, the DFM 408 can request the missing pump messages from the connectivity adapter 206. The messages from the infusion pump 204 may include one or more parameters. Some of those parameters may be data fields that are overwritten as the parameters are updated. Other parameters are linked lists that include a sequence of past parameter values. For example, fields may be used for statuses such as power status, infusion status, and the like, and linked lists may be used for alerts, ruleset violations, and the like.

Connecting Infusion Pumps to Connectivity Adapter

In the event that the connection between the infusion pump 204 and the connectivity adapter 206 is terminated or otherwise unavailable, the MCU 204A may continue to generate messages and the CE 204B may continue to merge such additional messages into the most current state of the infusion pump 204. Once the connection between the infusion pump 204 and the connectivity adapter 206 is re-established, the CE 204B may transmit a single pump message (or multiple pump messages) that reflects all of the messages received from the MCU 204A during the time of lost connectivity. For example, if the CE 204B, during the time of lost connectivity, received a message that indicates that the power status changed to “on” and subsequently received another message that indicates that the infusion status changed to “on,” the CE 204B may generate a pump message that has two key-value pairs, “power status=on” and “infusion status=on.” In other cases, these messages may be transmitted to the connectivity adapter 206 as separate pump messages.

In some embodiments, when the infusion pump 204 is turned on after being off for a period of time, or upon the connection between the infusion pump 204 and the connectivity adapter 206 being re-established, the infusion pump 204 sends all of the available, unsent messages or data to the connectivity adapter 206. In some cases, such an approach may overload the internal network of the clinical environment 102 (e.g., if 500 infusion pumps 204 came back online after being offline for weeks). Thus, in some cases, the connectivity adapter 206 may deliberately reject such pump messages to reduce the network load, and have the infusion pumps 204 re-send the pump messages at a later time. The infusion pumps 204 may adopt a schedule for re-sending rejected pump messages that further reduces the network load (e.g., exponential back-offs where each retry is performed after a longer wait period, randomization where the back-offs are not strictly exponential and include random temporal variations, a combination of exponential back-offs and randomization, etc.).

By analyzing the pump messages received from the infusion pump 204, the connectivity adapter 206 may determine that it has missed one or more messages that it should have received (e.g., due to older data being overwritten in the pump message). For example, if the connectivity adapter 206 receives a pump message that indicates that the power state of the infusion pump 204 has gone from “sleep” to “on,” where the information in the cache 206C indicates that the most recent power state of the infusion pump 204 was “on.” By comparing the pump message and the information in the cache 206C, the connectivity adapter 206 can determine that it must have missed a pump message that indicates that the power state of the infusion pump 204 was changed from “on” to “sleep.” In some cases, the connectivity adapter 206 requests these missing messages from the infusion pump 204 immediately. In other cases, the connectivity adapter 206 requests these missing messages at a later time (e.g., when the network activity is light or below a threshold). In some cases, the connectivity adapter 206 determines missing pump messages based on message IDs that are not in sequence. For example, pump messages may include message IDs that are sequential (such that one pump message generated immediately subsequently to another pump message has a message ID that immediately follows the message ID of said another message in a predetermined sequence of numbers or identifiers). In such a case, upon processing pump messages having message IDs 100050 and 100055 in a row, the connectivity adapter 206 may determine that pump messages having message IDs 100051-100054 were deleted, overwritten, or lost.

Transformation of Pump Messages

The transformation worker 206A receives the pump messages and converts it to a standardized message format (e.g., standardized dataset messages used for transmitting information within and across the clinical environment 102 and the cloud environment 106). In some embodiments, the standardized dataset message can be a collection or envelope of messages that are each a key-value pair. For example, the standardized dataset message may include one key-value pair that says “message ID=100015,” another key-value pair that says “power status=on,” and another key-value pair that says “volume to be infused=5 mL.” In some cases, the standardized dataset message may include one or more keys having no value or having default values (e.g., “alarm count=0,” or “battery status=unknown”). Depending on the pump protocol associated with the pump message, the same information may be located in different parts of the pump message. The transformation worker 206A identifies the data included in the pump messages based on the pump protocol and places the data into the appropriate locations of a standardized dataset message. For example, based on the pump protocol, the transformation worker 206A extracts the power state of the infusion pump 204 and places the power state information in the standardized dataset message, which also includes information other than the power state. For example, all parameters or key-value pairs in the standardized dataset message other than those specified by the pump message may be set to default values. In some cases, such parameters or key-value pairs are left blank. Similarly, when requests are sent to the infusion pump 204, the transformation worker 206A transforms the standardized dataset message into a pump message understood by the infusion pump 204. In some embodiments, the transformation worker 206A may be implemented using a ruleset engine. In one embodiment, using a ruleset engine advantageously does not require the transformation worker 206A to be rebooted when a new infusion pump or a new pump protocol is added. For example, the ability to be able to translate pump messages in a new pump protocol can be implemented as a configuration file that can be added to the connectivity adapter 206, where the configuration file allows the transformation worker 206A to be able to receive and process pump messages in the new pump protocol. Once the configuration file is added to the connectivity adapter 206, the transformation worker 206A can begin transforming such pump messages into the standardized dataset messages for further processing by the device status manager 206B. In some cases, if the transformation worker 206A does not recognize a pump message or the protocol used by the pump message or otherwise cannot process the pump message, the transformation worker 206A stores the pump message in the connectivity adapter 206 and transforms the pump message upon the transformation mapping for the pump protocol becoming available.

The transformation worker 206A may further include hints in the header of the standardized dataset message. The hints indicate to the device status manager 206B which portions of the standardized dataset message contain new information and should thus be accessed by the device status manager 206B and merged into the cache 206C. Based on the hints, the device status manager 206B can refrain from having to process the entire standardized dataset message generated by the transformation worker 206A. For example, the standardized dataset message may have a hierarchical tree structure having five categories of pump parameters, where each category includes multiple pump parameters or sub-categories having multiple parameters. If only a parameter in one of the categories includes new information, the transformation worker 206A may set a binary flag associated with that category to 1 and the binary flags associated with the remaining categories to 0 to indicate that the four categories do not include any new information. A given standardized dataset message may include a single hint indicating the location of the single piece of new information. Alternatively, the standardized dataset message may include multiple hints indicating the multiple locations where new information is provided.

Caching in Connectivity Adapter

The device status manager 206B takes the message received from the transformation worker 206A and “merges” the message into the cache 206C. Merging a message into the cache may include updating the data stored in the cache 206C based on the information included in the message. In some cases, the message may include information that prompts the device status manager 206B to access additional information from other databases or sources and adding such additional information to the cache 206C. For example, based on the infusion ID provided in the message, the device status manager 206B may access the identity of the patient associated with the infusion pump having the infusion ID and store that information in the cache 206C. As another example, the device status manager 206B may access the clinical IT system 202 or the cloud environment 106 for additional information that can be stored in the cache 206C. Accordingly, information from multiple data sources may be merged into the cache 206C in response to the pump messages received from the infusion pump 204. In yet another example, in the event that the information needed by the device status manager 206B is in the cloud environment 106 (e.g., the pump message references a drug library that is not yet stored in the clinical environment 102), the device status manager 206B merges the message into the cache 206C and places the message in the outbound queue 206D without accessing the cloud environment 106 (e.g., to make the message more complete based on the information in the cloud environment 106). In such a case, the DFM 408 may, upon receiving the message, access the necessary information, fill in the missing information in the message, and merge the message into the cache 408A. In some cases, the device status manager 206B may add information to the message (e.g., facility ID, account ID, etc.) before (or after) merging the message into the cache 206C.

The cache 206C may store the current state of the individual infusion pumps 204 configured to communicate with the connectivity adapter 206. As additional messages are received from the infusion pumps 204, the device status manager 206B updates the current state stored in the cache 206C to reflect the changes made by the messages from the infusion pumps 204. In some embodiments, the device status manager 206B determines whether the message received from the transformation worker 206A is a live message or an historical message. A live message includes messages that are transmitted to the connectivity adapter 206 based on a new event at the infusion pump 204. An historical message includes messages that are transmitted to the connectivity adapter 206 based on a prior event at the infusion pump 204. Historical messages may be transmitted at the request of the connectivity adapter 206. The device status manager 206B is configured to merge the message into the cache 206C upon determining that the message is a live message (and alternatively, refrain from merging the message into the cache 206C upon determining that the message is an historical message). The cache 206C may be implemented using an in-memory cache (e.g., Redis) or other storage devices.

In some cases, the messages sent to the cloud environment 106 are copies of the current state of the infusion pump 204 stored in the cache 206C at the time the messages are sent to the cloud environment 106. In other cases, the messages sent to the cloud environment 106 may not include all the parameters included in the current state of the infusion pump 204 stored in the cache 206C. For example, the messages sent to the cloud environment 106 only includes information that might not be stored in the cloud environment 106. In some cases, the device status manager 206B does not include in the message transmitted to the cloud environment 106 at least some of the information in the cache 206C if such information is otherwise available to the cloud environment 106. In another example, the message may include a log request, which is not intended to reflect the current state of an infusion pump. Such a log request may include a flag that indicates that the message is a log request and a parameter identifying the requested information.

Outbound Queues

Once a message has been merged into the cache 206C, the device status manager 206B adds the message to the outbound queue 206D for transmission to the cloud environment 106. In some embodiments, the device status manager adds the message to the outbound queue 206D regardless of whether the connectivity adapter 206 is connected to the cloud environment 106. The connectivity adapter 206 may include a separate outbound queue for transmitting messages to the clinical IT system 202.

The connectivity adapter 206 may include a service that picks up the messages stored in the outbound queue 206D and tries to route them to the appropriate endpoints. Such a service may determine whether the connectivity adapter 206 is connected to the cloud environment 106 or not. As will be further described below, such a service may determine whether the messages in the outbound queue 206D should be kept in the outbound queue 206D or removed from the outbound queue 206D.

Network Outages

The clinical environment 102 may be designed such that clinical functions of the clinical environment 102 continue to operate normally even during Internet outages or loss of connectivity to the cloud environment 106. Thus, in some embodiments, clinical functions do not rely on connectivity to the cloud environment 106 or information to be requested and received from the cloud environment 106. However, in some cases, the messages stored in the outbound queue 206D may be held in the outbound queue 206D (e.g., in the event of network jitter or momentary loss of connection) or removed from the outbound queue 206D (e.g., in the event of prolonged outage or after the outbound queue 206D becomes full) during an Internet or network outage.

For example, upon determining that the connection to the cloud environment 106 has been terminated or otherwise become unavailable, the connectivity adapter 206 may determine whether the outbound queue 206D includes any messages to be transmitted to the cloud environment 106 and discard one or more of the messages from the outbound queue 206D. For example, in the event of a prolonged outage, there may be a large number of messages in the outbound queue 206D, which may overload the network. For example, the large number of messages in the outbound queue 206D may delay transmission of time-sensitive alerts and may even include messages that are no longer relevant due to the length of the network outage. To prevent such issues, some of the messages in the outbound queue 206D may be removed without transmitting them to the cloud environment 106. In such cases, the cloud environment 106 will request those “missing” messages at a later time. In some embodiments, the messages in the outbound queue are discarded based on time (e.g., after being in the outbound queue for a specific amount of time). Alternatively, the determination of whether to discard one or more messages may be based on the size of the outbound queue. For example, the outbound queue may be fixed in size, and the oldest message is discarded upon a new message being added to the outbound queue that is full. For example, the messages may be discarded based on a first-in first-out (FIFO) manner. In some cases, the connectivity adapter 206 starts removing messages from the outbound queue 206D only after the outbound queue 206D reaches a threshold message size.

Outbound Queue Clearing Method

With reference now to FIG. 6, an example outbound queue clearing method 600 will be described. Since the connectivity adapter 206 does not have unlimited resources, during a network outage, the connectivity adapter 206 cannot let unsent messages pile up in the outbound queue 206D indefinitely. Further, as discussed above, having to send old messages that have been in the outbound queue 206D for a long time and no longer relevant may reduce network performance and interfere with transmission of messages that are more relevant. The example method 600 may be carried out, for example, by the connectivity adapter 206 of FIG. 3 (or one or more components thereof). The method 600 illustrates an example algorithm that may be programmed, using any suitable programming environment or language, to create machine code capable of execution by a CPU or microcontroller. Various embodiments may be coded using assembly, C, OBJECTIVE-C, C++, JAVA, or other human-readable languages and then compiled, assembled, or otherwise transformed into machine code that can be loaded into read-only memory (ROM), erasable programmable read-only memory (EPROM), or other recordable memory that is coupled to the CPU or microcontroller and then executed by the CPU or microcontroller. For example, when the method 600 is initiated, a set of executable program instructions stored on one or more non-transitory computer-readable media (e.g., hard drive, flash memory, removable media, etc.) may be loaded into memory (e.g., random access memory or “RAM”) of a computing device of the clinical environment 102 and/or the cloud environment 106. The executable instructions may then be executed by a hardware-based computer processor (e.g., a central processing unit or “CPU”) of the computing device. In some embodiments, the method 600 or portions thereof may be implemented on multiple processors, serially or in parallel. For convenience, the steps of the example method 600 are described as being performed by the connectivity adapter 206.

At block 602, the connectivity adapter 206 transmits one or more messages to the cloud environment 106. As discussed above, the transmitted messages may be processed by the DFM 408 in the cloud environment 106 and merged into the cloud cache 408A.

At block 604, the connectivity adapter 206 detects a network outage. For example, the connectivity adapter 206 may detect the outage based on not having received during a specific time window an acknowledgement of receipt of a message transmitted to the cloud environment 106. In some other cases, the connectivity adapter 206 may detect the outage based on its ping receiver not receiving any pings from the cloud environment 106 during a specific time window. In yet other cases, the connectivity adapter 206 may detect the outage based on receiving a message that the connection to the cloud environment 106 has been terminated. In some cases, the connectivity adapter 206 does not determine whether there is a network outage and tries to transmit a given message to the cloud environment 106 until an acknowledgement signal is received for the receipt of the given message. In such cases, the given message may remain in the outbound queue 206D until the message is successfully transmitted to the cloud environment 106 or otherwise removed from the outbound queue 206D (e.g., as discussed with reference to block 606).

At block 606, the connectivity adapter 206 clears stale messages from the outbound queue 206D. For example, stale messages may include messages associated with a pump event that is older than a threshold amount of time. In another example, stale messages may include messages that have been in the outbound queue 206D for more than a threshold amount of time. In some cases, the threshold amount of time may be pump-specific or pump-event-type-specific. For example, time-sensitive events may have a shorter threshold amount of time. In yet another example, a stale message may include a message that has been in the outbound queue 206D for the longest period of time (e.g., first in). In some cases, the connectivity adapter 206 may not clear or remove messages from the outbound queue 206D unless the outbound queue 206D is full.

At block 608, the connectivity adapter 206 determines whether the connectivity adapter 206 is connected to the cloud environment 106. Upon determining that the connectivity adapter 206 is not connected to the cloud environment 106, the connectivity adapter 206 proceeds to block 606 to clear any stale messages in the outbound queue 206D. Upon determining that the connectivity adapter 206 is connected to the cloud environment 106, the connectivity adapter 206 proceeds to block 610.

At block 610, the connectivity adapter 206 transmits any remaining messages received during the network outage and still stored in the outbound queue 206D (e.g., not deleted as stale).

In the method 600, one or more of the blocks shown in FIG. 6 may be removed (e.g., not performed) and/or the order in which the method 600 is performed may be switched. In some embodiments, additional blocks may be added to the method 600. The embodiments of the present disclosure are not limited to or by the example shown in FIG. 6, and other variations may be implemented without departing from the spirit of this disclosure.

Missing Messages

In some embodiments, each message generated by the MCU 204A is associated with a unique message ID. In other embodiments, each pump message generated by the CE 204B is associated with a unique message ID. In yet other embodiments, each standardized dataset message generated by the transformation worker is associated with a unique message ID. These message IDs may follow a predetermined sequence, and based on one or more combinations of these message IDs, the DFM 408 processing the messages from the connectivity adapter 206 may determine whether one or more messages are missing (e.g., have been generated but not received by the DFM 408). For example, upon determining that a message having a message ID of 10010 was immediately followed by a message having a message ID of 10016, the DFM 408 may determine that messages having message IDs 10011-10015 were not received and therefore missing. In some cases, the DFM 408 may be aware of periodic or scheduled messages expected to be received from the connectivity adapter 206. Upon determining that such messages were not received according to the schedule, the DFM 408 may request such messages from the connectivity adapter 206.

Upon determining that the DFM 408 is missing one or more events or messages, the DFM 408 may generate a request for such messages and store the request in the outbound queue 408B for transmission to the connectivity adapter 206. In some embodiments, the request is in the standardized dataset format and includes a flag having a value indicating that the request is a log retrieval request and not live data. A single log retrieval request may identify multiple messages to be requested from the infusion pump 204. Upon receiving the log retrieval requests from the cloud environment 106, the connectivity adapter 206 may transform the requests to one or more messages in the pump protocol and send to the infusion pump 204. Alternatively, the connectivity adapter 206 may throttle the requests based on the network load or condition of the clinical environment 102.

Missing Message Detection Method

With reference now to FIG. 7, an example missing message detection method 700 will be described. The example method 700 may be carried out, for example, by the DFM 408 of FIG. 5 (or one or more components thereof). The method 700 illustrates an example algorithm that may be programmed, using any suitable programming environment or language, to create machine code capable of execution by a CPU or microcontroller. Various embodiments may be coded using assembly, C, OBJECTIVE-C, C++, JAVA, or other human-readable languages and then compiled, assembled, or otherwise transformed into machine code that can be loaded into read-only memory (ROM), erasable programmable read-only memory (EPROM), or other recordable memory that is coupled to the CPU or microcontroller and then executed by the CPU or microcontroller. For example, when the method 700 is initiated, a set of executable program instructions stored on one or more non-transitory computer-readable media (e.g., hard drive, flash memory, removable media, etc.) may be loaded into memory (e.g., random access memory or “RAM”) of a computing device of the clinical environment 102 and/or the cloud environment 106. The executable instructions may then be executed by a hardware-based computer processor (e.g., a central processing unit or “CPU”) of the computing device. In some embodiments, the method 700 or portions thereof may be implemented on multiple processors, serially or in parallel. For convenience, the steps of the example method 700 are described as being performed by the DFM 408.

At block 702, the DFM 408 receives messages from the connectivity adapter 206. As discussed above, the messages may reflect the current state of the infusion pumps 204 connected to the connectivity adapter 206 and may be in the standardized dataset format.

At block 704, the DFM 408 detects missing messages. For example, the DFM 408 may detect one or more missing messages based on missing message IDs (i.e. after receiving a message with a message ID that does not immediately follow the message ID of the immediately prior message).

At block 706, the DFM 408 generates a request for the missing messages for transmission to the connectivity adapter 206. For example, the DFM 408 may wait until the number of missing messages reaches a threshold number (e.g., for a single pump or for a single connectivity adapter), and request the missing messages in bulk (e.g., under a single request). The generated request may be added to the outbound queue 408B.

At block 708, the DFM 408 transmits the request to the connectivity adapter 206. Upon receiving the request, the connectivity adapter 206 may generate a corresponding request for the requested messages for transmission to the infusion pump 204.

In the method 700, one or more of the blocks shown in FIG. 7 may be removed (e.g., not performed) and/or the order in which the method 700 is performed may be switched. In some embodiments, additional blocks may be added to the method 700. The embodiments of the present disclosure are not limited to or by the example shown in FIG. 7, and other variations may be implemented without departing from the spirit of this disclosure.

Merging Messages into Cloud Cache

The DFM 408 may merge the messages received from the connectivity adapter 206 into the cache 408A. In some cases, the DFM 408 merges a message into the cache 408A upon determining that the current time is within a threshold time period from the time associated with the message. For example, the DFM 408 may determine that a message associated with an alert generated 5 hours ago was received too late for the message to be merged into the cache 408A and refrain from merging the message into the cache 408A. In some embodiments, all data stored in the cloud cache 408A are received from the connectivity adapter 206, and the cloud cache 408A does not include any data that is not in the connectivity adapter 206 or was not previously processed by the connectivity adapter 206. In other embodiments, the cloud cache 408A stores drug library information, software update information, and the like that may not be in the connectivity adapter cache 206C. In some embodiments, the DFM 408 pre-processes a portion of the data stored in the cache 408A and/or pre-generates user interface data that may be requested by the clinical environment 102 and stores them in the cache 408A for faster access.

Message Merging and Caching Method

With reference now to FIG. 8, an example message merging and caching method 800 will be described. The example method 800 may be carried out, for example, by the DFM 408 of FIG. 5 (or one or more components thereof). The method 800 illustrates an example algorithm that may be programmed, using any suitable programming environment or language, to create machine code capable of execution by a CPU or microcontroller. Various embodiments may be coded using assembly, C, OBJECTIVE-C, C++, JAVA, or other human-readable languages and then compiled, assembled, or otherwise transformed into machine code that can be loaded into read-only memory (ROM), erasable programmable read-only memory (EPROM), or other recordable memory that is coupled to the CPU or microcontroller and then executed by the CPU or microcontroller. For example, when the method 800 is initiated, a set of executable program instructions stored on one or more non-transitory computer-readable media (e.g., hard drive, flash memory, removable media, etc.) may be loaded into memory (e.g., random access memory or “RAM”) of a computing device of the clinical environment 102 and/or the cloud environment 106. The executable instructions may then be executed by a hardware-based computer processor (e.g., a central processing unit or “CPU”) of the computing device. In some embodiments, the method 800 or portions thereof may be implemented on multiple processors, serially or in parallel. For convenience, the steps of the example method 800 are described as being performed by the DFM 408.

At block 802, the DFM 408 receives a message from the connectivity adapter 206. As discussed above, the message may reflect the current state of the infusion pump 204 connected to the connectivity adapter 206 and may be in the standardized dataset format.

At block 804, the DFM 408 merges the message into the cache 408A. In some cases, the DFM 408 determines whether the message is relevant to any potential UI generation requests (e.g., may be used to generate a UI provided to the clinical environment 102). Based on determining that the message is relevant to a potential UI generation request, the DFM 408 may merge the message into the cache 408A. Alternatively, based on determining that the message is not relevant to a potential UI generation request, the DFM 408 may refrain from merging the message into the cache 408A and merge the message into a database (e.g., database 414). In other embodiments, the DFM 408 may merge the message into the cache 408A, and remove the information included in the message from the cache 408A to the database 414 based on a determination that the message is not relevant to a potential UI generation request (e.g., after a specific time window).

At block 806, the DFM 408 receives a request to generate a user interface (e.g., from the clinical environment 102). The user interface data to be generated may be based on information previously provided by the connectivity adapter 206 (e.g., pump status, infusion status, power status, etc.).

At block 808, the DFM 408 accesses the cache 408A for information to be used for generating the user interface. For example, the information may include the current state of a single infusion pump, multiple infusion pumps in communication with a single connectivity adapter at a single facility, multiple infusion pumps in communication with multiple connectivity adapters at a single facility, multiple infusion pumps at multiple facilities, or any combination thereof.

At block 810, the DFM 408 provides the information accessed from the cache 408A to other services such as the report manager 404 or the device manager 406. Such services may generate the user interface and transmit the generated user interface to the clinical environment 102 (e.g., for presentation via the cloud user interface 208). In some cases, the requested user interface data are pre-generated by such services and stored in the cache 408A. In such cases, the such services can simply access and transmit the user interface data stored in the cache 408A to the clinical environment 102 or update the user interface data stored in the cache 408A before transmitting them to the clinical environment 102.

In the method 800, one or more of the blocks shown in FIG. 8 may be removed (e.g., not performed) and/or the order in which the method 800 is performed may be switched. In some embodiments, additional blocks may be added to the method 800. The embodiments of the present disclosure are not limited to or by the example shown in FIG. 8, and other variations may be implemented without departing from the spirit of this disclosure.

Pump Message Conversion Method

With reference now to FIG. 9, an example pump message conversion method 900 connectivity adapter 206 of FIG. 3 (or one or more components thereof). The method 900 illustrates an example algorithm that may be programmed, using any suitable programming environment or language, to create machine code capable of execution by a CPU or microcontroller of the connectivity adapter 206. Various embodiments may be coded using assembly, C, OBJECTIVE-C, C++, JAVA, or other human-readable languages and then compiled, assembled, or otherwise transformed into machine code that can be loaded into read-only memory (ROM), erasable programmable read-only memory (EPROM), or other recordable memory of connectivity adapter 206 that is coupled to the CPU or microcontroller and then executed by the CPU or microcontroller. For example, when the method 900 is initiated, a set of executable program instructions stored on one or more non-transitory computer-readable media (e.g., hard drive, flash memory, removable media, etc.) may be loaded into memory (e.g., random access memory or “RAM”) of a computing device of the clinical environment 102 and/or the cloud environment 106. The executable instructions may then be executed by a hardware-based computer processor (e.g., a central processing unit or “CPU”) of the computing device. In some embodiments, the method 900 or portions thereof may be implemented on multiple processors, serially or in parallel. For convenience, the steps of the example method 900 are described as being performed by the transformation worker 206A.

At block 902, the transformation worker 206A detects a new type of infusion pump that uses a new pump protocol. For example, the transformation worker 206A may check the device ID or protocol ID associated with the infusion pump and determine that the device ID or protocol ID does not match a predetermined list of device IDs or protocol IDs.

At block 904, the transformation worker 206A generates a connector (e.g., a software module or a set of computer executable instructions) for converting messages in the new pump protocol to the standardized dataset messages. For example, the transformation worker 206A may download a new configuration file that can be used to implement the connector from the cloud environment 106. Alternatively, the transformation worker 206A may access the parameters included in a message in the new pump protocol and compare the parameters to the parameters in a standardized dataset message to generate a mapping between the two sets of parameters.

At block 906, the transformation worker 206A adds the connector between one or more infusion pumps using the new pump protocol. For example, the transformation worker 206A may add the protocol ID to the list of mappings that the transformation worker 206A is configured to perform. The transformation worker 206A may add the protocol ID to the list of mappings that the transformation worker 206A checks for upon receiving a pump message.

At block 908, the transformation worker 206A converts a message from the infusion pump using the new pump protocol to a standardized dataset message using the connector.

At block 910, the transformation worker 206A processes the converted message. For example, the transformation worker 206A may send the message to the device status manager 206B to be merged into the cache 206C and/or added to the outbound queue 206D.

In the method 900, one or more of the blocks shown in FIG. 9 may be removed (e.g., not performed) and/or the order in which the method 900 is performed may be switched. In some embodiments, additional blocks may be added to the method 900. The embodiments of the present disclosure are not limited to or by the example shown in FIG. 9, and other variations may be implemented without departing from the spirit of this disclosure.

Cloud Authentication via Proxy

FIG. 10 illustrates a computing environment 1000 including user device 1002, the clinical environment 102 including the connectivity adapter 206, and the cloud environment 106 including authentication system 1004 and authentication proxy 1006. As shown in FIG. 10, the authentication system 1004 may be configured to authenticate users based on login requests from the user devices 1002, and provide cloud services to user devices 1002 that are successfully authenticated. In such cases, the user device 1002 may own user accounts created by the authentication system 1004 and provide the login credentials for the user accounts each time accessing the cloud services provided by the cloud environment 106.

In some cases, the connectivity adapter 206 may be a network appliance and may lack the capability of managing and maintaining its own user account. In such cases, the connectivity adapter 206 may send an authentication request to the authentication proxy 1006 (e.g., via a connection such as a secured and authenticated WebSocket connection or another other TCP connection), and the authentication proxy 1006 may provide login credentials to the authentication system 1004 on behalf of the connectivity adapter 206 and receive a security token that can be used by the connectivity adapter 206 to generate a signed request. The connectivity adapter 206 may send the signed request to the authentication system 1004 (e.g., using HTTP), just as the authenticated user devices 1002 do in FIG. 10. In some cases, the connection between the connectivity adapter 206 and the authentication proxy 1006 utilize a different communications protocol (e.g., WebSocket) than the connection between the connectivity adapter 206 and the authentication system 1004 (e.g., HTTP). By using the authentication proxy 1006, the connectivity adapter can utilize the cloud services provided by the cloud environment 106 without having to manage user accounts or login credentials. The authentication proxy 1006 may maintain one or more user accounts per clinical environment account.

Connectivity Adapter Authentication Method

With reference now to FIG. 11, an example connectivity adapter authentication method 1100 will be described. The example method 1100 may be carried out, for example, by the authentication proxy 1006 of FIG. 10. The method 1100 illustrates an example algorithm that may be programmed, using any suitable programming environment or language, to create machine code capable of execution by a CPU or microcontroller. Various embodiments may be coded using assembly, C, OBJECTIVE-C, C++, JAVA, or other human-readable languages and then compiled, assembled, or otherwise transformed into machine code that can be loaded into read-only memory (ROM), erasable programmable read-only memory (EPROM), or other recordable memory that is coupled to the CPU or microcontroller and then executed by the CPU or microcontroller. For example, when the method 1100 is initiated, a set of executable program instructions stored on one or more non-transitory computer-readable media (e.g., hard drive, flash memory, removable media, etc.) may be loaded into memory (e.g., random access memory or “RAM”) of a computing device of the clinical environment 102 and/or the cloud environment 106. The executable instructions may then be executed by a hardware-based computer processor (e.g., a central processing unit or “CPU”) of the computing device. In some embodiments, the method 1100 or portions thereof may be implemented on multiple processors, serially or in parallel. For convenience, the steps of the example method 1100 are described as being performed by the authentication proxy 1006.

At block 1102, the authentication proxy 1006 receives an authentication request from the connectivity adapter 206 via a secured and authenticated WebSocket connection. For example, the WebSocket connection may be the connection via which the connectivity adapter 206 transmits messages to the cloud environment 106.

At block 1104, the authentication proxy 1006 identifies the login credentials of a user account to be used for authenticating the connectivity adapter 206. For example, the authentication proxy 1006 may identify the user account based on one or more identifiers associated with the clinical environment 102. In some embodiments, the clinical environment 102 is associated with one or more identifiers and has multiple regions, healthcare systems, and facilities therein.

At block 1106, the authentication proxy 1006 transmits the login credentials to the authentication system 1004, and at block 1108, the authentication proxy 1006 receives a security token from the authentication system 1004.

At block 1110, the authentication proxy 1006 transmits the security token to the connectivity adapter 206, and at block 1112, the authentication proxy 1006 causes the connectivity adapter 206 to transmit a signed request to the authentication system using HTTP.

In the method 1100, one or more of the blocks shown in FIG. 11 may be removed (e.g., not performed) and/or the order in which the method 1100 is performed may be switched. In some embodiments, additional blocks may be added to the method 1100. The embodiments of the present disclosure are not limited to or by the example shown in FIG. 11, and other variations may be implemented without departing from the spirit of this disclosure.

Data Segmentation

FIG. 12 shows a block diagram illustrating a segmented data structure 1200 including an account data node 1202, which includes region data nodes 1204 and 1206. The region data node 1204 includes system data node 1208, and the region data node 1206 includes system data nodes 1210 and 1212. The system data node 1208 includes facility data node 1214. As shown in FIG. 12, facility data node that used to belong to the system data node 1208 has been moved to the system data node 1210, which further includes facility data node 1218. The system data node 1212 includes facility data node 1220. As shown in FIG. 12, the facility data node includes infusion pumps 1218A, 1218B, 1218C, etc. The account data node 1202 corresponds to an account generated for each unique entity that may own, oversee, and/or manage one or more healthcare facilities (e.g., hospital facilities) in one or more healthcare systems (e.g., a network of hospitals) in one or more regions (e.g., geographical divisions including multiple networks of hospitals). For example, the clinical environment 102 may correspond to any of a facility, system, region, or account.

In some embodiments, the data generated by the infusion pumps 204 and/or the connectivity adapters 206 at the individual facilities may be tagged with the facility ID and the account ID, since those two identifiers may be permanent. For example, the connectivity adapter 206 may receive a message from the infusion pump 204, convert the message into a standardized dataset message, and inject one or more tags into the standardized dataset message by adding or setting one or more corresponding key-value pairs (e.g., facilityID=F0293, accountID=A29847, etc.) in the standardized dataset message. On the other hand, as the facilities are restructured and moved around within the enterprise structure, the data corresponding to the facilities may be assigned a different system ID or region ID. For example, in the example of FIG. 12, the facility data node 1216 has been moved from the system data node 1208 to system data node 1210 (e.g., representative of a change in the boundary between two regions), the data generated at the facility corresponding to the facility data node 1216, while still belonging to the facility data node 1216 and account data node 1202, no longer belongs to the system data node 1208 and region data node 1204, and instead belongs to the system data node 1210 and region data node 1206. Thus, by tagging the messages prior to transmitting them to the cloud environment 106 with immutable IDs (e.g., facility ID and account ID) and not IDs that may or may not change in the future, the connectivity adapter 206 facilitates security control, access, filtering, and reporting of such data. Further, as a result, the infusion pumps 204 need not be aware or keep track of the facility to which they are connected, since any messages or other data generated by the infusion pumps 204 will be appropriately tagged by the connectivity adapter 206 to which they are connected. For example, if an infusion pump is moved from one facility to another, the infusion pump can simply start sending messages to the connectivity adapter 206 at the new facility without worrying about the change in facility, since any new data generated by the infusion pump at the new facility will be tagged with the new facility ID by the new connectivity adapter 206. Further, by allowing the facilities to be moved across systems and regions, the segmented data structure 1200 allows facilities having one characteristic to be decoupled from other facilities having another characteristic (e.g., EHR vendor A vs. EHR vendor B, pump type X vs. pump type Y, etc.).

In some embodiments, data generated by the infusion pumps and/or connectivity adapters may include a facility ID and an account ID as immutable (permanent) IDs, and may include one or more mutable IDs such as a region ID and a system ID. The IDs associated with the data generated in a given facility may reflect the structural associations at the time of generation (old structure). When the facility is later restructured (new structure), the new structure is used in connection with the data (e.g., for reporting the data) and the prior mutable IDs may be ignored or updated as needed. Thus, data records are tagged based on the structure (e.g., account, region, system, facility) at the time that the data records are created. When the structure is subsequently modified, the system can (i) continue to use the data records as tagged at the time of creation despite the changes, (ii) update the mutable IDs to reflect the modified structure, and use the data records with the immutable IDs and updated mutable IDs, (iii) use the data records with only the immutable IDs (e.g., ignoring the mutable IDs), or (iv) use the data records with the immutable IDs and any mutable IDs that still reflect the modified structure.

Segmented Data Restructuring Method

With reference now to FIG. 13, an example segmented data restructuring method 1300 will be described. The example method 1300 may be carried out, for example, by the connectivity adapter 206 of FIG. 3 (or one or more components thereof) or the cloud environment 106 of FIG. 5 (or one or more components thereof). The method 1300 illustrates an example algorithm that may be programmed, using any suitable programming environment or language, to create machine code capable of execution by a CPU or microcontroller. Various embodiments may be coded using assembly, C, OBJECTIVE-C, C++, JAVA, or other human-readable languages and then compiled, assembled, or otherwise transformed into machine code that can be loaded into read-only memory (ROM), erasable programmable read-only memory (EPROM), or other recordable memory that is coupled to the CPU or microcontroller and then executed by the CPU or microcontroller. For example, when the method 1300 is initiated, a set of executable program instructions stored on one or more non-transitory computer-readable media (e.g., hard drive, flash memory, removable media, etc.) may be loaded into memory (e.g., random access memory or “RAM”) of a computing device of the clinical environment 102 and/or the cloud environment 106. The executable instructions may then be executed by a hardware-based computer processor (e.g., a central processing unit or “CPU”) of the computing device. In some embodiments, the method 1300 or portions thereof may be implemented on multiple processors, serially or in parallel. For convenience, the steps of the example method 1300 are described as being performed by the connectivity adapter 206 and/or the cloud environment 106.

At block 1302, the connectivity adapter 206 receives a message from an infusion pump 204 at a facility (e.g., hospital).

At block 1304, the connectivity adapter 206 adds an account ID and a facility ID to the message received from the infusion pump 204. In some cases, the message from the infusion pump 204 may be converted to a standardized dataset message, and the account ID and facility ID may be added to the standardized dataset message. In some embodiments, the connectivity adapter 206 determines one or more IDs described herein (e.g., account ID, facility ID, region ID, system ID, etc.) associated with the infusion pump 204 by checking one or more indicators in a priority order. For example, the connectivity adapter 206 may determine a given indicator associated with the infusion pump 204 and access a database of facility IDs (or other IDs) to determine whether any of the facility IDs are associated with the determined indicator associated with the infusion pump 204. The indicator may be one or more of (i) the network port via which the infusion pump 204 is connected to the connectivity adapter 206 (e.g., pumps associated with Facility A may connect via Port 9292, pumps associated with Facility B may connect via Port 9293, etc.), (ii) location data associated with the infusion pump 204, (iii) the Internet Protocol (IP) address associated with the infusion pump 204, (iv) the name associated with the infusion pump 204, (v) the Media Access Control (MAC) address associated with the infusion pump 204, (vi) the Wi-Fi access point associated with the infusion pump 204, and (vii) the serial number associated with the infusion pump 204. If the connectivity adapter 206 determines, after checking one or more of the indicators, that the facility ID (or another ID) cannot be found in the database, the connectivity adapter 206 may add a default facility ID to the message received from the infusion pump 204 at block 1304, indicating that the pump message originated from an infusion pump not associated with a known facility.

In some embodiments, one or more of the indicators described herein are checked in a specific priority order. For example, the connectivity adapter 206 may first try to determine the facility ID (or another ID) based on the MAC address of the infusion pump 204. If the connectivity adapter 206 does not find a facility ID matching the MAC address, the connectivity adapter 206 may then try to determine the facility ID based on the serial number of the infusion pump 204. If the connectivity adapter 206 does not find a facility ID matching the serial number, the connectivity adapter 206 may then try to determine the facility ID based on the location data associated with the infusion pump 204. If the connectivity adapter 206 does not find a facility ID matching the location data, the connectivity adapter 206 may add a default facility ID to the message received from the infusion pump 204 at block 1304, indicating that the pump message originated from an infusion pump not associated with a known facility. Although the priority order of MAC address, serial number, and location data is used as an example, the techniques described herein can be applied to any other combination of indicators may be checked in any other priority order.

At block 1306, the cloud environment 106 transfers the facility at which the infusion pump 204 is located to another system (e.g., a healthcare system or a network of facilities) without changing the account ID and the facility ID of the message. For example, the facility may be using the EMR system from vendor A, and all facilities using the EMR system from vendor A within the existing healthcare system may have been separated out to a new healthcare system.

At block 1308, the cloud environment 106 updates the region ID and the system ID associated with the facility in which the infusion pump 204 is located. By updating the region ID and system ID of the facility, any new data generated in the facility may be accessible using the new region ID and system ID. Further, even after moving the facility 1216 from the system 1208 to the system 1210, the pump messages generated by the infusion pumps at the facility 1216 may continue to be stamped, tagged, or otherwise associated with the same account ID and the facility ID as those used prior to the move. In some cases, when an infusion pump is physically moved to a new facility, the connectivity adapter 206 at the new facility may stamp, tag, or otherwise associate the pump messages generated by the infusion pump with a new facility ID corresponding to the new facility.

In the method 1300, one or more of the blocks shown in FIG. 13 may be removed (e.g., not performed) and/or the order in which the method 1300 is performed may be switched. In some embodiments, additional blocks may be added to the method 1300. The embodiments of the present disclosure are not limited to or by the example shown in FIG. 13, and other variations may be implemented without departing from the spirit of this disclosure.

Example Clauses

Embodiments of the present disclosure can be defined by the following non-limiting clauses:

Clause 1. A system configured to facilitate messaging during a network outage, the system comprising: a plurality of infusion pumps configured to deliver medication to patients, each infusion pump of the plurality of infusion pumps comprising a memory configured to store operational software and a processor configured to generate pump messages; a connectivity adapter comprising computer hardware and in communication with the plurality of infusion pumps over a first network; and a server comprising computer hardware and in communication with the connectivity adapter over a second network different from the first network, wherein the connectivity adapter is configured to: receive a first pump message from a first infusion pump of the plurality of infusion pumps, the first pump message including information that is new to the connectivity adapter; generate a first standardized dataset message based on the information in the first pump message; store the first standardized dataset message in an outbound queue for transmission to the server; subsequent to storing the first standardized dataset message in the outbound queue, receive a second pump message from the first infusion pump, the second pump message including additional information that is new to the connectivity adapter; generate a second standardized dataset message based on the additional information in the second pump message; store the second standardized dataset message in the outbound queue for transmission to the server; remove the first standardized dataset message from the outbound queue without transmitting the first standardized dataset message to the server; and transmit the second standardized dataset message in the outbound queue to the server.

Clause 2. The system of Clause 1, wherein the first pump message includes a first message identifier (ID), and the second pump message includes a second message ID that immediately follows the first message ID in value.

Clause 3. The system of Clause 1, wherein the first standardized dataset message includes a first message identifier (ID), and the second standardized dataset message includes a second message ID that immediately follows the first message ID in value.

Clause 4. The system of Clause 1, wherein the first pump message includes a first parameter indicative of a status of the first infusion pump, and the first standardized dataset message includes (i) the first parameter and (ii) a second parameter that is not in the first pump message and indicative of another status of the first infusion pump.

Clause 5. The system of Clause 4, wherein the second parameter is associated with one of a null value or a default value.

Clause 6. The system of Clause 1, wherein the connectivity adapter is further configured to store the information in the first pump message in a cache.

Clause 7. The system of Clause 6, wherein the connectivity adapter is further configured to receive a third pump message from the first infusion pump, and based on determining that the third pump message does not include information new to the connectivity adapter, refrain from storing the information in the third pump message in the cache.

Clause 8. The system of Clause 1, wherein the connectivity adapter is further configured to update a parameter stored in a cache based on the information in the first pump message.

Clause 9. The system of Clause 1, wherein the connectivity adapter is further configured to, subsequent to removing the first standardized dataset message from the outbound queue without transmitting the first standardized dataset message to the server, receive a request for the first pump message from the server.

Clause 10. The system of Clause 9, wherein the connectivity adapter is further configured to, in response to the request for the first pump message, transmit a request for the first pump message to the first infusion pump.

Clause 11. A method of facilitating messaging during a network outage, the method comprising: receiving a first pump message from a first infusion pump over a first network; generating a first standardized dataset message based on the information in the first pump message; storing the first standardized dataset message in an outbound queue for transmission to a server over a second network different from the first network; subsequent to storing the first standardized dataset message in the outbound queue, receiving a second pump message from the first infusion pump over the first network; generating a second standardized dataset message based on the additional information in the second pump message; storing the second standardized dataset message in the outbound queue for transmission to the server; removing the first standardized dataset message from the outbound queue without transmitting the first standardized dataset message to the server; and transmitting the second standardized dataset message in the outbound queue to the server over the second network.

Clause 12. The method of Clause 11, wherein the first pump message includes a first message identifier (ID), and the second pump message includes a second message ID that immediately follows the first message ID in value.

Clause 13. The method of Clause 11, wherein the first standardized dataset message includes a first message identifier (ID), and the second standardized dataset message includes a second message ID that immediately follows the first message ID in value.

Clause 14. The method of Clause 11, wherein the first pump message includes a first parameter indicative of a status of the first infusion pump, and the first standardized dataset message includes (i) the first parameter and (ii) a second parameter that is not in the first pump message and indicative of another status of the first infusion pump.

Clause 15. The method of Clause 14, wherein the second parameter is associated with one of a null value or a default value.

Clause 16. The method of Clause 11, further comprising storing the information in the first pump message in a cache.

Clause 17. The method of Clause 16, further comprising receiving a third pump message from the first infusion pump, and based on determining that the third pump message does not include information new to the connectivity adapter, refraining from storing the information in the third pump message in the cache.

Clause 18. The method of Clause 11, further comprising updating a parameter stored in a cache based on the information in the first pump message.

Clause 19. The method of Clause 11, further comprising, subsequent to removing the first standardized dataset message from the outbound queue without transmitting the first standardized dataset message to the server, receiving a request for the first pump message from the server.

Clause 20. The method of Clause 19, further comprising, in response to the request for the first pump message, transmitting a request for the first pump message to the first infusion pump.

Clause 21. A system configured to facilitate messaging during a network outage, the system comprising: a plurality of infusion pumps configured to deliver medication to patients, each infusion pump of the plurality of infusion pumps comprising a memory configured to store operational software and a processor configured to generate pump messages; a connectivity adapter comprising computer hardware and in communication with the plurality of infusion pumps over a first network; and a server comprising computer hardware and in communication with the connectivity adapter over a second network different from the first network, wherein the connectivity adapter is configured to: receive a first pump message from a first infusion pump of the plurality of infusion pumps, the first pump message including information that is new to the connectivity adapter; generate a first standardized dataset message based on the information in the first pump message; store the first standardized dataset message in an outbound queue for transmission to the server; subsequent to storing the first standardized dataset message in the outbound queue, receive a second pump message from the first infusion pump, the second pump message including additional information that is new to the connectivity adapter; generate a second standardized dataset message based on the additional information in the second pump message; store the second standardized dataset message in the outbound queue for transmission to the server; determine whether a removal condition for removing the first standardized dataset message from the outbound queue without transmitting the first standardized dataset message to the server is satisfied; and subsequent to determining whether the removal condition is satisfied, removing the first standardized dataset message from the outbound queue.

Clause 22. The system of Clause 21, wherein the connectivity adapter is further configured to, subsequent to determining that the removal condition is satisfied, remove the first standardized dataset message from the outbound queue without transmitting the first standardized dataset message to the server.

Clause 23. The system of Clause 21, wherein the connectivity adapter is further configured to, subsequent to determining that the removal condition is not satisfied, remove the first standardized dataset message from the outbound queue and transmit the first standardized dataset message to the server.

Clause 24. The system of Clause 22 or 23, wherein determining whether the removal condition is satisfied comprises determining whether the first standardized dataset message has been in the outbound queue for a time period greater than a threshold time period.

Clause 25. The system of Clause 22 or 23, wherein determining whether the removal condition is satisfied comprises determining whether the outbound queue includes a number of messages that is greater than a threshold number of messages.

Clause 26. The system of Clause 22 or 23, wherein the first pump message includes a first message identifier (ID), and the second pump message includes a second message ID that immediately follows the first message ID in value.

Clause 27. The system of Clause 22 or 23, wherein the first standardized dataset message includes a first message identifier (ID), and the second standardized dataset message includes a second message ID that immediately follows the first message ID in value.

Clause 28. The system of Clause 22 or 23, wherein the first pump message includes a first parameter indicative of a status of the first infusion pump, and the first standardized dataset message includes (i) the first parameter and (ii) a second parameter that is not in the first pump message and indicative of another status of the first infusion pump.

Clause 29. The system of Clause 28, wherein the second parameter is associated with one of a null value or a default value.

Clause 30. The system of Clause 22 or 23, wherein the connectivity adapter is further configured to store the information in the first pump message in a cache.

Clause 31. The system of Clause 30, wherein the connectivity adapter is further configured to receive a third pump message from the first infusion pump, and based on determining that the third pump message does not include information new to the connectivity adapter, refrain from storing the information in the third pump message in the cache.

Clause 32. The system of Clause 22 or 23, wherein the connectivity adapter is further configured to update a parameter stored in a cache based on the information in the first pump message.

Clause 33. The system of Clause 22, wherein the connectivity adapter is further configured to, subsequent to removing the first standardized dataset message from the outbound queue without transmitting the first standardized dataset message to the server, receive a request for the first pump message from the server.

Clause 34. The system of Clause 33, wherein the connectivity adapter is further configured to, in response to the request for the first pump message, transmit a request for the first pump message to the first infusion pump.

Clause 35. A method for providing messaging in a clinical environment, the method comprising: storing a plurality of messages in a message queue, wherein the plurality of messages contain information about one or more infusion pumps residing in the clinical environment, the plurality of messages stored in the message queue including at least a first message and a second message; transmitting at least some of the plurality of messages to a remote server configured to receive messages generated in the clinical environment; subsequent to the transmission, detecting a network outage, wherein the network outage prevents transmission of messages to the remote server; determining that the first message in the message queue satisfies a condition for being removed from the message queue without being successfully transmitted to the remote server; removing the first message from the message queue such that the first message is removed from the message queue prior to being received by the remote server; determining that the network outage has been resolved; and transmitting the second message to the remote server such that the second message is received by the remote server and the first message is not received by the remote server.

Clause 36. The method of Clause 35, further comprising detecting the network outage based at least on not having received an acknowledgement from the remote server during a specific time window.

Clause 37. The method of Clause 35, further comprising detecting the network outage based at least on receiving a message from the remote server that a connection to the remote server is terminated.

Clause 38. The method of Clause 35, further comprising determining that the first message satisfies the condition based at least on the first message being associated with an infusion pump event that is older than a threshold amount of time.

Clause 39. The method of Clause 35, further comprising determining that the first message satisfies the condition based at least on the first message being the oldest message in the message queue.

Clause 40. The method of Clause 35, further comprising determining that the first message satisfies the condition based at least on the message queue being full.

Clause 41. The method of Clause 35, further comprising attempting, prior to determining that the first message satisfies the condition, to transmit the first message to the remote server, and determining that the first message was not received by the remote server.

Clause 42. An apparatus configured to provide messaging in a clinical environment, the apparatus comprising: one or more processors; and one or more memories in communication with the one or more processors and storing computer-executable instructions that, when executed by the one or more processors, configure the one or more processors to: cause a plurality of messages to be stored in a message queue, wherein the plurality of messages contain information about one or more infusion pumps residing in the clinical environment, the plurality of messages stored in the message queue including at least a first message and a second message; cause at least some of the plurality of messages to be transmitted to a remote server configured to receive messages generated in the clinical environment; subsequent to the transmission, determine that the first message in the message queue satisfies a condition for being removed from the message queue; cause the first message to be removed from the message queue such that the first message is removed from the message queue prior to being received by the remote server; and cause the second message to be transmitted to the remote server such that the second message is received by the remote server and the first message is not received by the remote server.

Clause 43. The apparatus of Clause 42, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to detect a network outage that prevents transmission of messages to the remote server.

Clause 44. The apparatus of Clause 43, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to detect the network outage based at least on not having received an acknowledgement from the remote server during a specific time window.

Clause 45. The apparatus of Clause 43, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to detect the network outage based at least on receiving a message from the remote server that a connection to the remote server is terminated.

Clause 46. The apparatus of Clause 42, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to determine that the first message satisfies the condition based at least on the first message being associated with an infusion pump event that is older than a threshold amount of time.

Clause 47. The apparatus of Clause 42, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to determine that the first message satisfies the condition based at least on the first message being the oldest message in the message queue.

Clause 48. The apparatus of Clause 42, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to determine that the first message satisfies the condition based at least on the message queue being full.

Clause 49. The apparatus of Clause 42, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to attempt, prior to determining that the first message satisfies the condition, to transmit the first message to the remote server, and determine that the first message was not received by the remote server.

Clause 50. Non-transitory physical computer storage storing computer-executable instructions that, when executed by one or more computing devices, configure the one or more computing devices to: cause a plurality of messages to be stored in a message queue, wherein the plurality of messages contain information about one or more infusion pumps residing in the clinical environment, the plurality of messages stored in the message queue including at least a first message and a second message; cause at least some of the plurality of messages to be transmitted to a remote server configured to receive messages generated in the clinical environment; subsequent to the transmission, determine that the first message in the message queue satisfies a condition for being removed from the message queue; cause the first message to be removed from the message queue such that the first message is removed from the message queue prior to being received by the remote server; and cause the second message to be transmitted to the remote server such that the second message is received by the remote server and the first message is not received by the remote server.

Clause 51. The non-transitory physical computer storage of Clause 50, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to detect a network outage that prevents transmission of messages to the remote server.

Clause 52. The non-transitory physical computer storage of Clause 50, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to determine that the first message satisfies the condition based at least on the first message being associated with an infusion pump event that is older than a threshold amount of time.

Clause 53. The non-transitory physical computer storage of Clause 50, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to determine that the first message satisfies the condition based at least on the first message being the oldest message in the message queue.

Clause 54. The non-transitory physical computer storage of Clause 50, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to attempt, prior to determining that the first message satisfies the condition, to transmit the first message to the remote server, and determine that the first message was not received by the remote server.

Clause 55. A method for providing messaging in a clinical environment, the method comprising: storing a plurality of messages in a message queue, wherein the plurality of messages contain information about one or more infusion pumps residing in the clinical environment, the plurality of messages stored in the message queue including at least a first message; transmitting at least some of the plurality of messages to a remote server configured to receive messages generated in the clinical environment; subsequent to the transmission, detecting a temporary interruption in a network connection to the remote server, wherein the temporary interruption prevents transmission of messages to the remote server; determining that the first message in the message queue does not satisfy a condition for being removed from the message queue without being successfully transmitted to the remote server; determining that the temporary interruption has been resolved; and transmitting the first message to the remote server such that the first message is received by the remote server.

Clause 56. The method of Clause 55, further comprising detecting the temporary interruption based at least on not having received an acknowledgement from the remote server during a specific time window.

Clause 57. The method of Clause 55, further comprising detecting the temporary interruption based at least on receiving a message from the remote server that a connection to the remote server is terminated.

Clause 58. The method of Clause 55, further comprising determining that the first message does not satisfy the condition based at least on the first message being associated with an infusion pump event that is not older than a threshold amount of time.

Clause 59. The method of Clause 55, further comprising determining that the first message does not satisfy the condition based at least on the first message not being a time-sensitive message.

Clause 60. The method of Clause 55, further comprising attempting, prior to determining that the first message does not satisfy the condition, to transmit the first message to the remote server, and determining that the first message was not received by the remote server.

Clause 61. An apparatus configured to provide messaging in a clinical environment, the apparatus comprising: one or more processors; and one or more memories in communication with the one or more processors and storing computer-executable instructions that, when executed by the one or more processors, configure the one or more processors to: cause a plurality of messages to be stored in a message queue, wherein the plurality of messages contain information about one or more infusion pumps residing in the clinical environment, the plurality of messages stored in the message queue including at least a first message; cause at least some of the plurality of messages to be transmitted to a remote server configured to receive messages generated in the clinical environment; subsequent to the transmission, determine that the first message in the message queue does not satisfy a condition for being removed from the message queue; and cause the first message to be transmitted to the remote server such that the first message is received by the remote server.

Clause 62. The apparatus of Clause 61, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to detect an interruption in a network connection between the apparatus and the remote server that prevents transmission of messages from the apparatus to the remote server.

Clause 63. The apparatus of Clause 62, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to detect the interruption based at least on not having received an acknowledgement from the remote server during a specific time window.

Clause 64. The apparatus of Clause 62, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to detect the interruption based at least on receiving a message from the remote server that the network connection between the apparatus and the remote server is terminated.

Clause 65. The apparatus of Clause 61, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to determine that the first message does not satisfy the condition based at least on the first message being associated with an infusion pump event that is not older than a threshold amount of time.

Clause 66. The apparatus of Clause 61, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to determine that the first message does not satisfy the condition based at least on the first message not being a time-sensitive message.

Clause 67. The apparatus of Clause 61, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to attempt, prior to determining that the first message does not satisfy the condition, to transmit the first message to the remote server, and determine that the first message was not received by the remote server.

Clause 68. Non-transitory physical computer storage storing computer-executable instructions that, when executed by one or more computing devices, configure the one or more computing devices to: cause a plurality of messages to be stored in a message queue, wherein the plurality of messages contain information about one or more infusion pumps residing in the clinical environment, the plurality of messages stored in the message queue including at least a first message; cause at least some of the plurality of messages to be transmitted to a remote server configured to receive messages generated in the clinical environment; subsequent to the transmission, determine that the first message in the message queue does not satisfy a condition for being removed from the message queue; and cause the first message to be transmitted to the remote server such that the first message is received by the remote server.

Clause 69. The non-transitory physical computer storage of Clause 68, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to detect an interruption in a network connection to the remote server that prevents transmission of messages to the remote server.

Clause 70. The non-transitory physical computer storage of Clause 69, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to detect the interruption based at least on not having received an acknowledgement from the remote server during a specific time window.

Clause 71. The non-transitory physical computer storage of Clause 69, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to detect the interruption based at least on receiving a message from the remote server that the network connection to the remote server is terminated.

Clause 72. The non-transitory physical computer storage of Clause 68, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to determine that the first message does not satisfy the condition based at least on the first message being associated with an infusion pump event that is not older than a threshold amount of time.

Clause 73. The non-transitory physical computer storage of Clause 68, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to determine that the first message does not satisfy the condition based at least on the first message not being a time-sensitive message.

Clause 74. The non-transitory physical computer storage of Clause 68, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to attempt, prior to determining that the first message does not satisfy the condition, to transmit the first message to the remote server, and determine that the first message was not received by the remote server.

Clause 75. A method for detecting missing messages from a clinical environment, the method comprising: processing a plurality of messages from a network device residing in the clinical environment, wherein the plurality of messages contain information about one or more infusion pumps residing in the clinical environment, wherein the plurality of messages includes a first message having a first message identifier value and a second message having a second message identifier value; determining that one or more messages are missing between the first message and the second message based on (i) receiving the second message after the first message without receiving any other message therebetween and (ii) determining that there is at least one message identifier value between the first message identifier value and the second message identifier value in a predetermined sequence; and transmitting a message request to the network device residing in the clinical environment, wherein the message request identifies the one or more messages that should have been received from the network device but have not been received.

Clause 76. The method of Clause 75, further comprising, in response to the message request, receiving one or more additional messages from the network device, wherein the one or more messages include information that would have been included in the one or more messages.

Clause 77. The method of Clause 76, further comprising updating, based at least on the one or more additional messages received in response to the message request, a cache to include additional information about the one or more infusion pumps residing in the clinical environment.

Clause 78. The method of Clause 75, further comprising causing the network device to request additional information from the one or more infusion pumps that would have been included in the one or more messages.

Clause 79. The method of Clause 75, further comprising, in response to determining that the one or more messages has reached a threshold count, transmitting the message request to the network device residing in the clinical environment.

Clause 80. A system configured to detect missing messages from a clinical environment, the system comprising: one or more processors; and one or more memories in communication with the one or more processors and storing computer-executable instructions that, when executed by the one or more processors, configure the one or more processors to: process a plurality of messages from a network device residing in the clinical environment, wherein the plurality of messages contain information about one or more infusion pumps residing in the clinical environment; detect one or more missing messages that should have been received from the network device but have not been received; and cause a message request to be transmitted to the network device residing in the clinical environment, wherein the message request identifies the one or more missing messages that should have been received from the network device but have not been received.

Clause 81. The system of Clause 80, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to receive, in response to the message request, one or more additional messages from the network device, wherein the one or more messages include information that would have been included in the one or more missing messages.

Clause 82. The system of Clause 81, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to cause, based at least on the one or more additional messages received in response to the message request, a cache to be updated to include additional information about the one or more infusion pumps residing in the clinical environment.

Clause 83. The system of Clause 80, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to detect the one or more missing messages based at least on message identifier information associated with one or more of the plurality of messages.

Clause 84. The system of Clause 80, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to detect the one or more missing messages based at least on a first message in the plurality of messages having a message identifier that does not immediately follow another message identifier of a second message of the plurality of messages that immediately follows the first message.

Clause 85. The system of Clause 80, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to cause the network device to request additional information from the one or more infusion pumps that would have been included in the one or more missing messages.

Clause 86. The system of Clause 80, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to cause, in response to determining that the one or more missing messages has reached a threshold count, the message request to be transmitted to the network device residing in the clinical environment.

Clause 87. The system of Clause 80, wherein the message request includes a flag having a value indicating that the message request is a log retrieval request and not live data.

Clause 88. Non-transitory physical computer storage storing computer-executable instructions that, when executed by one or more computing devices, configure the one or more computing devices to: process a plurality of messages from a network device residing in the clinical environment, wherein the plurality of messages contain information about one or more infusion pumps residing in the clinical environment; detect one or more missing messages that should have been received from the network device but have not been received; and cause a message request to be transmitted to the network device residing in the clinical environment, wherein the message request identifies the one or more missing messages that should have been received from the network device but have not been received.

Clause 89. The non-transitory physical computer storage of Clause 88, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to receive, in response to the message request, one or more additional messages from the network device, wherein the one or more messages include information that would have been included in the one or more missing messages.

Clause 90. The non-transitory physical computer storage of Clause 89, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to cause, based at least on the one or more additional messages received in response to the message request, a cache to be updated to include additional information about the one or more infusion pumps residing in the clinical environment.

Clause 91. The non-transitory physical computer storage of Clause 88, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to detect the one or more missing messages based at least on message identifier information associated with one or more of the plurality of messages.

Clause 92. The non-transitory physical computer storage of Clause 88, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to detect the one or more missing messages based at least on a first message in the plurality of messages having a message identifier that does not immediately follow another message identifier of a second message of the plurality of messages that immediately follows the first message.

Clause 93. The non-transitory physical computer storage of Clause 88, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to cause the network device to request additional information from the one or more infusion pumps that would have been included in the one or more missing messages.

Clause 94. The non-transitory physical computer storage of Clause 88, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to cause, in response to determining that the one or more missing messages has reached a threshold count, the message request to be transmitted to the network device residing in the clinical environment.

Clause 95. A method for generating a user interface based on messages from a clinical environment, the method comprising: processing a message from a network device residing in the clinical environment, wherein the message includes information about one or more infusion pumps in communication with the network device in the clinical environment; determining that the information included in the message satisfies a condition for updating a cache to include at least some of the information included in the message, wherein the cache stores information usable to generate user interfaces in response to a request from a computing device residing in the clinical environment; updating the cache to include at least some of the information included in the message from the network device; receiving a request for a user interface from the computing device residing in the clinical environment; accessing, from the updated cache, user interface information to be used to generate the user interface, wherein the user interface information includes at least some of the information that the cache was updated to include; and outputting instructions for displaying the user interface on the computing device, wherein the instructions are based at least on the user interface information accessed from the updated cache.

Clause 96. The method of Clause 95, wherein the message includes information indicating a current state of the one or more infusion pumps.

Clause 97. The method of Clause 95, wherein the cache stores information associated with two or more infusion pumps residing in different medical facilities.

Clause 98. The method of Clause 95, wherein the user interface information includes user interface data previously generated and stored in the cache.

Clause 99. The method of Clause 95, further comprising updating user interface data stored in the cache, and outputting the instructions based at least on the updated user interface data.

Clause 100. The method of Clause 95, wherein the condition is satisfied based on the information in the message being usable to generate one or more user interfaces in response to a request from the clinical environment.

Clause 101. The method of Clause 95, further comprising causing the user interface to be outputted on a display of the computing device.

Clause 102. A system configured to detect missing messages from a clinical environment, the system comprising: one or more processors; and one or more memories in communication with the one or more processors and storing computer-executable instructions that, when executed by the one or more processors, configure the one or more processors to: process a message from a network device residing in the clinical environment, wherein the message includes information about one or more infusion pumps in communication with the network device in the clinical environment; determine that the information included in the message satisfies a condition for updating a cache to include at least some of the information included in the message, wherein the cache stores information usable to generate user interfaces in response to a request from a computing device residing in the clinical environment; cause the cache to be updated to include at least some of information included in the message from the network device; process a request for a user interface from the computing device residing in the clinical environment; access, from the updated cache, user interface information to be used to generate the user interface, wherein the user interface information includes at least some of the information that the cache was updated to include; and output instructions for displaying the user interface on the computing device, wherein the instructions are based at least on the user interface information accessed from the updated cache.

Clause 103. The system of Clause 102, wherein the message includes information indicating a current state of the one or more infusion pumps.

Clause 104. The system of Clause 102, wherein the cache is configured to store information associated with two or more infusion pumps residing in different medical facilities.

Clause 105. The system of Clause 102, wherein the user interface information includes user interface data previously generated and stored in the cache.

Clause 106. The system of Clause 102, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to cause user interface data stored in the cache to be updated, and output the instructions based at least on the updated user interface data.

Clause 107. The system of Clause 102, wherein the condition is satisfied based on the information in the message being usable to generate one or more user interfaces in response to a request from the clinical environment.

Clause 108. The system of Clause 102, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to cause the user interface to be outputted on a display of the computing device.

Clause 109. Non-transitory physical computer storage storing computer-executable instructions that, when executed by one or more computing devices, configure the one or more computing devices to: process a message from a network device residing in the clinical environment, wherein the message includes information about one or more infusion pumps in communication with the network device in the clinical environment; determine that the information included in the message satisfies a condition for updating a cache to include at least some of the information included in the message, wherein the cache stores information usable to generate user interfaces in response to a request from a computing device residing in the clinical environment; cause the cache to be updated to include at least some of information included in the message from the network device; process a request for a user interface from the computing device residing in the clinical environment; access, from the updated cache, user interface information to be used to generate the user interface, wherein the user interface information includes at least some of the information that the cache was updated to include; and output instructions for displaying the user interface on the computing device, wherein the instructions are based at least on the user interface information accessed from the updated cache.

Clause 110. The non-transitory physical computer storage of Clause 109, wherein the message includes information indicating a current state of the one or more infusion pumps.

Clause 111. The non-transitory physical computer storage of Clause 109, wherein the cache is configured to store information associated with two or more infusion pumps residing in different medical facilities.

Clause 112. The non-transitory physical computer storage of Clause 109, wherein the user interface information includes user interface data previously generated and stored in the cache.

Clause 113. The non-transitory physical computer storage of Clause 109, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to cause user interface data stored in the cache to be updated, and output the instructions based at least on the updated user interface data.

Clause 114. The non-transitory physical computer storage of Clause 109, wherein the condition is satisfied based on the information in the message being usable to generate one or more user interfaces in response to a request from the clinical environment.

Clause 115. A method for converting messages having one message format from infusion pumps residing in a clinical environment into messages having another message format, the method comprising: detecting a first pump protocol used by one or more infusion pumps in the clinical environment, the first pump protocol defining the first message format; generating a message converter configured to convert a pump message having the first message format into a standardized dataset message having a second message format different from the first message format and including at least some additional data or metadata not included in the pump message; receiving a first pump message from an infusion pump in the clinical environment, wherein the infusion pump is configured to generate pump messages using the first pump protocol; converting the first pump message into a standardized dataset message having the second message format using the message converter, wherein the standardized dataset message includes information associated with the infusion pump and includes at least some additional data or metadata not included in the first pump message; and transmitting the standardized dataset message to a remote server configured to receive standardized dataset messages.

Clause 116. The method of Clause 115, wherein the standardized dataset message includes one or more key-value pairs that are not included in the first pump message.

Clause 117. The method of Clause 116, wherein the one or more key-value pairs are each set to a default value or a null value.

Clause 118. The method of Clause 115, wherein the standardized dataset message includes identification data that identifies one or more portions of the standardized dataset message that include new information.

Clause 119. The method of Clause 115, further comprising detecting the first pump protocol based on a protocol identifier associated with the first pump protocol not being on a predetermined list of protocol identifiers.

Clause 120. The method of Clause 119, further comprising subsequent to detecting the first pump protocol, adding the protocol identifier associated with the first pump protocol to the predetermined list of protocol identifiers.

Clause 121. The method of Clause 115, wherein the message converter comprises a software module that is configured to receive a pump message in the first pump protocol as input and output a standardized dataset message based on the pump message.

Clause 122. The method of Clause 115, wherein the message converter is a configuration file downloaded from the remote server.

Clause 123. An apparatus configured to convert messages having one message format from infusion pumps residing in a clinical environment into messages having another message format, the apparatus comprising: one or more processors; and one or more memories in communication with the one or more processors and storing computer-executable instructions that, when executed by the one or more processors, configure the one or more processors to: detect a first pump protocol used by one or more infusion pumps in the clinical environment, the first pump protocol defining a first message format; generate a message converter configured to convert a pump message having the first message format into another message having a second message format different from the first message format and including at least some additional data or metadata not included in the pump message; receive a first message from an infusion pump in the clinical environment, wherein the infusion pump is configured to generate messages using the first pump protocol; cause the first message to be converted into a second message having the second message format using the message converter, wherein the second message includes information associated with the infusion pump and includes at least some additional data or metadata not included in the first message; and cause the second message to be transmitted to a remote server configured to receive messages having the second message format.

Clause 124. The apparatus of Clause 123, wherein the second message includes one or more key-value pairs that are not included in the first message.

Clause 125. The apparatus of Clause 124, wherein the one or more key-value pairs are each set to a default value or a null value.

Clause 126. The apparatus of Clause 123, wherein the second message includes identification data that identifies one or more portions of the second message that include new information.

Clause 127. The apparatus of Clause 123, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to detect the first pump protocol based on a protocol identifier associated with the first pump protocol not being on a predetermined list of protocol identifiers.

Clause 128. The apparatus of Clause 123, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to, subsequent to detecting the first pump protocol, cause the protocol identifier associated with the first pump protocol to be added to the predetermined list of protocol identifiers.

Clause 129. The apparatus of Clause 123, wherein the message converter comprises a software module that is configured to receive a pump message having the first message format as input and output another message having the second message format based on the pump message.

Clause 130. The apparatus of Clause 123, wherein the message converter is a configuration file downloaded from the remote server.

Clause 131. Non-transitory physical computer storage storing computer-executable instructions that, when executed by one or more computing devices, configure the one or more computing devices to: detect a first pump protocol used by one or more infusion pumps in the clinical environment, the first pump protocol defining a first message format; generate a message converter configured to convert a pump message having the first message format into another message having a second message format different from the first message format and including at least some additional data or metadata not included in the pump message; receive a first message from an infusion pump in the clinical environment, wherein the infusion pump is configured to generate messages using the first pump protocol; cause the first message to be converted into a second message having the second message format using the message converter, wherein the second message includes information associated with the infusion pump and includes at least some additional data or metadata not included in the first message; and cause the second message to be transmitted to a remote server configured to receive messages having the second message format.

Clause 132. The non-transitory physical computer storage of Clause 131, wherein the second message includes one or more key-value pairs that are not included in the first message, the one or more key-value pairs each having a default value or a null value.

Clause 133. The non-transitory physical computer storage of Clause 131, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to detect the first pump protocol based on a protocol identifier associated with the first pump protocol not being on a predetermined list of protocol identifiers, and subsequent to detecting the first pump protocol, cause the protocol identifier associated with the first pump protocol to be added to the predetermined list of protocol identifiers.

Clause 134. The non-transitory physical computer storage of Clause 131, wherein the message converter comprises a software module that is downloaded from the remote server, the message converter being configured to receive a pump message having the first message format as input and output another message having the second message format based on the pump message.

Clause 135. A method for authenticating a network device residing in a clinical environment using a token, the method comprising: processing an authentication request from the network device residing in the clinical environment via a first network connection, wherein the authentication request includes identifying information associated with the clinical environment, and wherein the clinical environment includes one or more infusion pumps in communication with the network device; identifying login credentials to be used to authenticate the network device residing in the clinical environment; transmitting the login credentials to an authentication system configured to authenticate requests from the network device residing in the clinical environment via a second network connection different from the first network connection; receiving a security token from the authentication system, the security token being usable by the network device to transmit requests to the authentication system via the second network connection; and transmitting the security token to the network device residing in the clinical environment via the first network connection.

Clause 136. The method of Clause 135, wherein the first network connection is a WebSocket connection.

Clause 137. The method of Clause 135, wherein the first network connection is secured and authenticated.

Clause 138. The method of Clause 135, further comprising causing the network device residing in the clinical environment to transmit a signed request to the authentication system.

Clause 139. The method of Clause 135, wherein the first network connection and the second network connection are both established over a wide area network.

Clause 140. The method of Clause 135, further comprising receiving a message from the network device residing in the clinical environment via the first network connection, wherein the messages include information associated with the one or more infusion pumps in communication with the network device.

Clause 141. The method of Clause 140, wherein the network device is configured to communicate with the one or more infusion pumps over a local area network.

Clause 142. A system configured to authenticate a network device residing in a clinical environment using a token, the system comprising: one or more processors; and one or more memories in communication with the one or more processors and storing computer-executable instructions that, when executed by the one or more processors, configure the one or more processors to: process an authentication request from the network device residing in the clinical environment via a first network connection, wherein the authentication request includes identifying information associated with the clinical environment, and wherein the clinical environment includes one or more infusion pumps in communication with the network device; identify login credentials to be used to authenticate the network device residing in the clinical environment; cause the login credentials to be transmitted to an authentication system configured to authenticate requests from the network device residing in the clinical environment via a second network connection different from the first network connection; receive a security token from the authentication system, the security token being usable by the network device to transmit requests to the authentication system via the second network connection; and cause the security token to be transmitted to the network device residing in the clinical environment via the first network connection.

Clause 143. The system of Clause 142, wherein the first network connection is a WebSocket connection.

Clause 144. The system of Clause 142, wherein the first network connection is secured and authenticated.

Clause 145. The system of Clause 142, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to cause the network device residing in the clinical environment to transmit a signed request to the authentication system.

Clause 146. The system of Clause 142, wherein the first network connection and the second network connection are both established over a wide area network.

Clause 147. The system of Clause 142, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to receive a message from the network device residing in the clinical environment via the first network connection, wherein the messages include information associated with the one or more infusion pumps in communication with the network device.

Clause 148. The system of Clause 147, wherein the network device is configured to communicate with the one or more infusion pumps over a local area network.

Clause 149. Non-transitory physical computer storage storing computer-executable instructions that, when executed by one or more computing devices, configure the one or more computing devices to: process an authentication request from the network device residing in the clinical environment via a first network connection, wherein the authentication request includes identifying information associated with the clinical environment, and wherein the clinical environment includes one or more infusion pumps in communication with the network device; identify login credentials to be used to authenticate the network device residing in the clinical environment; cause the login credentials to be transmitted to an authentication system configured to authenticate requests from the network device residing in the clinical environment via a second network connection different from the first network connection; receive a security token from the authentication system, the security token being usable by the network device to transmit requests to the authentication system via the second network connection; and cause the security token to be transmitted to the network device residing in the clinical environment via the first network connection.

Clause 150. The non-transitory physical computer storage of Clause 149, wherein the first network connection is a secured and authenticated WebSocket connection.

Clause 151. The non-transitory physical computer storage of Clause 149, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to cause the network device residing in the clinical environment to transmit a signed request to the authentication system.

Clause 152. The non-transitory physical computer storage of Clause 149, wherein the first network connection and the second network connection are both established over a wide area network.

Clause 153. The non-transitory physical computer storage of Clause 149, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to receive a message from the network device residing in the clinical environment via the first network connection, wherein the messages include information associated with the one or more infusion pumps in communication with the network device.

Clause 154. The non-transitory physical computer storage of Clause 149, wherein the condition is satisfied based on the information in the message being usable to generate one or more user interfaces in response to a request from the clinical environment.

Clause 155. A method for tagging messages from infusion pumps residing in a clinical environment, the method comprising: processing a pump message including information about an infusion pump residing in the clinical environment; tagging the pump message with a facility identifier indicative of a facility associated with the infusion pump and an account identifier indicative of an account associated with the infusion pump, wherein the facility is below the account in a hierarchical structure, and wherein the hierarchical structure includes one or more intermediate levels that are between the facility and the account in the hierarchical structure; and transmitting the tagged pump message to a remote server such that the facility identifier of the tagged pump message and the account identifier of the tagged message need not be changed by the remote server in response to the facility being moved within the hierarchical structure.

Clause 156. The method of Clause 155, wherein the facility identifier and the account identifier are permanent identifiers that are not changed in response to the facility being moved to another system or region in the hierarchical structure.

Clause 157. The method of Clause 155, wherein the infusion pump is configured to generate pump messages without determining the facility associated with the infusion pump or the account associated with the infusion pump.

Clause 158. The method of Clause 155, further comprising determining, in a priority order, whether one or more facility detection indicators correspond to one of a plurality of facility identifiers stored in a database.

Clause 159. The method of Clause 158, further comprising, in response to determining that none of the one or more facility detection indicators corresponds to any of the plurality of facility identifiers stored in the database, tagging the pump message with a default facility identifier indicating that the pump message originated from an infusion pump that is not associated with a known facility.

Clause 160. The method of Clause 155, further comprising tagging the pump message with a first intermediate identifier indicative of a first intermediate level of the one or more intermediate levels such that the tagged pump message includes the facility identifier, the account identifier, and the first intermediate identifier.

Clause 161. The method of Clause 160, in response to determining that the facility is no longer associated with the first intermediate level in the hierarchical structure, updating the first intermediate identifier, such that the tagged pump message includes the updated first intermediate identifier.

Clause 162. The method of Clause 155, wherein processing the pump message comprises converting a message in a first format received from the infusion pump into the pump message in a second format different from the first format.

Clause 163. An apparatus configured to tag messages from infusion pumps residing in a clinical environment, the apparatus comprising: one or more processors; and one or more memories in communication with the one or more processors and storing computer-executable instructions that, when executed by the one or more processors, configure the one or more processors to: process a pump message including information about an infusion pump residing in the clinical environment; cause the pump message to be tagged with a facility identifier indicative of a facility associated with the infusion pump and an account identifier indicative of an account associated with the infusion pump, wherein the facility is below the account in a hierarchical structure, and wherein the message is not tagged with at least one other identifier indicative of an intermediate level that is between the facility and the account in the hierarchical structure; and cause the tagged pump message to be transmitted to a remote server such that the facility identifier of the tagged pump message and the account identifier of the tagged message need not be changed by the remote server in response to the facility being moved within the hierarchical structure.

Clause 164. The apparatus of Clause 163, wherein the facility identifier and the account identifier are permanent identifiers that are not changed in response to the facility being moved within the hierarchical structure.

Clause 165. The apparatus of Clause 163, wherein the facility identifier and the account identifier are permanent identifiers that are not changed in response to the facility being moved to another system or region in the hierarchical structure.

Clause 166. The apparatus of Clause 163, wherein the infusion pump is configured to generate pump messages without determining the facility associated with the infusion pump or the account associated with the infusion pump.

Clause 167. The apparatus of Clause 163, wherein the computer-executable instructions further configure the one or more processors to cause the pump message to be tagged with a first intermediate identifier indicative of a first intermediate level of the one or more intermediate levels such that the tagged pump message includes the facility identifier, the account identifier, and the first intermediate identifier.

Clause 168. The apparatus of Clause 167, wherein the computer-executable instructions further configure the one or more processors to, in response to determining that the facility is no longer associated with the first intermediate level in the hierarchical structure, cause the first intermediate identifier to be updated, such that the tagged pump message includes the updated first intermediate identifier.

Clause 169. The apparatus of Clause 163, wherein processing the pump message comprises converting a message in a first format received from the infusion pump into the pump message in a second format different from the first format.

Clause 170. Non-transitory physical computer storage storing computer-executable instructions that, when executed by one or more computing devices, configure the one or more computing devices to: process a pump message including information about an infusion pump residing in the clinical environment; cause the pump message to be tagged with a facility identifier indicative of a facility associated with the infusion pump and an account identifier indicative of an account associated with the infusion pump, wherein the facility is below the account in a hierarchical structure, and wherein the message is not tagged with at least one other identifier indicative of an intermediate level that is between the facility and the account in the hierarchical structure; and cause the tagged pump message to be transmitted to a remote server such that the facility identifier of the tagged pump message and the account identifier of the tagged message need not be changed by the remote server in response to the facility being moved within the hierarchical structure.

Clause 171. The non-transitory physical computer storage of Clause 170, wherein the facility identifier and the account identifier are permanent identifiers that are not changed in response to the facility being moved to another system or region in the hierarchical structure.

Clause 172. The non-transitory physical computer storage of Clause 170, wherein the infusion pump is configured to generate pump messages without determining the facility associated with the infusion pump or the account associated with the infusion pump.

Clause 173. The non-transitory physical computer storage of Clause 170, wherein the intermediate level in the hierarchical structure is a system associated with the infusion pump or a region associated with the infusion pump.

Clause 174. The non-transitory physical computer storage of Clause 170, wherein processing the pump message comprises converting a message in a first format received from the infusion pump into the pump message in a second format different from the first format.

Other Considerations

It is to be understood that not necessarily all objects or advantages may be achieved in accordance with any particular embodiment described herein. Thus, for example, those skilled in the art will recognize that certain embodiments may be configured to operate in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other objects or advantages as may be taught or suggested herein.

Many other variations than those described herein will be apparent from this disclosure. For example, depending on the embodiment, certain acts, events, or functions of any of the algorithms described herein can be performed in a different sequence, can be added, merged, or left out altogether (e.g., not all described acts or events are necessary for the practice of the algorithms). Moreover, in certain embodiments, acts or events can be performed concurrently, e.g., through multi-threaded processing, interrupt processing, or multiple processors or processor cores or on other parallel architectures, rather than sequentially. In addition, different tasks or processes can be performed by different machines and/or computing systems that can function together.

The various illustrative logical blocks, modules, and algorithm elements described in connection with the embodiments disclosed herein can be implemented as electronic hardware, computer software, or combinations of both. To clearly illustrate this interchangeability of hardware and software, various illustrative components, blocks, modules, and elements have been described above generally in terms of their functionality. Whether such functionality is implemented as hardware or software depends upon the particular application and design constraints imposed on the overall system. The described functionality can be implemented in varying ways for each particular application, but such implementation decisions should not be interpreted as causing a departure from the scope of the disclosure.

The various illustrative logical blocks and modules described in connection with the embodiments disclosed herein can be implemented or performed by a machine, such as a general purpose processor, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA) or other programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof designed to perform the functions described herein. A general-purpose processor can be a microprocessor, but in the alternative, the processor can be a controller, microcontroller, or state machine, combinations of the same, or the like. A processor can include electrical circuitry configured to process computer-executable instructions. In another embodiment, a processor includes an FPGA or other programmable device that performs logic operations without processing computer-executable instructions. A processor can also be implemented as a combination of computing devices, e.g., a combination of a DSP and a microprocessor, a plurality of microprocessors, one or more microprocessors in conjunction with a DSP core, or any other such configuration. Although described herein primarily with respect to digital technology, a processor may also include primarily analog components. For example, some or all of the signal processing algorithms described herein may be implemented in analog circuitry or mixed analog and digital circuitry. A computing environment can include any type of computer system, including, but not limited to, a computer system based on a microprocessor, a mainframe computer, a digital signal processor, a portable computing device, a device controller, or a computational engine within an appliance, to name a few.

The elements of a method, process, or algorithm described in connection with the embodiments disclosed herein can be embodied directly in hardware, in a software module stored in one or more memory devices and executed by one or more processors, or in a combination of the two. A software module can reside in RAM memory, flash memory, ROM memory, EPROM memory, EEPROM memory, registers, hard disk, a removable disk, a CD-ROM, or any other form of non-transitory computer-readable storage medium, media, or physical computer storage known in the art. An example storage medium can be coupled to the processor such that the processor can read information from, and write information to, the storage medium. In the alternative, the storage medium can be integral to the processor. The storage medium can be volatile or nonvolatile. The processor and the storage medium can reside in an ASIC. The ASIC can reside in a user terminal. In the alternative, the processor and the storage medium can reside as discrete components in a user terminal.

Conditional language used herein, such as, among others, “can,” “might,” “may,” “e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements, and/or states. Thus, such conditional language is not generally intended to imply that features, elements and/or states are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without author input or prompting, whether these features, elements and/or states are included or are to be performed in any particular embodiment. The terms “comprising,” “including,” “having,” and the like are synonymous and are used inclusively, in an open-ended fashion, and do not exclude additional elements, features, acts, operations, and so forth. Also, the term “or” is used in its inclusive sense (and not in its exclusive sense) so that when used, for example, to connect a list of elements, the term “or” means one, some, or all of the elements in the list. Further, the term “each,” as used herein, in addition to having its ordinary meaning, can mean any subset of a set of elements to which the term “each” is applied.

Disjunctive language such as the phrase “at least one of X, Y, or Z,” unless specifically stated otherwise, is otherwise understood with the context as used in general to present that an item, term, etc., may be either X, Y, or Z, or any combination thereof (e.g., X, Y, and/or Z). Thus, such disjunctive language is not generally intended to, and should not, imply that certain embodiments require at least one of X, at least one of Y, or at least one of Z to each be present.

Unless otherwise explicitly stated, articles such as “a”, “an”, or “the” should generally be interpreted to include one or more described items. Accordingly, phrases such as “a device configured to” are intended to include one or more recited devices. Such one or more recited devices can also be collectively configured to carry out the stated recitations. For example, “a processor configured to carry out recitations A, B, and C” can include a first processor configured to carry out recitation A working in conjunction with a second processor configured to carry out recitations B and C.

While the above detailed description has shown, described, and pointed out novel features as applied to various embodiments, it will be understood that various omissions, substitutions, and changes in the form and details of the devices or algorithms illustrated can be made without departing from the spirit of the disclosure. As will be recognized, certain embodiments described herein can be implemented within a form that does not provide all of the features and benefits set forth herein, as some features can be used or practiced separately from others. All such modifications and variations are intended to be included herein within the scope of this disclosure. Further, additional embodiments created by combining any two or more features or techniques of one or more embodiments described herein are also intended to be included herein within the scope of this disclosure.

Claims

1. A method for authenticating a network device residing in a network environment, the method comprising: processing, by a proxy, an authentication request from the network device residing in the network environment, wherein the proxy is in communication with (i) the network device residing in the network environment, and (ii) an authentication system configured to perform authentication based on login requests from a plurality of user devices not residing in the network environment as well as the network device residing in the network environment, wherein the authentication request from the network device includes identifying information associated with the network environment, and wherein the network environment includes one or more devices in communication with the network device;transmitting login information to the authentication system;receiving a token from the authentication system; andtransmitting the token to the network device residing in the network environment such that the token is usable by the network device to transmit requests to the authentication system.
2. The method of claim 1, wherein the login information is transmitted via a WebSocket connection.
3. The method of claim 1, wherein the login information is transmitted via a network connection that is secured and authenticated.
4. The method of claim 1, further comprising causing the network device residing in the network environment to transmit a signed request to the authentication system.
5. The method of claim 1, wherein the login information is transmitted, and the token is received, via one or more network connections that are established over a wide area network.
6. The method of claim 1, further comprising receiving a message from the network device residing in the network environment via a network connection via which the login information was transmitted, wherein the message includes information associated with the one or more devices in communication with the network device.
7. The method of claim 1, wherein the network device is configured to communicate with the one or more devices over a local area network.
8. A system configured to authenticate a network device residing in a network environment, the system comprising: one or more processors in communication with (i) a network device residing in the network environment, and (ii) an authentication system configured to perform authentication based on login requests from a plurality of user devices not residing in the network environment as well as the network device residing in the network environment; andone or more memories in communication with the one or more processors and storing computer-executable instructions that, when executed by the one or more processors, configure the one or more processors to: process an authentication request from the network device residing in the network environment, wherein the authentication request includes identifying information associated with the network environment, and wherein the network environment includes one or more devices in communication with the network device;cause login information to be transmitted to the authentication system;receive a token from the authentication system; andcause the token to be transmitted to the network device residing in the network environment such that the token is usable by the network device to transmit requests to the authentication system.
9. The system of claim 8, wherein the login information is transmitted via a WebSocket connection.
10. The system of claim 8, wherein the login information is transmitted via a network connection that is secured and authenticated.
11. The system of claim 8, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to cause the network device residing in the network environment to transmit a signed request to the authentication system.
12. The system of claim 8, wherein the login information is transmitted, and the token is received, via one or more network connections that are established over a wide area network.
13. The system of claim 8, wherein the computer-executable instructions, when executed by the one or more processors, further configure the one or more processors to receive a message from the network device residing in the network environment via a network connection via which the login information was transmitted, wherein the message includes information associated with the one or more devices in communication with the network device.
14. The system of claim 8, wherein the network device is configured to communicate with the one or more devices over a local area network.
15. Non-transitory physical computer storage storing computer-executable instructions that, when executed by one or more computing devices in communication with (i) a network device residing in a network environment, and (ii) an authentication system configured to perform authentication based on login requests from a plurality of user devices not residing in the network environment as well as the network device residing in the network environment, configure the one or more computing devices to: process an authentication request from the network device residing in the network environment, wherein the authentication request includes identifying information associated with the network environment, and wherein the network environment includes one or more devices in communication with the network device;cause login information to be transmitted to the authentication system;receive a token from the authentication system, the token being usable by the network device to transmit requests to the authentication system; andcause the token to be transmitted to the network device residing in the network environment such that the token is usable by the network device to transmit requests to the authentication system.
16. The non-transitory physical computer storage of claim 15, wherein the login information is transmitted via a secured and authenticated WebSocket connection.
17. The non-transitory physical computer storage of claim 15, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to cause the network device residing in the network environment to transmit a signed request to the authentication system.
18. The non-transitory physical computer storage of claim 15, wherein the login information is transmitted, and the token is received, via one or more network connections that are established over a wide area network.
19. The non-transitory physical computer storage of claim 15, wherein the computer-executable instructions, when executed by the one or more computing devices, further configure the one or more computing devices to receive a message from the network device residing in the network environment via a network connection via which the login information was transmitted, wherein the message includes information associated with the one or more devices in communication with the network device.
20. The non-transitory physical computer storage of claim 15, wherein the network device is configured to communicate with the one or more devices over a local area network.

INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 17/447,557 filed Sep. 13, 2021 and titled “PASSING AUTHENTICATION TOKEN TO AUTHORIZE ACCESS TO REST CALLS VIA WEB SOCKETS,” which is a continuation of U.S. patent application Ser. No. 16/512,224, filed Jul. 15, 2019 and titled “PASSING AUTHENTICATION TOKEN TO AUTHORIZE ACCESS TO REST CALLS VIA WEB SOCKETS,” which is a continuation of International Application No. PCT/US19/41706, filed Jul. 12, 2019 and titled “SYSTEMS AND METHODS FOR FACILITATING CLINICAL MESSAGING IN A NETWORK ENVIRONMENT,” which claims priority to U.S. Provisional Application No. 62/699,499, filed on Jul. 17, 2018 and titled “SYSTEMS AND METHODS FOR FACILITATING CLINICAL MESSAGING IN A NETWORK ENVIRONMENT.” Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated herein by reference in their entirety under 37 CFR 1.57.

US Referenced Citations (1368)

Number	Name	Date	Kind
4024864	Davies et al.	May 1977	A
4055175	Clemens et al.	Oct 1977	A
4151845	Clemens	May 1979	A
4213454	Shim	Jul 1980	A
4240438	Updike et al.	Dec 1980	A
4280494	Cosgrove et al.	Jul 1981	A
4308866	Jeliffe	Jan 1982	A
4370983	Lichtenstein et al.	Feb 1983	A
4373527	Fischell	Feb 1983	A
4392849	Petre et al.	Jul 1983	A
4395259	Prestele et al.	Jul 1983	A
4457751	Rodler	Jul 1984	A
4464170	Clemens	Aug 1984	A
4469481	Kobayashi	Sep 1984	A
4475901	Kraegen et al.	Oct 1984	A
4494950	Fischell	Jan 1985	A
4498843	Schneider et al.	Feb 1985	A
4515584	Abe et al.	May 1985	A
4526568	Clemens et al.	Jul 1985	A
4529401	Leslie et al.	Jul 1985	A
4543955	Schroeppel	Oct 1985	A
4551133	Zegers de Beyl et al.	Nov 1985	A
4553958	LeCocq	Nov 1985	A
4559037	Franetzki et al.	Dec 1985	A
4613937	Batty	Sep 1986	A
4624661	Arimond	Nov 1986	A
4633878	Bombardieri	Jan 1987	A
4634426	Kamen	Jan 1987	A
4634427	Hannula et al.	Jan 1987	A
4674652	Aten et al.	Jun 1987	A
4676776	Howson et al.	Jun 1987	A
4679562	Luksha	Jul 1987	A
4685903	Cable et al.	Aug 1987	A
4695954	Rose	Sep 1987	A
4696671	Epstein et al.	Sep 1987	A
4714462	DiDomenico	Dec 1987	A
4722734	Kolin	Feb 1988	A
4730849	Siegel	Mar 1988	A
4731051	Fischell	Mar 1988	A
4741732	Crankshaw et al.	May 1988	A
4756706	Kerns et al.	Jul 1988	A
4776842	Franetzki et al.	Oct 1988	A
4785969	McLaughlin	Nov 1988	A
4803625	Fu et al.	Feb 1989	A
4835372	Gombrich et al.	May 1989	A
4838275	Lee	Jun 1989	A
4838856	Mulreany et al.	Jun 1989	A
4838857	Strowe et al.	Jun 1989	A
4854324	Hirschman et al.	Aug 1989	A
4857716	Gombrich et al.	Aug 1989	A
4858154	Anderson et al.	Aug 1989	A
4898578	Rubalcaba, Jr.	Feb 1990	A
4908017	Howson et al.	Mar 1990	A
4933873	Kaufman et al.	Jun 1990	A
4943279	Samiotes et al.	Jul 1990	A
4946439	Eggers	Aug 1990	A
4953745	Rowlett	Sep 1990	A
4978335	Arthur, III	Dec 1990	A
5000739	Kulisz et al.	Mar 1991	A
5010473	Jacobs	Apr 1991	A
5014698	Cohen	May 1991	A
5016172	Dessertine	May 1991	A
5026084	Paisfield	Jun 1991	A
5034004	Crankshaw	Jul 1991	A
5041086	Koenig et al.	Aug 1991	A
5058161	Weiss	Oct 1991	A
5078683	Sancoff et al.	Jan 1992	A
5084828	Kaufman et al.	Jan 1992	A
5088981	Howson et al.	Feb 1992	A
5097505	Weiss	Mar 1992	A
5100380	Epstein et al.	Mar 1992	A
5102392	Sakai et al.	Apr 1992	A
5104374	Bishko et al.	Apr 1992	A
5109850	Blanco et al.	May 1992	A
5131816	Brown	Jul 1992	A
5142484	Kaufman et al.	Aug 1992	A
5153827	Coutre et al.	Oct 1992	A
5157640	Backner	Oct 1992	A
5161222	Montejo et al.	Nov 1992	A
5177993	Beckman et al.	Jan 1993	A
5181910	Scanlon	Jan 1993	A
5190522	Wocicki et al.	Mar 1993	A
5199439	Zimmerman et al.	Apr 1993	A
5200891	Kehr et al.	Apr 1993	A
5216597	Beckers	Jun 1993	A
5221268	Barton et al.	Jun 1993	A
5230061	Welch	Jul 1993	A
5243982	Möstl et al.	Sep 1993	A
5244463	Cordner, Jr. et al.	Sep 1993	A
5249260	Nigawara et al.	Sep 1993	A
5254096	Rondelet et al.	Oct 1993	A
5256156	Kern et al.	Oct 1993	A
5256157	Samiotes et al.	Oct 1993	A
5261702	Mayfield	Nov 1993	A
5317506	Coutre et al.	May 1994	A
5319355	Russek	Jun 1994	A
5319363	Welch et al.	Jun 1994	A
5330634	Wong et al.	Jul 1994	A
5338157	Blomquist	Aug 1994	A
5341476	Lowell	Aug 1994	A
5364346	Schrezenmeir	Nov 1994	A
5366346	Danby	Nov 1994	A
5368562	Blomquist et al.	Nov 1994	A
5373454	Kanda et al.	Dec 1994	A
5376070	Purvis et al.	Dec 1994	A
5378231	Johnson et al.	Jan 1995	A
5389071	Kawahara et al.	Feb 1995	A
5389078	Zalesky et al.	Feb 1995	A
5417222	Dempsey et al.	May 1995	A
5423748	Uhala	Jun 1995	A
5429602	Hauser	Jul 1995	A
5431627	Pastrone et al.	Jul 1995	A
5432777	Le Boudec et al.	Jul 1995	A
5445621	Poli et al.	Aug 1995	A
5447164	Shaya et al.	Sep 1995	A
5455851	Chaco et al.	Oct 1995	A
5461365	Schlager et al.	Oct 1995	A
5464392	Epstein et al.	Nov 1995	A
5465082	Chaco	Nov 1995	A
5485408	Blomquist	Jan 1996	A
5486286	Peterson et al.	Jan 1996	A
5493430	Lu et al.	Feb 1996	A
5496273	Pastrone et al.	Mar 1996	A
5505828	Wong et al.	Apr 1996	A
5507288	Bocker et al.	Apr 1996	A
5507786	Morgan et al.	Apr 1996	A
5508499	Ferrario	Apr 1996	A
5515713	Saugues et al.	May 1996	A
5520637	Pager et al.	May 1996	A
5522798	Johnson et al.	Jun 1996	A
5547470	Johnson et al.	Aug 1996	A
5554013	Owens et al.	Sep 1996	A
5562615	Nassif	Oct 1996	A
5577169	Prezioso	Nov 1996	A
5582323	Kurtenbach	Dec 1996	A
5582593	Hultman	Dec 1996	A
5594786	Chaco et al.	Jan 1997	A
5598519	Narayanan	Jan 1997	A
5620608	Rosa et al.	Apr 1997	A
5630710	Tune et al.	May 1997	A
5636044	Yuan et al.	Jun 1997	A
5643212	Coutre et al.	Jul 1997	A
5651775	Walker et al.	Jul 1997	A
5658131	Aoki et al.	Aug 1997	A
5658250	Blomquist et al.	Aug 1997	A
5665065	Colman et al.	Sep 1997	A
5669877	Blomquist	Sep 1997	A
5672154	Sillén et al.	Sep 1997	A
5681285	Ford et al.	Oct 1997	A
5685844	Marttila	Nov 1997	A
5687717	Halpern et al.	Nov 1997	A
5689229	Chaco et al.	Nov 1997	A
5697899	Hillman et al.	Dec 1997	A
5699509	Gary et al.	Dec 1997	A
5708714	Lopez et al.	Jan 1998	A
5713350	Yokota et al.	Feb 1998	A
5713856	Eggers et al.	Feb 1998	A
5718562	Lawless et al.	Feb 1998	A
5719761	Gatti et al.	Feb 1998	A
5733259	Valcke et al.	Mar 1998	A
5738102	Lemelson	Apr 1998	A
5744027	Connell et al.	Apr 1998	A
5752621	Passamante	May 1998	A
5754111	Garcia	May 1998	A
5764034	Bowman et al.	Jun 1998	A
5764159	Neftel et al.	Jun 1998	A
5772635	Dastur et al.	Jun 1998	A
5774865	Glynn	Jun 1998	A
5778256	Darbee	Jul 1998	A
5778345	McCartney	Jul 1998	A
5781442	Engleson et al.	Jul 1998	A
5782805	Meinzer et al.	Jul 1998	A
5788669	Peterson	Aug 1998	A
5797515	Liff et al.	Aug 1998	A
5800387	Duffy et al.	Sep 1998	A
5814015	Gargano et al.	Sep 1998	A
5822544	Chaco et al.	Oct 1998	A
5822715	Worthington et al.	Oct 1998	A
5827179	Lichter et al.	Oct 1998	A
5832448	Brown	Nov 1998	A
5836910	Duffy et al.	Nov 1998	A
5850344	Conkright	Dec 1998	A
5867821	Ballantyne et al.	Feb 1999	A
5870733	Bass et al.	Feb 1999	A
5871465	Vasko	Feb 1999	A
5873731	Predergast	Feb 1999	A
5885245	Lynch et al.	Mar 1999	A
5897493	Brown	Apr 1999	A
5897498	Canfield, II et al.	Apr 1999	A
5910252	Truitt et al.	Jun 1999	A
5912818	McGrady et al.	Jun 1999	A
5915240	Karpf	Jun 1999	A
5920054	Uber, III	Jul 1999	A
5920263	Huttenhoff et al.	Jul 1999	A
5924074	Evans	Jul 1999	A
5931764	Freeman et al.	Aug 1999	A
5935099	Peterson et al.	Aug 1999	A
5935106	Olsen	Aug 1999	A
5941846	Duffy et al.	Aug 1999	A
5956501	Brown	Sep 1999	A
5957885	Bollish et al.	Sep 1999	A
5960085	de la Huerga	Sep 1999	A
5961448	Swenson et al.	Oct 1999	A
5967559	Abramowitz	Oct 1999	A
5971594	Sahai et al.	Oct 1999	A
5975081	Hood et al.	Nov 1999	A
5990838	Burns et al.	Nov 1999	A
5997476	Brown	Dec 1999	A
6000828	Leet	Dec 1999	A
6003006	Colella et al.	Dec 1999	A
6012034	Hamparian et al.	Jan 2000	A
6017318	Gauthier et al.	Jan 2000	A
6021392	Lester et al.	Feb 2000	A
6024539	Blomquist	Feb 2000	A
6024699	Surwit et al.	Feb 2000	A
6032155	de la Huerga	Feb 2000	A
6032676	Moore	Mar 2000	A
6039251	Holowko et al.	Mar 2000	A
6070761	Bloom et al.	Jun 2000	A
6073106	Rozen et al.	Jun 2000	A
6104295	Gaisser et al.	Aug 2000	A
6112182	Akers et al.	Aug 2000	A
6112323	Meizlik et al.	Aug 2000	A
RE36871	Epstein et al.	Sep 2000	E
6115365	Newberg	Sep 2000	A
6115390	Chuah	Sep 2000	A
6122536	Sun et al.	Sep 2000	A
6126637	Kriesel et al.	Oct 2000	A
6135949	Russo et al.	Oct 2000	A
6150942	O'Brien	Nov 2000	A
6151643	Cheng et al.	Nov 2000	A
6157914	Seto et al.	Dec 2000	A
6159147	Lichter et al.	Dec 2000	A
6167567	Chiles et al.	Dec 2000	A
6182667	Hanks et al.	Feb 2001	B1
6189105	Lopes	Feb 2001	B1
6195589	Ketcham	Feb 2001	B1
6208974	Campbell et al.	Mar 2001	B1
6222323	Yamashita et al.	Apr 2001	B1
6223440	Rashman	May 2001	B1
6226277	Chuah	May 2001	B1
6227371	Song	May 2001	B1
6234176	Domae et al.	May 2001	B1
6241704	Peterson et al.	Jun 2001	B1
6248067	Causey, III et al.	Jun 2001	B1
6249705	Snell	Jun 2001	B1
6257265	Brunner et al.	Jul 2001	B1
6259355	Chaco et al.	Jul 2001	B1
6269340	Ford et al.	Jul 2001	B1
6270455	Brown	Aug 2001	B1
6271813	Palalau	Aug 2001	B1
6277072	Bardy	Aug 2001	B1
6280380	Bardy	Aug 2001	B1
6283761	Joao	Sep 2001	B1
6285665	Chuah	Sep 2001	B1
6292860	Cochcroft, Jr.	Sep 2001	B1
6312378	Bardy	Nov 2001	B1
6327254	Chuah	Dec 2001	B1
6330008	Razdow et al.	Dec 2001	B1
6339718	Zatezalo et al.	Jan 2002	B1
6346886	de la Huerga	Feb 2002	B1
6363282	Nichols et al.	Mar 2002	B1
6371719	Hildebrandt	Apr 2002	B1
6377548	Chuah	Apr 2002	B1
6388951	Matsumoto et al.	May 2002	B1
6406426	Reuss et al.	Jun 2002	B1
6408330	de la Huerga	Jun 2002	B1
6418334	Unger et al.	Jul 2002	B1
6427088	Bowman et al.	Jul 2002	B1
6428483	Carlebach	Aug 2002	B1
6442432	Lee	Aug 2002	B2
6469991	Chuah	Oct 2002	B1
6475180	Peterson et al.	Nov 2002	B2
6482158	Mault	Nov 2002	B2
6485418	Yasushi et al.	Nov 2002	B2
6494694	Lawless et al.	Dec 2002	B2
6494831	Koritzinsky	Dec 2002	B1
6497680	Holst et al.	Dec 2002	B1
6514460	Fendrock	Feb 2003	B1
6517482	Eiden et al.	Feb 2003	B1
6519569	White et al.	Feb 2003	B1
6520930	Critchlow et al.	Feb 2003	B2
6540672	Simonsen et al.	Apr 2003	B1
6542902	Dulong et al.	Apr 2003	B2
6544212	Galley et al.	Apr 2003	B2
6544228	Heitmeier	Apr 2003	B1
6546350	Hartmann et al.	Apr 2003	B1
6551276	Mann et al.	Apr 2003	B1
6554798	Mann et al.	Apr 2003	B1
6558320	Causey et al.	May 2003	B1
6558351	Steil et al.	May 2003	B1
6565509	Say et al.	May 2003	B1
6567416	Chuah	May 2003	B1
6571294	Simmon et al.	May 2003	B2
6572542	Houben et al.	Jun 2003	B1
6572545	Knobbe et al.	Jun 2003	B2
6578002	Derzay et al.	Jun 2003	B1
6581117	Klein et al.	Jun 2003	B1
6587034	Heiman et al.	Jul 2003	B1
6589229	Connelly et al.	Jul 2003	B1
6599281	Struys et al.	Jul 2003	B1
6602191	Quy	Aug 2003	B2
6605072	Struys et al.	Aug 2003	B2
6628809	Rowe et al.	Sep 2003	B1
6631353	Davis et al.	Oct 2003	B1
6640246	Gardy, Jr. et al.	Oct 2003	B1
6641533	Causey, III et al.	Nov 2003	B2
6647299	Bourget	Nov 2003	B2
6652455	Kocher	Nov 2003	B1
6653937	Nelson et al.	Nov 2003	B2
6659947	Carter et al.	Dec 2003	B1
6669630	Joliat et al.	Dec 2003	B1
6671563	Engleson et al.	Dec 2003	B1
6673033	Sciulli et al.	Jan 2004	B1
6674403	Gray et al.	Jan 2004	B2
6681003	Linder et al.	Jan 2004	B2
6689091	Bui et al.	Feb 2004	B2
6692241	Watanabe et al.	Feb 2004	B2
6694191	Starkweather et al.	Feb 2004	B2
6694334	DuLong et al.	Feb 2004	B2
6721286	Williams et al.	Apr 2004	B1
6721582	Trepagnier et al.	Apr 2004	B2
6725200	Rost	Apr 2004	B1
6731989	Engleson et al.	May 2004	B2
6740072	Starkweather et al.	May 2004	B2
6751651	Crockett	Jun 2004	B2
6752787	Causey, III et al.	Jun 2004	B1
6753830	Gelbman	Jun 2004	B2
6758810	Lebel et al.	Jul 2004	B2
6773396	Flach et al.	Aug 2004	B2
6774786	Havekost et al.	Aug 2004	B1
6775577	Cmkovich et al.	Aug 2004	B2
6780156	Haueter et al.	Aug 2004	B2
6790198	White et al.	Sep 2004	B1
6792470	Hakenberg et al.	Sep 2004	B2
6796956	Hartlaub et al.	Sep 2004	B2
6799149	Hartlaub	Sep 2004	B2
6809653	Mann et al.	Oct 2004	B1
6811534	Bowman, IV et al.	Nov 2004	B2
6816605	Rowe et al.	Nov 2004	B2
6839753	Biondi et al.	Jan 2005	B2
6852104	Blomquist	Feb 2005	B2
6859134	Heiman et al.	Feb 2005	B1
6871211	Labounty et al.	Mar 2005	B2
6873268	Lebel et al.	Mar 2005	B2
6876303	Reeder et al.	Apr 2005	B2
6885881	Leonhardt	Apr 2005	B2
6891525	Ogoro	May 2005	B2
6892278	Ebergen	May 2005	B2
6899695	Herrera	May 2005	B2
6915170	Engleson et al.	Jul 2005	B2
6923763	Kovatchev et al.	Aug 2005	B1
6924781	Gelbman	Aug 2005	B1
6928338	Buchser et al.	Aug 2005	B1
6928490	Bucholz et al.	Aug 2005	B1
6936029	Mann et al.	Aug 2005	B2
6945954	Hochman et al.	Sep 2005	B2
6948492	Wemeling et al.	Sep 2005	B2
6958677	Carter	Oct 2005	B1
6958691	Anderson et al.	Oct 2005	B1
6958705	Lebel et al.	Oct 2005	B2
6961448	Nichols et al.	Nov 2005	B2
6969352	Chiang et al.	Nov 2005	B2
6969865	Duchon et al.	Nov 2005	B2
6974437	Lebel et al.	Dec 2005	B2
6979326	Mann et al.	Dec 2005	B2
6980958	Surwit et al.	Dec 2005	B1
6985870	Martucci et al.	Jan 2006	B2
6986347	Hickle	Jan 2006	B2
6997880	Carlebach et al.	Feb 2006	B2
6997920	Mann et al.	Feb 2006	B2
6998984	Zittrain	Feb 2006	B1
7016752	Ruben et al.	Mar 2006	B1
7017293	Riley	Mar 2006	B2
7025743	Mann et al.	Apr 2006	B2
7029455	Flaherty	Apr 2006	B2
7038584	Carter	May 2006	B2
7060031	Webb et al.	Jun 2006	B2
7060059	Keith et al.	Jun 2006	B2
7069552	Lindberg et al.	Jun 2006	B2
7072725	Bristol et al.	Jul 2006	B2
7079035	Bock et al.	Jul 2006	B2
7092943	Roese et al.	Aug 2006	B2
7096072	Engleson et al.	Aug 2006	B2
7099809	Dori	Aug 2006	B2
7103419	Engleson et al.	Sep 2006	B2
7103578	Beck et al.	Sep 2006	B2
7107106	Engleson et al.	Sep 2006	B2
7108680	Rohr et al.	Sep 2006	B2
7109878	Mann et al.	Sep 2006	B2
7114002	Okumura et al.	Sep 2006	B1
7117041	Engleson et al.	Oct 2006	B2
7136645	Hanson et al.	Nov 2006	B2
7137964	Flaherty	Nov 2006	B2
7142190	Martinez	Nov 2006	B2
7150741	Erickson et al.	Dec 2006	B2
7153289	Vasko	Dec 2006	B2
7154397	Zerhusen et al.	Dec 2006	B2
7156807	Carter et al.	Jan 2007	B2
7158030	Chung	Jan 2007	B2
7161484	Tsoukalis et al.	Jan 2007	B2
7167755	Seeberger et al.	Jan 2007	B2
7167920	Traversat	Jan 2007	B2
7171277	Engleson et al.	Jan 2007	B2
7171492	Borella et al.	Jan 2007	B1
7181493	English et al.	Feb 2007	B2
7185288	McKeever	Feb 2007	B2
7193514	Ritson	Mar 2007	B2
7197025	Chuah	Mar 2007	B2
7201734	Hickle	Apr 2007	B2
7204823	Estes et al.	Apr 2007	B2
7213009	Pestotnik	May 2007	B2
7216802	de la Huerga	May 2007	B1
7220240	Struys et al.	May 2007	B2
7224979	Singhal et al.	May 2007	B2
7229430	Hickle et al.	Jun 2007	B2
7230529	Ketcherside	Jun 2007	B2
7236936	White et al.	Jun 2007	B2
7238164	Childers et al.	Jul 2007	B2
7247154	Hickle	Jul 2007	B2
7248239	Dowling	Jul 2007	B2
7250856	Havekost et al.	Jul 2007	B2
7255683	Vanderveen et al.	Aug 2007	B2
7256888	Staehr et al.	Aug 2007	B2
7258534	Fathallah et al.	Aug 2007	B2
7263213	Rowe	Aug 2007	B2
7267664	Rizzo	Sep 2007	B2
7267665	Steil et al.	Sep 2007	B2
7275156	Balfanz et al.	Sep 2007	B2
7278983	Ireland et al.	Oct 2007	B2
7289815	Gfeller et al.	Oct 2007	B2
7289948	Mohri	Oct 2007	B1
7293107	Hanson et al.	Nov 2007	B1
7295119	Rappaport et al.	Nov 2007	B2
7295556	Roese et al.	Nov 2007	B2
7301451	Hastings	Nov 2007	B2
7308300	Toews et al.	Dec 2007	B2
7315825	Rosenfeld et al.	Jan 2008	B2
7319386	Collins, Jr. et al.	Jan 2008	B2
7324000	Zittrain et al.	Jan 2008	B2
7327705	Fletcher et al.	Feb 2008	B2
7343224	DiGianfilippo et al.	Mar 2008	B2
7346025	Bryson	Mar 2008	B2
7347836	Peterson et al.	Mar 2008	B2
7354420	Steil et al.	Apr 2008	B2
7369897	Boveja et al.	May 2008	B2
7369948	Ferenczi et al.	May 2008	B1
7383088	Spinelli et al.	Jun 2008	B2
7384410	Eggers et al.	Jun 2008	B2
7398183	Holland et al.	Jul 2008	B2
7398279	Muno, Jr. et al.	Jul 2008	B2
7399277	Saidara et al.	Jul 2008	B2
7402153	Steil et al.	Jul 2008	B2
7420472	Tran	Sep 2008	B2
7432807	Schmitt	Oct 2008	B2
7436454	Yamaguchi et al.	Oct 2008	B2
7447643	Olson	Nov 2008	B1
7454314	Holland et al.	Nov 2008	B2
7457804	Uber, III et al.	Nov 2008	B2
7464040	Joao	Dec 2008	B2
7469213	Rao	Dec 2008	B1
7471994	Ford et al.	Dec 2008	B2
7483756	Engleson et al.	Jan 2009	B2
7489808	Gerder	Feb 2009	B2
7490021	Holland et al.	Feb 2009	B2
7490048	Joao	Feb 2009	B2
7491187	Van Den Berghe et al.	Feb 2009	B2
7519905	Kougiouris et al.	Apr 2009	B2
7523401	Aldridge	Apr 2009	B1
7524304	Genosar	Apr 2009	B2
7551078	Carlson	Jun 2009	B2
7559321	Wermeling et al.	Jul 2009	B2
7565197	Haulbrich et al.	Jul 2009	B2
7572230	Neumann et al.	Aug 2009	B2
7578802	Hickle	Aug 2009	B2
7621009	Elhabashy	Nov 2009	B2
D606533	De Jong et al.	Dec 2009	S
7636718	Steen et al.	Dec 2009	B1
7640172	Kuth	Dec 2009	B2
7645258	White et al.	Jan 2010	B2
7647237	Malave et al.	Jan 2010	B2
7662124	Duchon et al.	Feb 2010	B2
7668731	Martucci et al.	Feb 2010	B2
7671733	McNeal et al.	Mar 2010	B2
7678071	Lebel et al.	Mar 2010	B2
7687678	Jacobs	Mar 2010	B2
7697994	VanDanacker et al.	Apr 2010	B2
7698239	Lieuallen	Apr 2010	B2
7705727	Pestotnik	Apr 2010	B2
7724147	Brown et al.	May 2010	B2
7739126	Cave	Jun 2010	B1
7746218	Collins, Jr.	Jun 2010	B2
7766873	Moberg et al.	Aug 2010	B2
7776029	Whitehurst et al.	Aug 2010	B2
7776031	Hartlaub et al.	Aug 2010	B2
7785313	Mastrototaro	Aug 2010	B2
7788369	McAllen et al.	Aug 2010	B2
7806852	Jurson	Oct 2010	B1
7806886	Kanderian, Jr. et al.	Oct 2010	B2
7826981	Goode, Jr. et al.	Nov 2010	B2
7835927	Schlotterbeck et al.	Nov 2010	B2
7836314	Chieu	Nov 2010	B2
7856276	Ripart et al.	Dec 2010	B2
7860583	Condurso et al.	Dec 2010	B2
7864771	Tavares et al.	Jan 2011	B2
7868754	Salvat, Jr.	Jan 2011	B2
7871394	Halbert et al.	Jan 2011	B2
7886231	Hopermann et al.	Feb 2011	B2
7895053	Holland et al.	Feb 2011	B2
7896842	Palmroos et al.	Mar 2011	B2
7899546	Sieracki et al.	Mar 2011	B2
7905710	Wang et al.	Mar 2011	B2
7920061	Klein et al.	Apr 2011	B2
7933780	de la Huerga	Apr 2011	B2
7938796	Moubayed	May 2011	B2
7945452	Fathallah et al.	May 2011	B2
7974714	Hoffberg	Jul 2011	B2
7976508	Hoag	Jul 2011	B2
7996241	Zak	Aug 2011	B2
8034026	Grant	Oct 2011	B2
8038593	Friedman et al.	Oct 2011	B2
8048040	Kiani	Nov 2011	B2
8060576	Chan et al.	Nov 2011	B2
8065161	Howard et al.	Nov 2011	B2
8066672	Mandro	Nov 2011	B2
8075514	Butterfield et al.	Dec 2011	B2
8078983	Davis et al.	Dec 2011	B2
8082018	Duchon et al.	Dec 2011	B2
8082312	Chan et al.	Dec 2011	B2
8095692	Mehta et al.	Jan 2012	B2
8126730	Dicks et al.	Feb 2012	B2
8147448	Sundar et al.	Apr 2012	B2
8149131	Blomquist	Apr 2012	B2
8169914	Bajpai	May 2012	B2
8171094	Chan et al.	May 2012	B2
8172798	Hungerford et al.	May 2012	B2
8185322	Schroeder et al.	May 2012	B2
8195478	Petersen et al.	Jun 2012	B2
8206350	Mann et al.	Jun 2012	B2
8219413	Martinez et al.	Jul 2012	B2
8231578	Fathallah et al.	Jul 2012	B2
8234128	Martucci et al.	Jul 2012	B2
8267892	Spencer et al.	Sep 2012	B2
8271106	Wehba et al.	Sep 2012	B2
8287495	Michaud et al.	Oct 2012	B2
8291337	Gannin et al.	Oct 2012	B2
8298184	DiPerna et al.	Oct 2012	B2
8312272	Serenyi	Nov 2012	B1
8352290	Bartz et al.	Jan 2013	B2
8359338	Butterfield et al.	Jan 2013	B2
8380536	Howard et al.	Feb 2013	B2
8387112	Ranjan et al.	Feb 2013	B1
8394077	Jacobson et al.	Mar 2013	B2
8398592	Leibner-Druska	Mar 2013	B2
8403908	Jacobson et al.	Mar 2013	B2
8435206	Evans et al.	May 2013	B2
8449523	Brukalo et al.	May 2013	B2
8452953	Buck et al.	May 2013	B2
8453645	Figueiredo et al.	Jun 2013	B2
8472630	Konrad et al.	Jun 2013	B2
8480648	Burnett et al.	Jul 2013	B2
8486019	White et al.	Jul 2013	B2
8489427	Simpson et al.	Jul 2013	B2
8494879	Davis et al.	Jul 2013	B2
8504179	Blomquist	Aug 2013	B2
8517990	Teel et al.	Aug 2013	B2
8518021	Stewart et al.	Aug 2013	B2
8543416	Palmroos et al.	Sep 2013	B2
8551038	Tsoukalis et al.	Oct 2013	B2
8560345	Wehba et al.	Oct 2013	B2
8567681	Borges et al.	Oct 2013	B2
8577692	Silkaitis et al.	Nov 2013	B2
8579884	Lanier et al.	Nov 2013	B2
8626530	Tran et al.	Jan 2014	B1
8655676	Wehba et al.	Feb 2014	B2
8660860	Wehba et al.	Feb 2014	B2
8662388	Belkin	Mar 2014	B2
8666769	Butler et al.	Mar 2014	B2
8667293	Birtwhistle et al.	Mar 2014	B2
8687811	Nierzwick et al.	Apr 2014	B2
8700421	Feng et al.	Apr 2014	B2
8731960	Butler et al.	May 2014	B2
8768719	Wehba et al.	Jul 2014	B2
8771251	Ruchti et al.	Jul 2014	B2
8777894	Butterfield et al.	Jul 2014	B2
8777895	Hsu et al.	Jul 2014	B2
8799012	Butler et al.	Aug 2014	B2
8876793	Ledford et al.	Nov 2014	B2
8886316	Juels	Nov 2014	B1
8922330	Moberg et al.	Dec 2014	B2
8936565	Chawla	Jan 2015	B2
8945043	Lee et al.	Feb 2015	B2
8952794	Blomquist et al.	Feb 2015	B2
8959617	Newlin et al.	Feb 2015	B2
8998100	Halbert et al.	Apr 2015	B2
9026370	Rubalcaba et al.	May 2015	B2
9069887	Gupta et al.	Jun 2015	B2
9077544	Baker	Jul 2015	B2
9089642	Murphy et al.	Jul 2015	B2
9114217	Sur et al.	Aug 2015	B2
9123077	Silkaitis et al.	Sep 2015	B2
9192712	DeBelser et al.	Nov 2015	B2
9240002	Hume et al.	Jan 2016	B2
9292692	Wallrabenstein	Mar 2016	B2
9302035	Marseille et al.	Apr 2016	B2
9313154	Son	Apr 2016	B1
9381296	Arrizza et al.	Jul 2016	B2
9393362	Cozmi et al.	Jul 2016	B2
9430655	Stockton et al.	Aug 2016	B1
9438580	Kupper	Sep 2016	B2
9483615	Roberts	Nov 2016	B2
9498583	Sur et al.	Nov 2016	B2
9539383	Kohlbrecher	Jan 2017	B2
9572923	Howard et al.	Feb 2017	B2
9594875	Arrizza et al.	Mar 2017	B2
9604000	Wehba et al.	Mar 2017	B2
9641432	Jha et al.	May 2017	B2
9649431	Gray et al.	May 2017	B2
9662436	Belkin et al.	May 2017	B2
9690909	Stewart et al.	Jun 2017	B2
9707341	Dumas, III et al.	Jul 2017	B2
9717845	Istoc	Aug 2017	B2
9724470	Day et al.	Aug 2017	B2
9764082	Day et al.	Sep 2017	B2
9886550	Lee et al.	Feb 2018	B2
9943269	Muhsin et al.	Apr 2018	B2
9967739	Proennecke et al.	May 2018	B2
9971871	Arrizza et al.	May 2018	B2
9995611	Ruchti et al.	Jun 2018	B2
10022498	Ruchti et al.	Jul 2018	B2
10042986	Ruchti et al.	Aug 2018	B2
10046112	Oruklu et al.	Aug 2018	B2
10166328	Oruklu et al.	Jan 2019	B2
10173008	Simpson et al.	Jan 2019	B2
10188849	Fangrow	Jan 2019	B2
10233179	Ng et al.	Mar 2019	B2
10238799	Kohlbrecher	Mar 2019	B2
10238801	Wehba et al.	Mar 2019	B2
10242060	Butler et al.	Mar 2019	B2
10300194	Day et al.	May 2019	B2
10311972	Kohlbrecher et al.	Jun 2019	B2
10314974	Day et al.	Jun 2019	B2
10333843	Jha et al.	Jun 2019	B2
10341866	Spencer et al.	Jul 2019	B1
10409995	Wasiq	Sep 2019	B1
10430761	Hume et al.	Oct 2019	B2
10434246	Silkaitis et al.	Oct 2019	B2
10438001	Hariprasad	Oct 2019	B1
10452842	Dhondse	Oct 2019	B2
10453157	Kamen et al.	Oct 2019	B2
10463788	Day	Nov 2019	B2
10516536	Rommel	Dec 2019	B2
10617815	Day et al.	Apr 2020	B2
10646651	Day et al.	May 2020	B2
10681207	Johnson et al.	Jun 2020	B1
10692595	Xavier et al.	Jun 2020	B2
10728262	Vaswani	Jul 2020	B1
10740436	Moskal et al.	Aug 2020	B2
10741280	Xavier et al.	Aug 2020	B2
10757219	Moskal	Aug 2020	B2
10765799	Belkin et al.	Sep 2020	B2
10799632	Kohlbrecher	Oct 2020	B2
10812380	Jha et al.	Oct 2020	B2
10861592	Xavier et al.	Dec 2020	B2
10898641	Day et al.	Jan 2021	B2
10950339	Xavier et al.	Mar 2021	B2
10964428	Xavier et al.	Mar 2021	B2
11013861	Wehba et al.	May 2021	B2
11037668	Ruchti et al.	Jun 2021	B2
11052193	Day et al.	Jul 2021	B2
11139058	Xavier et al.	Oct 2021	B2
11151290	Karakoyunlu et al.	Oct 2021	B2
11152108	Xavier et al.	Oct 2021	B2
11152109	Xavier et al.	Oct 2021	B2
11152110	Xavier et al.	Oct 2021	B2
11194810	Butler et al.	Dec 2021	B2
11235100	Howard et al.	Feb 2022	B2
11289183	Kohlbrecher	Mar 2022	B2
11309070	Xavier et al.	Apr 2022	B2
11328804	Xavier et al.	May 2022	B2
11328805	Xavier et al.	May 2022	B2
11373753	Xavier et al.	Jun 2022	B2
11437132	Xavier et al.	Sep 2022	B2
11470000	Jha et al.	Oct 2022	B2
11483402	Xavier et al.	Oct 2022	B2
11483403	Xavier et al.	Oct 2022	B2
11501877	Kohlbrecher et al.	Nov 2022	B2
11571508	Jacobson et al.	Feb 2023	B2
11574721	Kohlbrecher	Feb 2023	B2
11574737	Dharwad et al.	Feb 2023	B2
11587669	Xavier et al.	Feb 2023	B2
11590057	Tagliamento et al.	Feb 2023	B2
11594326	Xavier et al.	Feb 2023	B2
11605468	Jacobson et al.	Mar 2023	B2
11626205	Arrizza et al.	Apr 2023	B2
11628246	Day et al.	Apr 2023	B2
11628254	Day et al.	Apr 2023	B2
11654237	Wehba et al.	May 2023	B2
11670416	Xavier et al.	Jun 2023	B2
11763927	Ruchti et al.	Sep 2023	B2
11783935	Xavier et al.	Oct 2023	B2
11881297	Xavier et al.	Jan 2024	B2
20010016056	Westphal et al.	Aug 2001	A1
20010029178	Criss et al.	Oct 2001	A1
20010031944	Peterson et al.	Oct 2001	A1
20010032099	Joao	Oct 2001	A1
20010037060	Thompson et al.	Nov 2001	A1
20010044731	Coffman et al.	Nov 2001	A1
20010048027	Walsh	Dec 2001	A1
20010051787	Haller et al.	Dec 2001	A1
20010056358	Dulong et al.	Dec 2001	A1
20020010595	Kapp	Jan 2002	A1
20020013551	Zaitsu et al.	Jan 2002	A1
20020013723	Mise	Jan 2002	A1
20020015018	Shimazu et al.	Feb 2002	A1
20020019584	Schulze et al.	Feb 2002	A1
20020021700	Hata et al.	Feb 2002	A1
20020026103	Norris et al.	Feb 2002	A1
20020029776	Blomquist	Mar 2002	A1
20020032583	Joao	Mar 2002	A1
20020040208	Flaherty et al.	Apr 2002	A1
20020040282	Bailey et al.	Apr 2002	A1
20020044043	Chaco et al.	Apr 2002	A1
20020044059	Reeder et al.	Apr 2002	A1
20020082728	Mueller et al.	Jun 2002	A1
20020087115	Hartlaub	Jul 2002	A1
20020087116	Hartlaub	Jul 2002	A1
20020095486	Bahl	Jul 2002	A1
20020103675	Vanelli	Aug 2002	A1
20020123905	Goodroe et al.	Sep 2002	A1
20020143580	Bristol et al.	Oct 2002	A1
20020152239	Bautista-Lloyd et al.	Oct 2002	A1
20020154600	Ido et al.	Oct 2002	A1
20020173702	Lebel et al.	Nov 2002	A1
20020173875	Wallace et al.	Nov 2002	A1
20020193679	Malave et al.	Dec 2002	A1
20020194329	Alling	Dec 2002	A1
20030009244	Engleson	Jan 2003	A1
20030013959	Grunwald et al.	Jan 2003	A1
20030014222	Klass et al.	Jan 2003	A1
20030014817	Gallant et al.	Jan 2003	A1
20030025602	Medema et al.	Feb 2003	A1
20030028082	Thompson	Feb 2003	A1
20030036683	Kehr et al.	Feb 2003	A1
20030036744	Struys et al.	Feb 2003	A1
20030047126	Tomaschko	Mar 2003	A1
20030047600	Nakanishi et al.	Mar 2003	A1
20030050621	Lebel et al.	Mar 2003	A1
20030059750	Bindler et al.	Mar 2003	A1
20030060688	Ciarniello et al.	Mar 2003	A1
20030069963	Jayant et al.	Apr 2003	A1
20030079746	Hickle	May 2003	A1
20030097529	Arimilli et al.	May 2003	A1
20030104982	Wittmann et al.	Jun 2003	A1
20030105389	Noonan et al.	Jun 2003	A1
20030106553	Vanderveen	Jun 2003	A1
20030115358	Yun	Jun 2003	A1
20030120384	Haitin et al.	Jun 2003	A1
20030125662	Bui	Jul 2003	A1
20030130616	Steil	Jul 2003	A1
20030135087	Hickle et al.	Jul 2003	A1
20030139701	White et al.	Jul 2003	A1
20030140928	Bui et al.	Jul 2003	A1
20030140929	Wilkes et al.	Jul 2003	A1
20030141981	Bui et al.	Jul 2003	A1
20030143746	Sage, Jr.	Jul 2003	A1
20030144878	Wilkes et al.	Jul 2003	A1
20030158749	Olchanski et al.	Aug 2003	A1
20030187338	Say et al.	Oct 2003	A1
20030200116	Forrester	Oct 2003	A1
20030204416	Acharya	Oct 2003	A1
20030204781	Peebles et al.	Oct 2003	A1
20030212364	Mann et al.	Nov 2003	A1
20030212379	Bylund et al.	Nov 2003	A1
20030212821	Gillies et al.	Nov 2003	A1
20030216831	Hart et al.	Nov 2003	A1
20030217962	Childers et al.	Nov 2003	A1
20040008123	Carrender et al.	Jan 2004	A1
20040010786	Cool et al.	Jan 2004	A1
20040015132	Brown	Jan 2004	A1
20040019607	Moubayed et al.	Jan 2004	A1
20040030323	Ullestad et al.	Feb 2004	A1
20040039257	Hickle	Feb 2004	A1
20040057226	Berthou et al.	Mar 2004	A1
20040064341	Langan et al.	Apr 2004	A1
20040064342	Browne et al.	Apr 2004	A1
20040064435	Moubayed et al.	Apr 2004	A1
20040073161	Tachibana	Apr 2004	A1
20040073811	Sanin	Apr 2004	A1
20040077934	Massad	Apr 2004	A1
20040078231	Wilkes et al.	Apr 2004	A1
20040078236	Stoodley et al.	Apr 2004	A1
20040085186	Eveland et al.	May 2004	A1
20040104271	Martucci et al.	Jun 2004	A1
20040122530	Hansen	Jun 2004	A1
20040128162	Schlotterbeck et al.	Jul 2004	A1
20040128163	Goodman et al.	Jul 2004	A1
20040133441	Brady et al.	Jul 2004	A1
20040139004	Cohen et al.	Jul 2004	A1
20040145480	Despotis	Jul 2004	A1
20040147034	Gore et al.	Jul 2004	A1
20040167464	Ireland et al.	Aug 2004	A1
20040167465	Kohler	Aug 2004	A1
20040167804	Simpson	Aug 2004	A1
20040172222	Simpson et al.	Sep 2004	A1
20040172283	Vanderveen	Sep 2004	A1
20040172301	Mihai et al.	Sep 2004	A1
20040172302	Martucci et al.	Sep 2004	A1
20040176667	Mihai et al.	Sep 2004	A1
20040176980	Bulitta et al.	Sep 2004	A1
20040176984	White et al.	Sep 2004	A1
20040181314	Zaleski	Sep 2004	A1
20040189708	Larcheveque et al.	Sep 2004	A1
20040193325	Bonderud	Sep 2004	A1
20040193328	Butterfield et al.	Sep 2004	A1
20040193453	Butterfield et al.	Sep 2004	A1
20040204673	Flaherty et al.	Oct 2004	A1
20040215278	Stegink et al.	Oct 2004	A1
20040220517	Starkweather et al.	Nov 2004	A1
20040225252	Gillespie et al.	Nov 2004	A1
20040236240	Kraus et al.	Nov 2004	A1
20040243438	Mintz	Dec 2004	A1
20040254434	Goodnow et al.	Dec 2004	A1
20050010269	Lebel et al.	Jan 2005	A1
20050020886	Hutchinson et al.	Jan 2005	A1
20050021006	Tonnies	Jan 2005	A1
20050027560	Cook	Feb 2005	A1
20050027567	Taha	Feb 2005	A1
20050038311	Kuth	Feb 2005	A1
20050038669	Sachdeva et al.	Feb 2005	A1
20050038680	McMahon	Feb 2005	A1
20050040226	Al-Sheikh	Feb 2005	A1
20050043620	Fallows et al.	Feb 2005	A1
20050049910	Lancaster et al.	Mar 2005	A1
20050055242	Bello et al.	Mar 2005	A1
20050055244	Mullan et al.	Mar 2005	A1
20050065465	Lebel et al.	Mar 2005	A1
20050065817	Mihai et al.	Mar 2005	A1
20050075544	Shapiro et al.	Apr 2005	A1
20050080801	Kothandaraman et al.	Apr 2005	A1
20050086071	Fox, Jr. et al.	Apr 2005	A1
20050086072	Fox	Apr 2005	A1
20050088704	Vaschillo et al.	Apr 2005	A1
20050090808	Malave et al.	Apr 2005	A1
20050099624	Staehr	May 2005	A1
20050102162	Blumenfeld	May 2005	A1
20050102165	Oshita et al.	May 2005	A1
20050102167	Kapoor	May 2005	A1
20050102669	Marney et al.	May 2005	A1
20050107923	Vanderveen	May 2005	A1
20050108057	Cohen et al.	May 2005	A1
20050117529	Ramos-Escano	Jun 2005	A1
20050119788	Engleson et al.	Jun 2005	A1
20050119914	Batch	Jun 2005	A1
20050131739	Rabinowitz et al.	Jun 2005	A1
20050135306	McAllen et al.	Jun 2005	A1
20050137522	Aoki	Jun 2005	A1
20050137573	McLaughlin	Jun 2005	A1
20050138428	McAllen et al.	Jun 2005	A1
20050154769	Eckart et al.	Jul 2005	A1
20050160057	Wefers et al.	Jul 2005	A1
20050171503	Van Den Berghe et al.	Aug 2005	A1
20050171815	Vanderveen	Aug 2005	A1
20050177096	Bollish et al.	Aug 2005	A1
20050177395	Blomquist	Aug 2005	A1
20050182306	Sloan	Aug 2005	A1
20050182355	Bui	Aug 2005	A1
20050187950	Parker	Aug 2005	A1
20050192557	Brauker et al.	Sep 2005	A1
20050197554	Polcha	Sep 2005	A1
20050197621	Poulsen et al.	Sep 2005	A1
20050210037	Wefers et al.	Sep 2005	A1
20050216479	Wefers et al.	Sep 2005	A1
20050216480	Wefers et al.	Sep 2005	A1
20050223045	Funahashi et al.	Oct 2005	A1
20050224083	Crass	Oct 2005	A1
20050234746	Funahashi	Oct 2005	A1
20050240305	Bogash et al.	Oct 2005	A1
20050246416	Blomquist	Nov 2005	A1
20050251418	Fox, Jr. et al.	Nov 2005	A1
20050261660	Choi	Nov 2005	A1
20050273059	Mernoe et al.	Dec 2005	A1
20050273367	Nourie et al.	Dec 2005	A1
20050277873	Stewart et al.	Dec 2005	A1
20050277890	Stewart et al.	Dec 2005	A1
20050277911	Stewart et al.	Dec 2005	A1
20050278194	Holland et al.	Dec 2005	A1
20060004772	Hagan et al.	Jan 2006	A1
20060009727	O'Mahony et al.	Jan 2006	A1
20060009734	Martin	Jan 2006	A1
20060010098	Goodnow et al.	Jan 2006	A1
20060042139	Mendes	Mar 2006	A1
20060047270	Shelton	Mar 2006	A1
20060053036	Coffman et al.	Mar 2006	A1
20060064020	Burnes et al.	Mar 2006	A1
20060074633	Mahesh et al.	Apr 2006	A1
20060074920	Wefers et al.	Apr 2006	A1
20060079831	Gilbert	Apr 2006	A1
20060089539	Miodownik et al.	Apr 2006	A1
20060089854	Holland et al.	Apr 2006	A1
20060089855	Holland et al.	Apr 2006	A1
20060100746	Leibner-Druska	May 2006	A1
20060100907	Holland et al.	May 2006	A1
20060106649	Eggers et al.	May 2006	A1
20060111943	Wu	May 2006	A1
20060116904	Brem	Jun 2006	A1
20060116907	Rhodes et al.	Jun 2006	A1
20060122481	Sievenpiper et al.	Jun 2006	A1
20060122867	Eggers et al.	Jun 2006	A1
20060129140	Todd et al.	Jun 2006	A1
20060129429	Moubayed et al.	Jun 2006	A1
20060129434	Smitherman et al.	Jun 2006	A1
20060129435	Smitherman et al.	Jun 2006	A1
20060136266	Tarassenko et al.	Jun 2006	A1
20060136271	Eggers et al.	Jun 2006	A1
20060143051	Eggers et al.	Jun 2006	A1
20060173260	Gaoni et al.	Aug 2006	A1
20060173406	Hayes et al.	Aug 2006	A1
20060173715	Wang et al.	Aug 2006	A1
20060173927	Beyer et al.	Aug 2006	A1
20060190302	Eggers et al.	Aug 2006	A1
20060195022	Trepagnier et al.	Aug 2006	A1
20060200007	Brockway et al.	Sep 2006	A1
20060200369	Batch et al.	Sep 2006	A1
20060211404	Cromp et al.	Sep 2006	A1
20060224141	Rush et al.	Oct 2006	A1
20060229918	Fotsch et al.	Oct 2006	A1
20060236373	Graves et al.	Oct 2006	A1
20060247606	Batch	Nov 2006	A1
20060253554	Uwais	Nov 2006	A1
20060258985	Russell	Nov 2006	A1
20060259327	Hoag	Nov 2006	A1
20060264895	Flanders	Nov 2006	A1
20060265246	Hoag	Nov 2006	A1
20060267753	Hussey et al.	Nov 2006	A1
20060268710	Appanna et al.	Nov 2006	A1
20060270971	Gelfand et al.	Nov 2006	A1
20060277206	Bailey et al.	Dec 2006	A1
20060287885	Frick	Dec 2006	A1
20070015972	Wang et al.	Jan 2007	A1
20070016443	Wachman et al.	Jan 2007	A1
20070021715	Kohlbrenner et al.	Jan 2007	A1
20070027506	Stender et al.	Feb 2007	A1
20070060796	Kim	Mar 2007	A1
20070060870	Tolle et al.	Mar 2007	A1
20070060871	Istoc	Mar 2007	A1
20070061393	Moore	Mar 2007	A1
20070065363	Dalal et al.	Mar 2007	A1
20070073419	Sesay	Mar 2007	A1
20070078314	Grounsell	Apr 2007	A1
20070083870	Kanakogi	Apr 2007	A1
20070088333	Levin et al.	Apr 2007	A1
20070093786	Goldsmith et al.	Apr 2007	A1
20070100665	Brown	May 2007	A1
20070100667	Bardy	May 2007	A1
20070106126	Mannheimer et al.	May 2007	A1
20070112298	Mueller et al.	May 2007	A1
20070116037	Moore	May 2007	A1
20070118405	Campbell et al.	May 2007	A1
20070135866	Baker et al.	Jun 2007	A1
20070136098	Smythe et al.	Jun 2007	A1
20070142822	Remde	Jun 2007	A1
20070156282	Dunn	Jul 2007	A1
20070156452	Batch	Jul 2007	A1
20070169008	Varanasi et al.	Jul 2007	A1
20070179448	Lim et al.	Aug 2007	A1
20070186923	Poutiatine et al.	Aug 2007	A1
20070191817	Martin	Aug 2007	A1
20070191973	Holzbauer et al.	Aug 2007	A1
20070213657	Jennewine et al.	Sep 2007	A1
20070213684	Hickle et al.	Sep 2007	A1
20070214003	Holland et al.	Sep 2007	A1
20070215545	Bissler et al.	Sep 2007	A1
20070232867	Hansmann	Oct 2007	A1
20070233035	Wehba et al.	Oct 2007	A1
20070233049	Wehba et al.	Oct 2007	A1
20070233206	Frikart	Oct 2007	A1
20070233520	Wehba et al.	Oct 2007	A1
20070240215	Flores	Oct 2007	A1
20070251835	Mehta et al.	Nov 2007	A1
20070253021	Mehta et al.	Nov 2007	A1
20070254593	Jollota et al.	Nov 2007	A1
20070255125	Moberg et al.	Nov 2007	A1
20070257788	Carlson	Nov 2007	A1
20070258395	Jollota et al.	Nov 2007	A1
20070299687	Palmer et al.	Dec 2007	A1
20070299695	Jung et al.	Dec 2007	A1
20080001771	Faoro et al.	Jan 2008	A1
20080004904	Tran	Jan 2008	A1
20080009684	Corsetti et al.	Jan 2008	A1
20080033361	Evans et al.	Feb 2008	A1
20080033966	Wahl	Feb 2008	A1
20080034323	Blomquist	Feb 2008	A1
20080041942	Aissa	Feb 2008	A1
20080052704	Wysocki	Feb 2008	A1
20080065007	Peterson et al.	Mar 2008	A1
20080065417	Jung et al.	Mar 2008	A1
20080071217	Moubayed et al.	Mar 2008	A1
20080071251	Moubayed et al.	Mar 2008	A1
20080086088	Malcolm	Apr 2008	A1
20080091466	Butler et al.	Apr 2008	A1
20080095339	Elliott	Apr 2008	A1
20080097289	Steil et al.	Apr 2008	A1
20080097552	Dicks et al.	Apr 2008	A1
20080126969	Blomquist	May 2008	A1
20080139907	Rao et al.	Jun 2008	A1
20080148047	Appenzeller et al.	Jun 2008	A1
20080149117	Raghuram	Jun 2008	A1
20080154177	Moubayed et al.	Jun 2008	A1
20080172337	Banfield et al.	Jul 2008	A1
20080184219	Matsumoto	Jul 2008	A1
20080188796	Steil et al.	Aug 2008	A1
20080214919	Harmon et al.	Sep 2008	A1
20080246748	Cassidy et al.	Oct 2008	A1
20080256305	Kwon	Oct 2008	A1
20080259926	Tavares et al.	Oct 2008	A1
20080262469	Bristol et al.	Oct 2008	A1
20080269714	Mastrototaro et al.	Oct 2008	A1
20080269723	Mastrototaro et al.	Oct 2008	A1
20080275384	Mastrototaro et al.	Nov 2008	A1
20080300572	Rankers et al.	Dec 2008	A1
20080301298	Bernardi et al.	Dec 2008	A1
20080320387	Sasaki et al.	Dec 2008	A1
20080320466	Dias	Dec 2008	A1
20090003554	Katis et al.	Jan 2009	A1
20090005703	Fasciano	Jan 2009	A1
20090005728	Weinert et al.	Jan 2009	A1
20090006061	Thukral et al.	Jan 2009	A1
20090006129	Thukral	Jan 2009	A1
20090006133	Weinert	Jan 2009	A1
20090018495	Panduro	Jan 2009	A1
20090036750	Weinstein et al.	Feb 2009	A1
20090051560	Manning et al.	Feb 2009	A1
20090054743	Stewart	Feb 2009	A1
20090054754	McMahon et al.	Feb 2009	A1
20090057399	Sajkowsky	Mar 2009	A1
20090063187	Johnson et al.	Mar 2009	A1
20090069785	Miller et al.	Mar 2009	A1
20090099867	Newman	Apr 2009	A1
20090135196	Holland et al.	May 2009	A1
20090143662	Estes et al.	Jun 2009	A1
20090149743	Barron et al.	Jun 2009	A1
20090150174	Buck et al.	Jun 2009	A1
20090150439	Gejdos et al.	Jun 2009	A1
20090150878	Pathak et al.	Jun 2009	A1
20090156991	Roberts	Jun 2009	A1
20090157695	Roberts	Jun 2009	A1
20090158274	Roberts	Jun 2009	A1
20090177146	Nesbitt et al.	Jul 2009	A1
20090177769	Roberts	Jul 2009	A1
20090177992	Rubalcaba et al.	Jul 2009	A1
20090183147	Davis et al.	Jul 2009	A1
20090209938	Aalto-Setala	Aug 2009	A1
20090210250	Prax et al.	Aug 2009	A1
20090221890	Saffer et al.	Sep 2009	A1
20090231249	Wang et al.	Sep 2009	A1
20090270833	DeBelser	Oct 2009	A1
20090275886	Blomquist et al.	Nov 2009	A1
20090275896	Kamen et al.	Nov 2009	A1
20090284691	Marhefka et al.	Nov 2009	A1
20090292340	Mass et al.	Nov 2009	A1
20090306573	Gagner et al.	Dec 2009	A1
20090326340	Wang	Dec 2009	A1
20090326516	Bangera et al.	Dec 2009	A1
20100008377	Hasti et al.	Jan 2010	A1
20100022988	Wochner	Jan 2010	A1
20100036310	Hillman	Feb 2010	A1
20100056992	Hayter	Mar 2010	A1
20100083060	Rahman	Apr 2010	A1
20100095229	Dixon et al.	Apr 2010	A1
20100121170	Rule	May 2010	A1
20100121246	Peters et al.	May 2010	A1
20100121415	Skelton et al.	May 2010	A1
20100121654	Portnoy et al.	May 2010	A1
20100121752	Banigan et al.	May 2010	A1
20100130933	Holland et al.	May 2010	A1
20100131434	Magent et al.	May 2010	A1
20100138523	Umess et al.	Jun 2010	A1
20100146137	Wu et al.	Jun 2010	A1
20100156633	Buck et al.	Jun 2010	A1
20100160854	Gauthier	Jun 2010	A1
20100160860	Celentano et al.	Jun 2010	A1
20100174266	Estes	Jul 2010	A1
20100191525	Rabenko et al.	Jul 2010	A1
20100198034	Thomas et al.	Aug 2010	A1
20100198196	Wei	Aug 2010	A1
20100200506	Ware et al.	Aug 2010	A1
20100209268	Davis	Aug 2010	A1
20100212675	Walling et al.	Aug 2010	A1
20100217621	Schoenberg	Aug 2010	A1
20100234708	Buck et al.	Sep 2010	A1
20100250732	Bucknell	Sep 2010	A1
20100271479	Heydlauf	Oct 2010	A1
20100273738	Valcke et al.	Oct 2010	A1
20100274218	Yodfat et al.	Oct 2010	A1
20100280486	Khair et al.	Nov 2010	A1
20100292634	Kircher	Nov 2010	A1
20100298765	Budiman et al.	Nov 2010	A1
20100318025	John	Dec 2010	A1
20110001605	Kiani et al.	Jan 2011	A1
20110021898	Wei et al.	Jan 2011	A1
20110028885	Eggers et al.	Feb 2011	A1
20110040158	Katz et al.	Feb 2011	A1
20110060758	Schlotterbeck et al.	Mar 2011	A1
20110071844	Cannon et al.	Mar 2011	A1
20110072379	Gannon	Mar 2011	A1
20110078253	Chan et al.	Mar 2011	A1
20110078608	Gannon et al.	Mar 2011	A1
20110093284	Dicks et al.	Apr 2011	A1
20110099313	Bolanowski	Apr 2011	A1
20110125095	Lebel et al.	May 2011	A1
20110138185	Ju et al.	Jun 2011	A1
20110166628	Jain	Jul 2011	A1
20110175728	Baker, Jr.	Jul 2011	A1
20110178462	Moberg et al.	Jul 2011	A1
20110185010	Shatsky et al.	Jul 2011	A1
20110196748	Caron et al.	Aug 2011	A1
20110231216	Fyke et al.	Sep 2011	A1
20110252230	Segre	Oct 2011	A1
20110257496	Terashima et al.	Oct 2011	A1
20110257798	Ali et al.	Oct 2011	A1
20110259954	Bartz et al.	Oct 2011	A1
20110264043	Kotnick et al.	Oct 2011	A1
20110264044	Bartz et al.	Oct 2011	A1
20110266221	Ware et al.	Nov 2011	A1
20110270045	Lebel et al.	Nov 2011	A1
20110275904	Lebel et al.	Nov 2011	A1
20110286457	Ee	Nov 2011	A1
20110289314	Whitcomb	Nov 2011	A1
20110289497	Kiaie et al.	Nov 2011	A1
20110295196	Chazot et al.	Dec 2011	A1
20110295341	Estes et al.	Dec 2011	A1
20110296051	Vange	Dec 2011	A1
20110296411	Tang et al.	Dec 2011	A1
20110313789	Karmen et al.	Dec 2011	A1
20110319813	Kamen et al.	Dec 2011	A1
20110320049	Chossat et al.	Dec 2011	A1
20120005680	Dolby et al.	Jan 2012	A1
20120011253	Friedman et al.	Jan 2012	A1
20120016305	Jollota	Jan 2012	A1
20120029941	Malave et al.	Feb 2012	A1
20120036102	Fletcher et al.	Feb 2012	A1
20120036550	Rodriguez	Feb 2012	A1
20120066501	Xiong	Mar 2012	A1
20120070045	Vesper et al.	Mar 2012	A1
20120095437	Hemmerling	Apr 2012	A1
20120112903	Kaib et al.	May 2012	A1
20120130198	Beaule	May 2012	A1
20120143116	Ware et al.	Jun 2012	A1
20120150556	Galasso et al.	Jun 2012	A1
20120157920	Flachbart et al.	Jun 2012	A1
20120179135	Rinehart et al.	Jul 2012	A1
20120179136	Rinehart et al.	Jul 2012	A1
20120185267	Kamen et al.	Jul 2012	A1
20120203177	Lanier	Aug 2012	A1
20120245554	Kawamura	Sep 2012	A1
20120259978	Petersen et al.	Oct 2012	A1
20120260012	Gao-Saari et al.	Oct 2012	A1
20120277716	Ali et al.	Nov 2012	A1
20120283630	Lee et al.	Nov 2012	A1
20120284734	McQuaid et al.	Nov 2012	A1
20120323212	Murphy	Dec 2012	A1
20120330380	Corndorf	Dec 2012	A1
20130006666	Schneider	Jan 2013	A1
20130006702	Wu	Jan 2013	A1
20130012877	Debelser et al.	Jan 2013	A1
20130012879	Debelser et al.	Jan 2013	A1
20130012880	Blomquist	Jan 2013	A1
20130015980	Evans et al.	Jan 2013	A1
20130036403	Geist	Feb 2013	A1
20130036412	Birtwhistle et al.	Feb 2013	A1
20130066265	Grant	Mar 2013	A1
20130072872	Yodfat et al.	Mar 2013	A1
20130091350	Gluck	Apr 2013	A1
20130096444	Condurso et al.	Apr 2013	A1
20130096648	Benson	Apr 2013	A1
20130102963	Marsh et al.	Apr 2013	A1
20130114594	Van Zijst	May 2013	A1
20130116578	An	May 2013	A1
20130133083	Kurumai	May 2013	A1
20130138452	Cork et al.	May 2013	A1
20130144206	Lee et al.	Jun 2013	A1
20130150824	Estes et al.	Jun 2013	A1
20130167245	Birtwhistle et al.	Jun 2013	A1
20130173473	Birtwhistle	Jul 2013	A1
20130191770	Bartz et al.	Jul 2013	A1
20130204188	Kamen et al.	Aug 2013	A1
20130218080	Peterfreund et al.	Aug 2013	A1
20130274669	Stempfle et al.	Oct 2013	A1
20130275539	Gross et al.	Oct 2013	A1
20130291116	Homer	Oct 2013	A1
20130296823	Melker et al.	Nov 2013	A1
20130296984	Burnett et al.	Nov 2013	A1
20130317753	Kamen et al.	Nov 2013	A1
20130346108	Kamen et al.	Dec 2013	A1
20140025392	Chandrasenan	Jan 2014	A1
20140108783	Suzuki	Apr 2014	A1
20140142540	Imhof	May 2014	A1
20140142963	Hill et al.	May 2014	A1
20140163517	Finan et al.	Jun 2014	A1
20140172994	Raumann et al.	Jun 2014	A1
20140180711	Kamen et al.	Jun 2014	A1
20140194817	Lee	Jul 2014	A1
20140197950	Shupp et al.	Jul 2014	A1
20140215490	Mathur et al.	Jul 2014	A1
20140257251	Bush et al.	Sep 2014	A1
20140266790	Al-Ali et al.	Sep 2014	A1
20140266794	Brown	Sep 2014	A1
20140269643	Sun	Sep 2014	A1
20140276571	Ludolph	Sep 2014	A1
20140280522	Watte	Sep 2014	A1
20140288947	Simpson et al.	Sep 2014	A1
20140294177	Shastry et al.	Oct 2014	A1
20140297329	Rock	Oct 2014	A1
20140316819	Dunsirn et al.	Oct 2014	A1
20140318639	Peret et al.	Oct 2014	A1
20140366878	Baron	Dec 2014	A1
20140371543	Steinhauer et al.	Dec 2014	A1
20150005935	Bae et al.	Jan 2015	A1
20150006907	Brouwer et al.	Jan 2015	A1
20150045729	Denzer et al.	Feb 2015	A1
20150058960	Schmoyer et al.	Feb 2015	A1
20150066531	Jacobson et al.	Mar 2015	A1
20150081894	Blomquist	Mar 2015	A1
20150100038	McCann et al.	Apr 2015	A1
20150100787	Westin et al.	Apr 2015	A1
20150117234	Raman et al.	Apr 2015	A1
20150151051	Tsoukalis	Jun 2015	A1
20150161354	Blomquist	Jun 2015	A1
20150199192	Borges et al.	Jul 2015	A1
20150199485	Borges et al.	Jul 2015	A1
20150220890	Seshadri	Aug 2015	A1
20150230760	Schneider	Aug 2015	A1
20150281128	Sindhu	Oct 2015	A1
20150325064	Downey	Nov 2015	A1
20150328396	Adams et al.	Nov 2015	A1
20150352301	Stedman et al.	Dec 2015	A1
20150371004	Jones	Dec 2015	A1
20150379237	Mills et al.	Dec 2015	A1
20160001003	Perazzo et al.	Jan 2016	A1
20160006695	Prodoehl et al.	Jan 2016	A1
20160015885	Pananen et al.	Jan 2016	A1
20160034655	Gray et al.	Feb 2016	A1
20160045661	Gray et al.	Feb 2016	A1
20160051749	Istoc	Feb 2016	A1
20160063471	Kobres et al.	Mar 2016	A1
20160158437	Biasi et al.	Jun 2016	A1
20160228633	Welsch et al.	Aug 2016	A1
20160241391	Fenster	Aug 2016	A1
20160277152	Xiang et al.	Sep 2016	A1
20160285876	Perez et al.	Sep 2016	A1
20160317742	Gannon et al.	Nov 2016	A1
20160350513	Jacobson et al.	Dec 2016	A1
20160378618	Cmielowski	Dec 2016	A1
20170034277	Jackson et al.	Feb 2017	A1
20170063559	Wallrabenstein	Mar 2017	A1
20170099148	Ochmanski et al.	Apr 2017	A1
20170104645	Wooton et al.	Apr 2017	A1
20170111301	Robinson	Apr 2017	A1
20170146381	Eckel et al.	May 2017	A1
20170149567	Moskal	May 2017	A1
20170149929	Moskal	May 2017	A1
20170214762	Swain et al.	Jul 2017	A1
20170258401	Volpe	Sep 2017	A1
20170258986	Tsoiukalis	Sep 2017	A1
20170262590	Karakosta et al.	Sep 2017	A1
20170274140	Howard et al.	Sep 2017	A1
20170286637	Arrizza et al.	Oct 2017	A1
20170319780	Belkin et al.	Nov 2017	A1
20170325091	Freeman et al.	Nov 2017	A1
20170351841	Moskal	Dec 2017	A1
20180063724	Zhang et al.	Mar 2018	A1
20180121613	Connely, IV et al.	May 2018	A1
20180122502	Jones et al.	May 2018	A1
20180126067	Ledford et al.	May 2018	A1
20180157821	Fan	Jun 2018	A1
20180181712	Ensey et al.	Jun 2018	A1
20180247712	Muhsin et al.	Aug 2018	A1
20180272117	Fangrow	Sep 2018	A1
20180278594	Schiffman et al.	Sep 2018	A1
20180317826	Muhsin et al.	Nov 2018	A1
20180322948	Drost et al.	Nov 2018	A1
20180359085	Dervyn	Dec 2018	A1
20190006044	Brask	Jan 2019	A1
20190030329	Hannaman et al.	Jan 2019	A1
20190036688	Wasily et al.	Jan 2019	A1
20190096518	Pace	Mar 2019	A1
20190132196	Trivedi et al.	May 2019	A1
20190147998	Ruchti et al.	May 2019	A1
20190166501	Debates et al.	May 2019	A1
20190172590	Vesto et al.	Jun 2019	A1
20190207965	Espinosa	Jul 2019	A1
20190228863	Dharwad et al.	Jul 2019	A1
20190229982	Ikuta et al.	Jul 2019	A1
20190240405	Wehba et al.	Aug 2019	A1
20190243829	Butler et al.	Aug 2019	A1
20190244689	Atkin	Aug 2019	A1
20190245942	Moskal	Aug 2019	A1
20190269852	Kohlbrecher	Sep 2019	A1
20190311803	Kohlbrecher et al.	Oct 2019	A1
20190348160	Heavelyn et al.	Nov 2019	A1
20190392929	Gassman	Dec 2019	A1
20200023127	Simpson et al.	Jan 2020	A1
20200027541	Xavier et al.	Jan 2020	A1
20200027542	Xavier et al.	Jan 2020	A1
20200027543	Xavier et al.	Jan 2020	A1
20200027548	Xavier et al.	Jan 2020	A1
20200027549	Xavier et al.	Jan 2020	A1
20200027550	Xavier et al.	Jan 2020	A1
20200027551	Xavier et al.	Jan 2020	A1
20200028914	Xavier et al.	Jan 2020	A1
20200035346	Xavier et al.	Jan 2020	A1
20200035355	Xavier et al.	Jan 2020	A1
20200054825	Kamen et al.	Feb 2020	A1
20200061291	Day et al.	Feb 2020	A1
20200153627	Wentz	May 2020	A1
20200206413	Silkaitis et al.	Jul 2020	A1
20200220865	Finger et al.	Jul 2020	A1
20200282139	Susi	Sep 2020	A1
20200306443	Day	Oct 2020	A1
20200330685	Day	Oct 2020	A1
20200334497	Barrett et al.	Oct 2020	A1
20200335194	Jacobson et al.	Oct 2020	A1
20200351376	Moskal	Nov 2020	A1
20200353167	Vivek et al.	Nov 2020	A1
20200353168	Keenan et al.	Nov 2020	A1
20210014259	Harris et al.	Jan 2021	A1
20210043296	Xavier et al.	Feb 2021	A1
20210045640	Poltorak	Feb 2021	A1
20210085855	Belkin et al.	Mar 2021	A1
20210098106	Kohlbrecher et al.	Apr 2021	A1
20210098107	Xavier et al.	Apr 2021	A1
20210105206	Jha et al.	Apr 2021	A1
20210252210	Day et al.	Aug 2021	A1
20210358603	Xavier et al.	Nov 2021	A1
20210375421	Ruchti et al.	Dec 2021	A1
20210375438	Xavier et al.	Dec 2021	A1
20210409362	Katis et al.	Dec 2021	A1
20220023535	Day	Jan 2022	A1
20220037011	Fryman	Feb 2022	A1
20220037012	Fryman	Feb 2022	A1
20220051777	Xavier et al.	Feb 2022	A1
20220062541	Kamen et al.	Mar 2022	A1
20220129452	Butler et al.	Apr 2022	A1
20220139536	Xavier et al.	May 2022	A1
20220139538	Xavier et al.	May 2022	A1
20220150307	Walsh et al.	May 2022	A1
20220165404	Vivek et al.	May 2022	A1
20220189605	Kelly et al.	Jun 2022	A1
20220223283	Biasi et al.	Jul 2022	A1
20220328175	Arrizza et al.	Oct 2022	A1
20220331513	Howard et al.	Oct 2022	A1
20220384059	Xavier et al.	Dec 2022	A1
20230009405	Xavier et al.	Jan 2023	A1
20230009417	Xavier et al.	Jan 2023	A1
20230139360	Kohlbrecher et al.	May 2023	A1
20230145267	Xavier et al.	May 2023	A1
20230147762	Xavier et al.	May 2023	A1
20230166026	Jacobson et al.	Jun 2023	A1
20230188465	Jha et al.	Jun 2023	A1
20230253108	Dharwad et al.	Aug 2023	A1
20230285660	Day et al.	Sep 2023	A1
20230298768	Jacobson et al.	Sep 2023	A1
20230320935	Tagliamento	Oct 2023	A1
20230321350	Day	Oct 2023	A1
20230321351	Wehba et al.	Oct 2023	A1
20230326570	Kohlbrecher	Oct 2023	A1
20240038358	Xavier et al.	Feb 2024	A1

Foreign Referenced Citations (171)

Number	Date	Country
2004226440	Oct 2004	AU
2004305087	Jul 2005	AU
2 060 151	Aug 1997	CA
2 125 300	Oct 1999	CA
2 630 102	Oct 2008	CA
2 687 587	Dec 2008	CA
2 897 897	Jul 2014	CA
2 898 825	Jul 2014	CA
2 900 564	Oct 2014	CA
2 606 968	Jan 2020	CA
1759398	Apr 2006	CN
102521474	Jun 2012	CN
103816582	May 2014	CN
103920206	Jul 2014	CN
102300501	Apr 2015	CN
104487976	Apr 2015	CN
107810536	Jan 2023	CN
01110843	Aug 2003	CO
31 12 762	Jan 1983	DE
34 35 647	Jul 1985	DE
198 44 252	Mar 2000	DE
199 32 147	Jan 2001	DE
103 52 456	Jul 2005	DE
0 319 267	Jun 1989	EP
0 380 061	Aug 1990	EP
0 384 155	Aug 1990	EP
0 460 533	Dec 1991	EP
0 564 127	Jun 1993	EP
0 633 035	Jan 1995	EP
0 652 528	May 1995	EP
0 672 427	Sep 1995	EP
0 683 465	Nov 1995	EP
0 880 936	Dec 1998	EP
1 050 993	Nov 2000	EP
1 157 711	Nov 2001	EP
1 174 817	Jan 2002	EP
0 664 102	Apr 2002	EP
1 197 178	Apr 2002	EP
0 830 775	Aug 2002	EP
1 500 025	Apr 2003	EP
1 487 171	Jul 2007	EP
1 933 497	Jun 2008	EP
2 026 223	Feb 2009	EP
2 113 842	Nov 2009	EP
2 228 004	Sep 2010	EP
2 243 506	Oct 2010	EP
2 410 448	Jan 2012	EP
2 742 961	Jun 2014	EP
2 874 087	May 2015	EP
2 371 995	Jan 2012	ES
2 717 919	Sep 1995	FR
2 285 135	Jun 1995	GB
04-161139	Jun 1992	JP
07-502678	Mar 1995	JP
11-500643	Jan 1999	JP
2000-316820	Nov 2000	JP
2002-531154	Sep 2002	JP
2003-016183	Jan 2003	JP
2003-296173	Oct 2003	JP
2003-308586	Oct 2003	JP
2005-021463	Jan 2005	JP
2005-527284	Sep 2005	JP
2005-284846	Oct 2005	JP
2006-047319	Feb 2006	JP
2006-520949	Sep 2006	JP
2007-518479	Jul 2007	JP
2007-525256	Sep 2007	JP
2008-080036	Apr 2008	JP
2008-516303	May 2008	JP
2008-158622	Jul 2008	JP
2008-529675	Aug 2008	JP
2009-163534	Jul 2009	JP
2010-502361	Jan 2010	JP
2011-506048	Mar 2011	JP
2012-011204	Jan 2012	JP
2012-070991	Apr 2012	JP
2012-523895	Oct 2012	JP
2014-068283	Apr 2014	JP
5647644	Jan 2015	JP
200426656	Dec 2004	TW
I631966	Aug 2018	TW
WO 84001719	May 1984	WO
WO 91016416	Oct 1991	WO
WO 92010985	Jul 1992	WO
WO 92013322	Aug 1992	WO
WO 94005355	Mar 1994	WO
WO 96008755	Mar 1996	WO
WO 96025186	Aug 1996	WO
WO 96025963	Aug 1996	WO
WO 98012670	Mar 1998	WO
WO 98019263	May 1998	WO
WO 99051003	Oct 1999	WO
WO 00013580	Mar 2000	WO
WO 00053243	Sep 2000	WO
WO 01014974	Mar 2001	WO
WO 01033484	May 2001	WO
WO 01045014	Jun 2001	WO
WO 01083007	Nov 2001	WO
WO 02005702	Jan 2002	WO
WO 02036044	May 2002	WO
WO 02049153	Jun 2002	WO
WO 02049279	Jun 2002	WO
WO 02069099	Sep 2002	WO
WO 02081015	Oct 2002	WO
WO 02088875	Nov 2002	WO
WO 03006091	Jan 2003	WO
WO 03023551	Mar 2003	WO
WO 03050917	Jun 2003	WO
WO 03091836	Nov 2003	WO
WO 03094092	Nov 2003	WO
WO 2004060455	Jul 2004	WO
WO 2004070557	Aug 2004	WO
WO 2004070562	Aug 2004	WO
WO 2004072828	Aug 2004	WO
WO 2005036447	Apr 2005	WO
WO 2005050526	Jun 2005	WO
WO 2005057175	Jun 2005	WO
WO 2005066872	Jul 2005	WO
WO 2007087443	Aug 2007	WO
WO 2007117705	Oct 2007	WO
WO 2007127879	Nov 2007	WO
WO 2007127880	Nov 2007	WO
WO 2008064254	May 2008	WO
WO 2008067245	Jun 2008	WO
WO 2008082854	Jul 2008	WO
WO 2008088490	Jul 2008	WO
WO 2008097316	Aug 2008	WO
WO 2008103915	Aug 2008	WO
WO 2008124478	Oct 2008	WO
WO 2008134146	Nov 2008	WO
WO 2009016504	Feb 2009	WO
WO 2009023406	Feb 2009	WO
WO 2009023407	Feb 2009	WO
WO 2009023634	Feb 2009	WO
WO 2009036327	Mar 2009	WO
WO 2009049252	Apr 2009	WO
WO 2010017279	Feb 2010	WO
WO 2010033919	Mar 2010	WO
WO 2010053703	May 2010	WO
WO 2010075371	Jul 2010	WO
WO 2010099313	Sep 2010	WO
WO 2010114929	Oct 2010	WO
WO 2010119409	Oct 2010	WO
WO 2010124127	Oct 2010	WO
WO 2010130992	Nov 2010	WO
WO 2010135646	Nov 2010	WO
WO 2010135654	Nov 2010	WO
WO 2010135686	Nov 2010	WO
WO 2011005633	Jan 2011	WO
WO 2011022549	Feb 2011	WO
WO 2012048833	Apr 2012	WO
WO 2012049214	Apr 2012	WO
WO 2012049218	Apr 2012	WO
WO 2012120078	Sep 2012	WO
WO 2012140547	Oct 2012	WO
WO 2012164556	Dec 2012	WO
WO 2012170942	Dec 2012	WO
WO 2013045506	Apr 2013	WO
WO 2014100736	Jun 2014	WO
WO 2014131729	Sep 2014	WO
WO 2014131730	Sep 2014	WO
WO 2015047595	Apr 2015	WO
WO 2015124569	Aug 2015	WO
WO 2016179389	Nov 2016	WO
WO 2019219290	Nov 2019	WO
WO 00003344	Jan 2020	WO
WO 2020227403	Nov 2020	WO
WO 2021201884	Oct 2021	WO
WO 2022006014	Jan 2022	WO
WO 2022051230	Mar 2022	WO
WO 2023159134	Aug 2023	WO

Non-Patent Literature Citations (129)

Entry
Sethia et al., “Security Framework for Portable NFC Mobile Based Health Record System”, Oct. 2016, IEEE 12th International Conference on Wireless and Mobile Computing, Networking and Communications, pp. 1-8 (Year: 2016).
Block, Alexander, “Secret Sharing and 1-11 Threshold Signatures with BLS”, Jul. 2, 2018, https://blog.dash.org/secret-sharing-and-threshold-signatures-with-bls-954d1587b5f, in 8 pages.
Murphy, Robert, “The Design of Safety-Critical Medical Infusion Devices”, May 30, 2007, Doctor of Philosophy submission, p. 317.
Nojoumian et al., “Social Secret Sharing in Cloud Computing Using a New Trust Function”, 2012 Tenth Annual International Conference on Privacy, Security and Trust, pp. 161-167.
Rahmani et al., “Smart e-Health Gateway: Bringing Intelligence to Internet-of-Things Based Ubiquitous Healthcare Systems”, 2015 12th Annual IEEE Consumer Communications and Networking Conference (CCNC), Jul. 2015, pp. 826-834.
Yoo et al., “Code-Based Authentication Scheme for Lightweight Integrity Checking of Smart Vehicles”, IEEE Access, 2018, vol. 6, pp. 46731-46741.
Ahn et al., “Towards Scalable Authentication in Health Services”, Eleventh IEEE International Workshops on Enabling Technologies: Infrastructure for Collaborative Enterprises, Jun. 2002, pp. 83-88.
Akridge, Jeannie, “New Pumps Outsmart User Error”, Healthcare Purchasing News, Apr. 2011, pp. 10, <http://web.archive.org/web/20110426122450/http://www.hpnonline.com/inside/2011-04/1104-OR-Pumps.html>.
Alur et al., “Formal Specifications and Analysis of the Computer-Assisted Resuscitation Algorithm (CARA) Infusion Pump Control System”, International Journal on Software Tools for Technology Transfer, Feb. 2004, vol. 5, No. 4, pp. 308-319.
Aragon, Daleen RN, Ph.D., CCRN, “Evaluation of Nursing Work Effort and Perceptions About Blood Glucose Testing in Tight Glycemic Control”, American Journal of Critical Care, Jul. 2006, vol. 15, No. 4, pp. 370-377.
ASHP Advantage, “Improving Medication Safety in Health Systems Through Innovations in Automation Technology”, Proceedings of Educational Symposium and Educational Sessions during the 39th ASHP Midyear Clinical Meeting, Dec. 5-9, 2004, Orlando, FL, pp. 28.
Beard et al., “Total Quality Pain Management: History, Background, Resources”, Abbott Laboratories, TQPM Survey History, available Feb. 2015 or earlier, pp. 1-3.
Bektas et al., “Bluetooth Communication Employing Antenna Diversity”, Proceedings of Eight IEEE International Symposium on Computers and Communication, Jul. 2003, pp. 6.
Bellare et al., “Security Proofs for Identity-Based Identification and Signature Schemes”, Lecture Notes in Computer Science, Jan. 2009, vol. 22, No. 1, pp. 18.
Bequette, Ph.D., “A Critical Assessment of Algorithms and Challenges in the Development of a Closed-Loop Artificial Pancreas”, Diabetes Technology & Therapeutics, Feb. 28, 2005, vol. 7, No. 1, pp. 28-47.
Bequette, B. Wayne, Ph.D., “Analysis of Algorithms for Intensive Care Unit Blood Glucose Control”, Journal of Diabetes Science and Technology, Nov. 2007, vol. 1, No. 6, pp. 813-824.
Braun, “Infusomat® Space and Accessories”, Instructions for Use, Nov. 2010, pp. 68. <http://corp.bbraun.ee/Extranet/Infusionipumbad/Kasutusjuhendid/Vanad/Kasutusjuhend-Infusomat_Space(vers688J,inglise_k).pdf>.
Brownlee, Seth, “Product Spotlight: The Plum A+ with Hospira MedNet Infusion System”, PP&P Magazine, Dec. 2005, vol. 2, No. 7, pp. 2.
Cannon, MD et al., “Automated Heparin-Delivery System to Control Activated Partial Thromboplastin Time”, Circulation, Feb. 16, 1999, vol. 99, pp. 751-756.
Cardinal Health, “Alaris® Syringe Pumps” Technical Service Manual, Copyright 2002-2006, Issue 9, pp. 1-88, <http://www.frankshospitalworkshop.com/equipment/documents/infusion_pumps/service_manuals/Cardinal_Alaris_-_Service_Manual.pdf>.
“CareAware® Infusion Management”, Cerner Store, as printed May 12, 2011, pp. 3, <https://store.cerner.com/items/7>.
Chen et al., “Enabling Location-Based Services on Wireless LANs”, The 11th IEEE International Conference on Networks, ICON 2003, Sep. 28-Oct. 1, 2003, pp. 567-572.
“Computer Dictionary”, Microsoft Press, Third Edition, Microsoft Press, 1997, pp. 430 & 506.
“Context-Free Grammar”, Wikipedia.org, as last modified Mar. 5, 2010 in 11 pages, <https://en.wikipedia.org/w/index.php/?title=Context-free_grammar&oldid=347915989>.
Crawford, Anne J., MSN, RNC, “Building a Successful Quality Pain Service: Using Patient Satisfaction Data and the Clinical Practice Guideline”, USA, 1995, pp. 1-6.
Crocker et al., “Augmented BNF for Syntax Specifications: ABNF”, Network Working Group, Standards Track, Jan. 2008, pp. 16.
Davidson et al., “A Computer-Directed Intravenous Insulin System Shown to be Safe, Simple, and Effective in 120,618 h of Operation”, Diabetes Care, Oct. 2005, vol. 28, No. 10, pp. 2418-2423.
Davies, T., “Cordless Data Acquisition in a Hospital Environment”, IEE Colloquium on Cordless Computing—Systems and User Experience, 1993, pp. 4.
Dayhoff et al., “Medical Data Capture and Display: The Importance of Clinicians' Workstation Design”, AMIA, Inc., 1994, pp. 541-545.
Diabetes Close Up, Close Concerns AACE Inpatient Management Conference Report, Consensus Development Conference on Inpatient Diabetes and Metabolic Control, Washington, D.C., Dec. 14-16, 2003, pp. 1-32.
Doesburg et al., “Improved Usability of a Multi-Infusion Setup Using a Centralized Control Interface: A Task-Based Usability Test”, Aug. 11, 2017, PLoS ONE, vol. 12, No. 8, pp. 10.
“Download”, Free On-Line Dictionary of Computing, as archived Jun. 16, 2010 in 1 page, http://web.archive.org/web/20100616010314/https://foldoc.org/download.
East PhD et al., “Digital Electronic Communication Between ICU Ventilators and Computers and Printers”, Respiratory Care, Sep. 1992, vol. 37, No. 9, pp. 1113-1122.
Edworthy, Judy, “Medical Audible Alarms: A Review”, Journal of the American Medical Informatics Association, vol. 20, No. 3, 2013, pp. 584-589.
Einhorn, George W., “Total Quality Pain Management: A Computerized Quality Assessment Tool for Postoperative Pain Management”, Abbott Laboratories, Chicago, IL, Mar. 2, 2000, pp. 1-4.
Eskew et al., “Using Innovative Technologies to Set New Safety Standards for the Infusion of Intravenous Medications”, Hospital Pharmacy, 2002, vol. 37, No. 11, pp. 1179-1189.
Felleiter et al., “Data Processing in Prehospital Emergency Medicine”, International journal of Clinical Monitoring and Computing, Feb. 1995, vol. 12, No. 1, pp. 37-41.
“File Verification”, Wikipedia.org, as last modified Oct. 11, 2011 in 2 pages, <https://en.wikipedia.org/w/index.php?title=File_verification&oldid=455048290>.
Fogt et al., Development and Evaluation of a Glucose Analyzer for a Glucose-Controlled Insulin Infusion System (Biostator®), Clinical Chemistry, 1978, vol. 24, No. 8, pp. 1366-1372.
Gabel et al., “Camp: A Common API for Measuring Performance”, 21st Large Installations System Administration Conference (LISA '07), 2007, pp. 49-61.
Gage et al., “Automated Anesthesia Surgery Medical Record System”, International Journal of Clinical Monitoring and Computing, Dec. 1990, vol. 7, No. 4, pp. 259-263.
Galt et al., “Personal Digital Assistant-Based Drug Information Sources: Potential to Improve Medication Safety”, Journal of Medical Library Association, Apr. 2005, vol. 93, No. 2, pp. 229-236.
Gardner, Ph.D. et al., “Real Time Data Acquisition: Recommendations for the Medical Information Bus (MIB)”, 1992, pp. 813-817.
“General-Purpose Infusion Pumps”, Health Devices, EXRI Institute, Oct. 1, 2002, vol. 31, No. 10, pp. 353-387.
Givens et al., “Exploring the Internal State of User Interfaces by Combining Computer Vision Techniques with Grammatical Inference”, Proceedings of the 2013 International Conference on Software Engineering, San Francisco, CA, May 18-26, 2013, pp. 1165-1168.
Glaeser, “A Hierarchical Minicomputer System for Continuous Post-Surgical Monitoring”, Computers and Biomedical Research, Aug. 31, 1975, pp. 336-361.
Goldberg et al., “Clinical Results of an Updated Insulin Infusion Protocol in Critically Ill Patients”, Diabetes Spectrum, 2005, vol. 18, No. 3, pp. 188-191.
Gomez et al., “CLAM: Connection-Less, Lightweight, and Multiway Communication Support for Distributed Computing”, Computer Science, 1997, vol. 1199, pp. 227-240.
“GPS Tracker for Medical Equipment”, <http://www.trackingsystem.com/forbusinesses/corporate-trackingsystem/1098-gps-tracker-formedicalequipment.html>, Mar. 15, 2015, pp. 2.
Graseby, “Model 3000/500 and Micro 3100/505: Volumetric Infusion Pump”, Technical Service Manual, Graseby Medical Ltd., Apr. 2002, Issue A, pp. 160.
Graseby, “Model 3000/500 and Micro 3100/505: Volumetric Infusion Pump: Illustrated Parts List for Pump Serial Numbers from 3000 to 59,999”, Technical Service Manual, Graseby Medical Ltd., Apr. 2002, Issue A, pp. 71.
Gutwin et al., “Gone but Not Forgotten: Designing for Disconnection in Synchronous Groupware”, CSCW 2010, Feb. 6-10, 2010, Savannah, Georgia, USA., pp. 179-188.
Halpern et al., “Changes in Critical Care Beds and Occupancy in the United States 1985-2000: Differences Attributable to Hospital Size”, Critical Care Medical, Aug. 2006, vol. 34, No. 8, pp. 2105-2112.
Hamann et al., “Pumpsim: A Software Package for Simulating Computer-Controlled Drug Infusion Pumps”, Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 1990, vol. 12, No. 5, pp. 2019-2020.
Hasegawa et al., “On a Portable Memory Device for Physical Activities and Informations of Maternal Perception”, Journal of Perinatal Medicine, 1988, vol. 16, No. 4, pp. 349-356.
Hawley et al., “Clinical Implementation of an Automated Medical Information Bus in an Intensive Care Unit”, Proceedings of the Annual Symposium on Computer Application in Medical Care, Nov. 9, 1988, pp. 621-624.
Hayes-Roth et al., “Guardian: A Prototype Intelligent Agent for Intensive-Care Monitoring”, Artificial Intelligence in Medicine, vol. 4, Dec. 31, 1992, pp. 165-185.
Hospira, GemStar® Pain Management Infusion System 9-084-PR1-2-2, <www.hospira.com/products/gemstar_painmanagement.aspx>, Jan. 28, 2010, pp. 1-2.
Huang et al., “Secure Identity-Based Data Sharing and Profile Matching for Mobile Healthcare Social Networks in Cloud Computing”, vol. 6, Jul. 2018, pp. 36584-36594.
Introducing Abbott TQPM (Total Quality Pain Management), Abbott Laboratories, Abbott Park, IL, May 2000, pp. 1-4.
“Infusion Pump”, Wikipedia.org, as last modified Mar. 27, 2014, in 3 pages, <https://web.archive.org/web/20140703024932/https://en.wikipedia.org/wiki/Infusion_pump>.
Isaka et al., “Control Strategies for Arterial Blood Pressure Regulation”, IEEE Transactions on Biomedical Engineering, Apr. 1993, vol. 40, No. 4, pp. 353-363.
Johnson et al., “Using BCMA Software to Improve Patient Safety in Veterans Administration Medical Centers”, Journal of Healthcare Information Management, Dec. 6, 2004, vol. 16, No. 1, pp. 46-51.
Kent Displays, “Reflex™ Electronic Skins”, Product Brief 25127B, 2009, pp. 2.
Kent Displays, “Reflex Electronic Skins Engineering Evaluation Kit”, 25136A, Mar. 10, 2009.
Lefkowitz et al., “A Trial of the Use of Bar Code Technology to Restructure a Drug Distribution and Administration System”, Hospital Pharmacy, Mar. 31, 1991, vol. 26, No. 3, pp. 239-242.
Lenssen et al., “Bright Color Electronic Paper Technology and Applications”, IDS '09 Publication EP1-2 (Phillips Research), 2009, pp. 529-532.
Leveson, Nancy, “Medical Devices: The Therac-25”, Appendix A, University of Washington, 1995, pp. 49.
Li et al., “Hijacking an Insulin Pump: Security Attacks and Defenses for a Diabetes Therapy System”, 2011 IEEE 13th International Conference on e-Health Networking, Applications and Services, 2011, pp. 150-156.
Linkens, D.A. “Computer Control for Patient Care”, Computer Control of Real-Time Processes, IEE Control Engineering Series 41, 1990, Ch. 13, pp. 216-238.
Mako Hill et al., “The Official Ubuntu Book”, Shoeisha Co., Ltd., 1st Edition, Jun. 11, 2007, pp. 115 to 125.
Marshall, et al., “New Microprocessor-Based Insulin Controller”, IEEE Transactions on Biomedical Engineering, Nov. 1983, vol. BME-30, No. 11, pp. 689-695.
Martino et al., “Automation of a Medical Intensive Care Environment with a Flexible Configuration of Computer Systems”, Proceedings of the Annual Symposium on Computer Application in Medical Care, Nov. 5, 1980, vol. 3, pp. 1562-1568.
Matsunaga et al., “On the Use of Machine Learning to Predict the Time and Resources Consumed by Applications”, 2010 10th IEEE/ACM International Conference on Cluster, Cloud and Grid Computing (CCGrid), May 17-20, 2010, pp. 495-504.
Mauseth et al., “Proposed Clinical Application for Tuning Fuzzy Logic Controller of Artificial Pancreas Utilizing a Personalization Factor”, Journal of Diabetes Science and Technology, Jul. 2010, vol. 4, No. 4, pp. 913-922.
“McKesson Automation and ALARIS Medical Systems Developing Point-of-Care Bar Coding Solution to Improve IV Medication Safety”, PR Newswire, NY, Dec. 9, 2002, pp. 4.
Medfusion™, “Medfusion Syringe Infusion Pump Model 4000”, Operator's Manual, Software Version V1.1, Sep. 2011, pp. 154. <http://www.medfusionpump.com/assets/literature/manuals/Operators_Manual_4000_40-5760-51A.pdf>.
Metnitz et al., “Computer Assisted Data Analysis in Intensive Care: the ICDEV Project—Development of a Scientific Database System for Intensive Care”, International Journal of Clinical Monitoring and Computing, Aug. 1995, vol. 12, No. 3, pp. 147-159.
Michienzi, Kelly, “Managing Drug Library Updates”, Pharmacy Purchasing Products, https://www.pppmag.com/article/1061, Feb. 2012, vol. 9, pp. 22-23.
Micrel Medical Devices, “MP Daily +” <http://web.archive.org/web/20130803235715/http://www.micrelmed.com/index.aspx?productid=9> as archived Aug. 3, 2013 in 1 page.
Moghissi, Etie, MD, FACP, FACE, “Hyperglycemia in Hospitalized Patients”, A Supplement to ACP Hospitalist, Jun. 15, 2008, pp. 32.
Murray, Jr. et al., “Automated Drug Identification System (during surgery)”, IEEE Proceedings of Southeastcon '91, Apr. 7-10, 1991, pp. 265.
Nicholson et al., “‘Smart’ Infusion Apparatus for Computation and Automated Delivery of Loading, Tapering, and Maintenance Infusion Regimens of Lidocaine, Procainamide, and Theophylline”, Proceedings of the Seventh Annual Symposium on Computer Applications in Medical Care, Oct. 1983, pp. 212-213.
Nolan et al., “The P1073 Medical Information Bus Standard: Overview and Benefits for Clinical Users”, 1990, pp. 216-219.
Omnilink Systems, Inc., “Portable Medical Equipment Tracking”, <http://www.omnilink.com/portablemedicalequipmenttracking/>, Mar. 15, 2015, pp. 2.
O'Shea, Kristen L., “Infusion Management: Working Smarter, Not Harder”, Hospital Pharmacy, Apr. 2013, vol. 48, No. 3, pp. S1-S14.
Package Management in Debian GNU/Linux, Debian GNU/Linux Expert Desktop Use Special, Giutsu-Hyohron Co., Ltd., First Edition, Sep. 25, 2004, pp. 183-185.
Passos et al., “Distributed Software Platform for Automation and Control of General Anaesthesia”, Eighth International Symposium on Parallel and Distributed Computing, ISPDC '09, Jun. 30-Jul. 4, 2009, pp. 8.
Philips, “IntelliSpace Event Management and IntelliVue Patient Monitoring”, Release 10, 2011, <http://incenter.medical.philips.com/doclib/enc/fetch/2000/4504/577242/577243/577247/582646/583147/8359175/Philips_Patient_Monitoring_and_IntelliSpace_Event_Management_Interoperability.pdf%3fnodeid%3d8508574%26vernum%3d-2>, pp. 2.
Pretty et al., “Hypoglycemia Detection in Critical Care Using Continuous Glucose Monitors: An in Silico Proof of Concept Analysis”, Journal of Diabetes Science and Technology, Jan. 2010, vol. 4, No. 1, pp. 15-24.
Rappoport, Arthur E., “A Hospital Patient and Laboratory machine-Readable Identification System (MRIS) Revisited”, Journal of Medical Systems, Apr. 1984, vol. 8, Nos. 1/2, pp. 133-156.
Ritchie et al., “A Microcomputer Based Controller for Neuromuscular Block During Surgery”, Annals of Biomedical Engineering, Jan. 1985, vol. 13, No. 1, pp. 3-15.
Saager et al., “Computer-Guided Versus Standard Protocol for Insulin Administration in Diabetic Patients Undergoing Cardiac Surgery”, Annual Meeting of the American Society of Critical Care Anesthesiologists, Oct. 13, 2006.
Sanders et al., “The Computer in a Programmable Implantable Medication System (PIMS)”, Proceedings of the Annual Symposium on Computer Application in Medical Care, Nov. 2, 1982, pp. 682-685.
Schilling et al., “Optimizing Outcomes! Error Prevention and Evidence-Based Practice with IV Medications”, A Pro-Ce Publication, Hospira, Inc., Feb. 6, 2012, pp. 56.
Schulze et al., “Advanced Sensors Technology Survey”, Final Report, Feb. 10, 1992, pp. 161.
Scott, et al., “Using Bar-Code Technology to Capture Clinical Intervention Data in a Hospital with a Stand-Alone Pharmacy Computer System”, Mar. 15, 1996, American Journal of Health-System Pharmacy, vol. 53, No. 6, pp. 651-654.
Sebald et al., “Numerical Analysis of a Comprehensive in Silico Subcutaneous Insulin Absorption Compartmental Model”, 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Sep. 2-6, 2009, pp. 3901-3904.
Shabot, M. Michael, “Standardized Acquisition of Bedside Data: The IEEE P1073 Medical Information Bus”, International Journal of Clinical Monitoring and Computing, vol. 6, Sep. 27, 1989, pp. 197-204.
Sheppard, Louis, Ph.D., “Automation of the Infusion of Drugs Using Feedback Control”, Journal of Cardiothoracic and Vascular Anesthesia, Feb. 28, 1989, vol. 3, No. 1, pp. 1-3.
Sheppard, Louis, Ph.D., “Computer Control of the Infusion of Vasoactive Drugs”, Annals of Biomedical Engineering, Jul. 1980, vol. 8, No. 4-6, pp. 431-444.
Sheppard, Louis, Ph.D., “The Application of Computers to the Measurement, Analysis, and Treatment of Patients Following Cardiac Surgical Procedures”, The University of Alabama in Birmingham, Oct. 31, 1977, pp. 297-300.
Sheppard, Louis, Ph.D., “The Computer in the Care of Critically Ill Patients”, Proceedings of the IEEE, Sep. 1979, vol. 67, No. 9, pp. 1300-1306.
“Sigma Spectrum: Operator's Manual”, May 15, 2008, pp. 63. <https://usme.com/content/manuals/sigma-spectrum-operator-manual.pdf>.
“Sigma Spectrum: Operator's Manual”, Oct. 2009, pp. 72. <http://static.medonecapital.com/manuals/userManuals/Sigma-Spectrum-Operator-Manual-Oct. 2009.pdf>.
Simonsen, Michael Ph.D., POC Testing, New Monitoring Strategies on Fast Growth Paths in European Healthcare Arenas, Biomedical Business & Technology, Jan. 2007, vol. 30, No. 1, pp. 1-36.
Siv-Lee et al., “Implementation of Wireless ‘Intelligent’ Pump IV Infusion Technology in a Not-for-Profit Academic Hospital Setting”, Hospital Pharmacy, Sep. 2007, vol. 42, No. 9, pp. 832-840. <http://www.thomasland.com/hpj4209-832.pdf>.
Slack, W.V., “Information Technologies for Transforming Health Care”, <https://www.andrew.cmu.edu/course/90-853/medis.dir/otadocs.dir/03ch2.pdf>, Ch. 2, 1995, pp. 29-78.
Smith, Joe, “Infusion Pump Informatics”, CatalyzeCare: Transforming Healthcare, as printed May 12, 2011, pp. 2.
Sodders, Lisa, “VA Center Keeps Medicine in Right Hands”, The Capital-Journal, Dec. 4, 1999, pp. 1-2.
“Software Versioning”, Wikipedia.org, dated Oct. 16, 2011 in 11 pages, <https://en.wikipedia.org/w/index.php?title=Software_versioning&oldid=455859110>.
Solapurkar et al., “Building Secure Healthcare Services Using OAuth 2.0 and JSON Web Token in IOT Cloud Scenario”, Dec. 2016, 2nd International Conference on Contemporary Computing and Informatics, pp. 99-10.
Stitt, F.W., “The Problem-Oriented Medical Synopsis: a Patient-Centered Clinical Information System”, Proceedings of the Annual Symposium on Computer Application in Medical Care, 1994, pp. 88-92.
Stokowski, Laura A. RN, MS, “Using Technology to Improve Medication Safety in the Newborn Intensive Care Unit”, Advances in Neonatal Care, Dec. 2001, vol. 1, No. 2, pp. 70-83.
Sutton et al., “The Syntax and Semantics of the PROforma Guideline Modeling Language”, Journal of the American Medical Informatics Association, Sep./Oct. 2003, vol. 10, No. 5, pp. 433-443.
Szeinbach et al., “Automated Dispensing Technologies: Effect on Managed Care”, Journal of Managed Care Pharmacy (JMCP), Sep./Oct. 1995, vol. 1, No. 2, pp. 121-127.
Szolovits et al., “Guardian Angel: Patient-Centered Health Information Systems”, Technical Report MIT/LCS/TR-604, Massachusetts Institute of Technology Laboratory for Computer Science, May 1994, pp. 39.
“TCG TPM v2.0 Provisioning Guidance”, Reference, Version 1, Revision 1, Mar. 15, 2017, pp. 1-43.
Van Den Berghe, M.D., Ph.D., et al., “Intensive Insulin Therapy in Critically Ill Patients”, The New England Journal of Medicine, Nov. 8, 2001, vol. 345, No. 19, pp. 1359-1367.
Van Den Berghe, M.D., Ph.D., et al., “Intensive Insulin Therapy in the Medical ICU”, The New England Journal of Medicine, Feb. 2, 2006, vol. 354, No. 5, pp. 449-461.
Van Der Maas et al., “Requirements for Medical Modeling Languages”, Journal of the American Medical Informatics Association, Mar./Apr. 2001, vol. 8, No. 2, pp. 146-162.
Villalobos et al., “Computerized System in Intensive Care medicine”, Medical Informatics, vol. 11, No. 3, 1986, pp. 269-275.
Wilkins et al., “A Regular Language: The Annotated Case Report Form”, PPD Inc., PharmaSUG2011—Paper CD18, 2011, pp. 1-9.
Ying et al., “Regulating Mean Arterial Pressure in Postsurgical Cardiac Patients. A Fuzzy Logic System to Control Administration of Sodium Nitroprusside”, IEEE Engineering in Medicine and Biology Magazine, vol. 13, No. 5, Nov.-Dec. 1994, pp. 671-677.
Yue, Ying Kwan, “A Healthcare Failure Mode and Effect Analysis on the Safety of Secondary Infusions”, Thesis, Institute of Biomaterials and Biomedical Engineering, University of Toronto, 2012, pp. 168.
Yurkonis et al., “Computer Simulation of Adaptive Drug Infusion”, IEEE Transactions on Biomedical Engineering, vol. BME-34, No. 8, Aug. 1987, pp. 633-635.
Zakariah et al., “Combination of Biphasic Transmittance Waveform with Blood Procalcitonin Levels for Diagnosis of Sepsis in Acutely Ill Patients”, Critical Care Medicine, 2008, vol. 36, No. 5, pp. 1507-1512.
International Search Report and Written Opinion received in PCT Application No. PCT/US2019/041706, dated Nov. 5, 2019 in 15 pages.
International Preliminary Report on Patentability and Written Opinion received in PCT Application No. PCT/US2019/041706, dated Jun. 11, 2020 in 6 pages.

Related Publications (1)

	Number	Date	Country
	20230410989 A1	Dec 2023	US

Provisional Applications (1)

	Number	Date	Country
	62699499	Jul 2018	US

Continuations (3)

	Number	Date	Country
Parent	17447557	Sep 2021	US
Child	18154750		US
Parent	16512224	Jul 2019	US
Child	17447557		US
Parent	PCT/US2019/041706	Jul 2019	WO
Child	16512224		US

Passing authentication token to authorize access to rest calls via web sockets

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

CPC

International Classifications

Disclaimer

Term Extension

Abstract